A O
portion O
of O
Region O
II O
also O
resembles O
part O
of O
the O
human O
c B
- I
jun I
oncoprotein O
' O
s O
leucine O
zipper O
, O
which O
in O
turn O
, O
has O
been O
demonstrated O
to O
be O
the O
heterodimerization O
site O
between O
the O
jun B
and O
fos O
oncoproteins O
. O

Influence O
of O
cyclo B
- I
oxygenase I
inhibition O
and O
of O
leukotriene O
receptor O
blockade O
on O
pulmonary O
vascular O
pressure O
/ O
cardiac O
index O
relationships O
in O
hyperoxic O
and O
in O
hypoxic O
dogs O
. O

The O
HMG B
domain I
of O
both O
HMG20 O
proteins O
is O
most O
similar O
to O
that O
of O
yeast O
NHP6A O
( O
38 O
% O
to O
42 O
% O
) O
. O

This O
strategy O
was O
used O
to O
place O
both O
the O
Tn903 O
neo O
gene O
and O
the O
Rhodosporidium O
toruloides O
phenylalanine O
ammonia O
lyase O
( O
PAL B
) O
- O
encoding O
gene O
under O
the O
transcriptional O
control O
of O
pPGK O
: O
: O
REP2 O
. O

Phosphatidylinositol B
3 I
- I
kinase I
requirement O
in O
activation O
of O
the O
ras B
/ O
C B
- I
raf I
- I
1 I
/ O
MEK B
/ O
ERK B
and O
p70 B
( O
s6k B
) O
signaling O
cascade O
by O
the O
insulinomimetic O
agent O
vanadyl O
sulfate O
. O

In O
the O
same O
period O
we O
pointed O
out O
an O
increase O
of O
hematocrit O
( O
from O
29 O
% O
to O
35 O
% O
) O
and O
of O
the O
Hb B
( O
from O
9 O
. O
3 O
to O
11 O
. O
2 O
g O
/ O
dl O
) O
. O

Cotransfection O
of O
Ets B
- I
2 I
and O
p44 B
mitogen B
- I
activated I
protein I
( I
MAP I
) I
kinase I
expression O
vectors O
strongly O
potentiated O
HB B
- O
EGF B
promoter O
activation O
in O
response O
to O
deltaRaf O
- O
1 O
: O
ER B
. O

Sequence O
analysis O
of O
the O
promoter O
region O
showed O
no O
TATA O
box O
but O
identified O
consensus O
binding O
motifs O
for O
Sp1 B
, O
CREB B
, O
and O
half O
sites O
of O
the O
estrogen O
receptor O
binding O
site O
. O

Unique O
to O
this O
system O
, O
the O
activity O
of O
TraR B
is O
negatively O
modulated O
by O
an O
antiactivator O
called O
TraM O
. O

E1A B
represses O
apolipoprotein O
AI O
enhancer O
activity O
in O
liver O
cells O
through O
a O
pRb B
- O
and O
CBP B
- O
independent O
pathway O
. O

Dominant O
negative O
Sos B
did O
not O
affect O
carbachol O
stimulation O
of O
HA B
- O
ERK2 B
but O
inhibited O
the O
stimulatory O
effect O
of O
EGF B
by O
60 O
% O
. O

Remarkably O
, O
U21 O
contains O
a O
long O
stretch O
( O
13 O
nt O
. O
) O
of O
complementarity O
to O
a O
highly O
conserved O
sequence O
in O
28S B
rRNA I
. O

Data O
from O
in O
vitro O
splicing O
assays O
, O
UV O
crosslinking O
and O
RNA O
- O
binding O
competition O
experiments O
indicates O
a O
strong O
correlation O
between O
the O
binding O
affinities O
of O
PSI O
for O
the O
SELEX O
sequences O
and O
their O
ability O
to O
modulate O
splicing O
of O
P B
element I
IVS3 O
in O
vitro O
. O

Factors O
involved O
in O
specific O
transcription O
by O
mammalian O
RNA B
polymerase I
II I
: O
purification O
, O
genetic O
specificity O
, O
and O
TATA O
box O
- O
promoter O
interactions O
of O
TFIID B
. O

CONCLUSION O
: O
Treatment O
of O
sepsis O
with O
the O
platelet B
- I
activating I
factor I
antagonist O
BB O
- O
882 O
offers O
no O
advantage O
over O
placebo O
on O
survival O
, O
hemodynamic O
status O
, O
respiratory O
function O
, O
or O
organ O
failure O
scores O
. O

Also O
, O
transient O
overexpression O
of O
this O
protein O
in O
C2C12 O
cells O
reduced O
the O
transcription O
of O
a O
CAT B
- O
reporter O
regulated O
by O
an O
E12 B
/ O
MyoD B
driven O
enhancer O
. O

CONCLUSIONS O
: O
Using O
icodextrin O
- O
based O
instead O
of O
glucose O
- O
based O
PD O
fluids O
can O
largely O
reduce O
the O
formation O
of O
Amadori O
albumin B
and O
AGEs O
. O

As O
in O
Tb O
, O
U6 B
is O
a O
single O
- O
copy O
gene O
and O
two O
tRNA O
genes O
, O
tRNAGln O
and O
tRNAIle O
, O
are O
found O
upstream O
to O
the O
gene O
. O

A O
4 O
. O
8 O
- O
kilobase O
BamHI B
- O
HindIII B
fragment O
encoding O
the O
entire O
Neurospora O
crassa O
CuZn O
superoxide O
dismutase O
gene O
( O
herein O
designated O
sod B
- I
1 I
) O
was O
isolated O
from O
a O
genomic O
library O
using O
two O
60 O
- O
base O
deoxyoligonucleotide O
probes O
corresponding O
to O
the O
published O
N O
. O
crassa O
amino O
acid O
sequence O
. O

We O
have O
previously O
shown O
that O
the O
adenoviral O
12S O
E1A O
protein O
modulates O
the O
phosphorylation O
status O
of O
p130 B
and O
p107 B
without O
apparent O
changes O
in O
the O
cell O
cycle O
dependent O
phosphorylation O
of O
the O
retinoblastoma B
protein I
. O

The O
5 O
' O
flanking O
region O
contains O
potential O
binding O
sites O
for O
TATA B
- I
binding I
protein I
, O
Sp1 B
, O
nuclear B
factor I
1 I
( O
NF1 B
) O
, O
CAAT O
- O
box O
binding O
protein O
( O
C B
/ I
EBP I
) O
, O
hepatocyte O
nuclear O
factors O
1 O
and O
5 O
( O
HNF1 B
, O
HNF5 O
) O
and O
activator O
proteins O
1 O
and O
2 O
( O
AP1 B
, O
AP2 B
) O
. O

The O
median O
post O
- O
treatment O
, O
pre O
- O
operative O
serum B
PSA I
was O
0 O
. O
4 O
ng O
/ O
ml O
. O

This O
finding O
is O
the O
first O
example O
of O
utilization O
of O
noncomplementary O
dinucleotide O
primer O
by O
an O
RNA B
polymerase I
. O

Weak O
promoter O
activity O
was O
observed O
for O
the O
promoter O
of O
the O
C1 B
and O
C2 B
ORFs O
( O
C1 B
- O
C2 B
gene O
) O
and O
for O
the O
promoter O
of O
the O
V1 O
ORF O
. O

Acute O
idiopathic O
thrombocytopenic O
purpura O
presenting O
a O
high O
serum O
level O
of O
immunoglobulin B
E I
and O
eosinophilia O
in O
an O
elderly O
patient O
. O

VDR B
/ O
RXR B
bound O
well O
to O
the O
VDREs O
and O
to O
DR4 O
and O
DR5 O
using O
the O
electrophoretic O
mobility O
shift O
assay O
. O

Targeted O
disruption O
of O
the O
OGG1 O
gene O
in O
yeast O
revealed O
a O
second O
OG O
glycosylase O
/ O
lyase O
protein O
, O
tentatively O
named O
Ogg2 O
, O
which O
differs O
from O
Ogg1 B
in O
that O
it O
preferentially O
acts O
on O
OG O
: O
G O
. O

Classical O
ligand O
- O
activated O
nuclear O
receptors O
( O
e O
. O
g O
. O
thyroid B
hormone I
receptor I
, O
retinoic B
acid I
receptor I
) O
, O
orphan B
nuclear I
receptors I
( O
e O
. O
g O
. O

To O
this O
end O
, O
an O
expression O
cassette O
consisting O
of O
the O
gene O
for O
a O
green B
fluorescent I
protein I
( O
GFP B
) O
flanked O
at O
its O
3 O
' O
end O
by O
EAV O
- O
specific O
transcription O
- O
regulating O
sequences O
was O
constructed O
. O

As O
an O
oral O
, O
nontoxic O
compound O
with O
a O
mechanism O
of O
action O
distinct O
from O
that O
of O
ABL O
tyrosine O
kinase O
inhibition O
, O
FTI O
SCH66336 O
shows O
promise O
for O
the O
treatment O
of O
BCR B
/ O
ABL B
- O
induced O
leukemia O
. O

Here O
we O
have O
examined O
the O
ability O
of O
the O
cellular O
protein O
YB B
- I
1 I
to O
modulate O
transcription O
of O
the O
HIV B
- I
1 I
promoter I
in O
a O
human O
astrocytic O
cell O
line O
( O
U O
- O
87MG O
) O
, O
a O
neuronal O
cell O
line O
( O
SK O
- O
N O
- O
MC O
) O
and O
lymphoid O
cells O
( O
Jurkat O
) O
by O
transfection O
assay O
. O

Biologically O
significant O
amounts O
of O
platelet B
activating I
factor I
were O
eluted O
from O
the O
sorbent O
during O
the O
entire O
treatment O
time O
. O

These O
results O
suggest O
that O
UBP41 O
may O
play O
an O
important O
role O
in O
the O
recycling O
of O
ubiquitin B
by O
hydrolysis O
of O
branched O
poly O
- O
ubiquitin O
chains O
generated O
by O
the O
action O
of O
26 O
S O
proteasome O
on O
poly O
- O
ubiquitinated O
protein O
substrates O
, O
as O
well O
as O
in O
the O
production O
of O
free O
ubiquitin B
from O
linear O
poly O
- O
ubiquitin O
chains O
and O
of O
certain O
ribosomal O
proteins O
from O
ubiquitin O
fusion O
proteins O
. O

Both O
Z B
and O
R B
expression O
resulted O
in O
PML O
dispersion O
in O
EBV O
- O
positive O
cells O
. O

Based O
on O
peptide O
map O
similarities O
, O
partial O
amino O
- O
terminal O
sequence O
data O
, O
and O
common O
genetic O
origin O
, O
it O
is O
suggested O
that O
p60 O
and O
p62 B
have O
identical O
amino O
acid O
sequences O
carboxy O
- O
terminal O
to O
the O
p60 O
initiator O
methionine O
( O
residue O
21 O
of O
p62 B
) O
. O

In O
order O
to O
examine O
the O
potential O
role O
of O
transcriptional O
silencing O
during O
productive O
HSV O
- O
1 O
infection O
, O
recombinant O
viruses O
were O
generated O
in O
which O
wild O
- O
type O
or O
mutant O
ICP34 O
. O
5 O
promoters O
controlling O
the O
expression O
of O
a O
chloramphenicol O
acetyltransferase O
reporter O
gene O
were O
inserted O
into O
the O
thymidine B
kinase I
gene I
of O
the O
viral O
genome O
. O

In O
patients O
with O
type O
IA O
maple O
syrup O
urine O
disease O
, O
the O
E1alpha O
subunit O
is O
affected O
, O
resulting O
in O
the O
loss O
of O
E1 B
and O
branched O
- O
chain O
ketoacid O
dehydrogenase O
catalytic O
activities O
. O

We O
have O
demonstrated O
that O
the O
activity O
of O
ILK B
is O
constitutively O
elevated O
in O
PTEN O
mutant O
cells O
. O

Members O
of O
the O
myocyte O
- O
specific O
enhancer O
- O
binding O
factor O
2 O
( O
MEF2 B
) O
family O
of O
transcription O
factors O
bind O
a O
conserved O
A O
/ O
T O
- O
rich O
sequence O
in O
the O
control O
regions O
of O
numerous O
muscle O
- O
specific O
genes O
. O

Two O
- O
dimensional O
gel O
electrophoresis O
of O
anti O
- O
p59fyn O
immunoprecipitates O
obtained O
from O
non O
- O
transformed O
resting O
human O
T O
lymphocytes O
resulted O
in O
the O
identification O
of O
an O
oligomeric O
protein O
complex O
which O
is O
constitutively O
formed O
between O
Fyn B
and O
several O
additional O
phosphoproteins O
( O
pp43 O
, O
pp72 O
, O
pp85 O
, O
the O
protein B
tyrosine I
kinase I
Pyk2 B
, O
as O
well O
as O
the O
two O
recently O
cloned O
adaptor O
proteins O
, O
SKAP55 O
and O
SLAP O
- O
130 O
) O
. O

Although O
the O
OC B
promoter I
is O
activated O
in O
a O
C O
terminus O
dependent O
manner O
, O
the O
MDR O
, O
LTR O
and O
BSP O
promoters O
are O
repressed O
by O
three O
distinct O
mechanisms O
, O
either O
independent O
of O
or O
involving O
the O
AML O
C O
terminus O
, O
or O
requiring O
only O
the O
conserved O
C O
- O
terminal O
pentapeptide O
VWRPY O
. O

E2F B
- I
1 I
is O
a O
transcription O
factor O
that O
regulates O
cell O
cycle O
progression O
into O
S O
- O
phase O
. O

Both O
toxins O
in O
a O
dose O
10 O
- O
fold O
surpassing O
the O
maximum O
permissible O
concentration O
increased O
activity O
of O
glutathione B
peroxidase I
in O
brain O
tissue O
; O
moreover O
, O
toluene O
increased O
chemiluminescence O
intensity O
, O
which O
attested O
to O
activation O
of O
free O
radical O
processes O
. O

In O
resting O
3T3 O
cells O
, O
jun O
- O
D O
is O
expressed O
at O
a O
higher O
level O
compared O
to O
c B
- I
jun I
and O
jun O
- O
B O
, O
and O
its O
transcription O
is O
stimulated O
only O
slightly O
by O
serum O
growth O
factors O
. O

A O
region O
approximately O
100 O
bp O
upstream O
from O
the O
transcription O
start O
point O
of O
virB O
was O
identified O
as O
being O
necessary O
for O
full O
activation O
of O
this O
promoter O
by O
VirF B
. O

In O
the O
last O
20 O
years O
, O
the O
therapeutic O
uses O
of O
botulinum B
toxin I
, O
a O
potent O
neurotoxin O
, O
have O
been O
investigated O
. O

AgMNPV O
and O
Orgyia O
pseudotsugata O
MNPV O
( O
OpMNPV O
) O
are O
similar O
in O
terms O
of O
promoter O
structure O
and O
polyhedrin O
primary O
sequence O
, O
and O
the O
polyhedrin B
gene I
of O
both O
viruses O
is O
transcribed O
in O
the O
anti O
- O
clockwise O
direction O
in O
relation O
to O
their O
physical O
maps O
. O

Expression O
of O
constitutively O
active O
MEK1 B
, O
the O
kinase O
that O
activates O
ERKs B
, O
or O
overexpression O
of O
ERK2 B
, O
but O
not O
JNK1 B
, O
inhibited O
Stat3 B
activation O
. O

Recent O
studies O
have O
revealed O
unconventional O
myosin O
V O
to O
be O
an O
important O
actin B
- O
based O
molecular O
motor O
involved O
in O
vesicular O
movement O
. O

EGFR B
levels O
were O
found O
to O
be O
elevated O
5 O
- O
, O
3 O
. O

It O
bound O
to O
vitamin B
D I
receptor I
( O
VDR B
) O
but O
not O
retinoic O
acid O
Xalpha O
receptor O
( O
RXRalpha B
) O
in O
the O
human O
T O
cell O
line O
MT2 O
cells O
. O

IgM B
and O
IgG O
anti O
A O
and O
anti O
B O
antibody O
status O
of O
100 O
antenatal O
O O
group O
mothers O
( O
who O
had O
non O
O O
group O
husbands O
) O
were O
studied O
. O

EMSA O
with O
crude O
nuclear O
extracts O
demonstrated O
that O
stimulation O
with O
CD40L B
results O
in O
the O
induction O
of O
NF O
- O
kappaB O
complexes O
that O
bind O
to O
each O
of O
the O
three O
NF O
- O
kappaB O
sites O
and O
are O
composed O
mainly O
of O
p50 B
and O
RelB O
, O
but O
also O
include O
c B
- I
Rel I
and O
p65 B
. O

Although O
metabolized O
by O
the O
cytochrome B
P I
- I
450 I
( O
CYP O
) O
system O
, O
venlafaxine O
inhibits O
CYP O
2D6 O
and O
3A4 O
to O
a O
far O
lesser O
extent O
than O
do O
the O
SSRIs O
. O

Collectively O
, O
the O
results O
suggest O
that O
ARF B
binding O
to O
Mdm2 B
induces O
a O
conformational O
change O
that O
facilitates O
nucleolar O
import O
of O
the O
ARF B
- O
Mdm2 B
complex O
and O
p53 B
- O
dependent O
cell O
cycle O
arrest O
. O

The O
leader O
sequence O
of O
the O
isolated O
cDNA O
clone O
contains O
several O
small O
open O
reading O
frames O
upstream O
of O
the O
initiation O
codon O
of O
the O
largest O
open O
reading O
frame O
coding O
for O
the O
homeodomain B
protein I
. O

The O
recruitment O
of O
constitutively O
phosphorylated O
p185 O
( O
neu B
) O
and O
the O
activated O
mitogenic O
pathway O
proteins O
to O
this O
membrane O
- O
microfilament O
interaction O
site O
provides O
a O
physical O
model O
for O
integrating O
the O
assembly O
of O
the O
mitogenic O
pathway O
with O
the O
transmission O
of O
growth O
factor O
signal O
to O
the O
cytoskeleton O
. O

Two O
mutants O
, O
each O
representative O
of O
a O
separate O
pet B
complementation O
group O
, O
have O
been O
analyzed O
. O

The O
levels O
of O
NPY B
- O
ir O
in O
the O
rat O
vas O
deferens O
were O
not O
affected O
by O
either O
surgical O
or O
pharmacological O
treatment O
. O

The O
diagnostic O
accuracy O
of O
serum O
PE O
- O
1 O
was O
0 O
. O
80 O
, O
and O
that O
of O
amylase B
0 O
. O
97 O
. O

These O
observations O
lead O
to O
the O
proposal O
that O
the O
RNAP O
II O
CTD O
might O
be O
an O
in O
vivo O
target O
for O
the O
activated O
p42mapk B
and O
p44mapk O
MAP O
kinases O
. O

Glomerular O
mesangial O
cells O
expressed O
an O
abundant O
1 O
. O
1 O
kb O
mRNA O
transcript O
for O
Id1 B
, O
but O
in O
contrast O
to O
other O
cell O
types O
Id1 O
mRNA O
was O
expressed O
in O
both O
randomly O
cycling O
cells O
and O
in O
serum O
- O
deprived O
, O
quiescent O
cultures O
. O

The O
overall O
results O
of O
this O
paper O
are O
consistent O
with O
the O
conclusion O
that O
the O
carboxyl O
- O
terminal O
LBD O
is O
not O
sufficient O
for O
mediating O
PR B
dimerization O
and O
that O
multiple O
regions O
, O
including O
the O
hinge O
and O
amino O
- O
terminal O
sequences O
, O
contribute O
either O
directly O
or O
indirectly O
to O
homodimerization O
of O
PR B
. O

The O
activity O
of O
the O
minimal O
promoter O
was O
found O
to O
be O
controlled O
by O
a O
combination O
of O
the O
activities O
of O
the O
transcription O
factors O
Sp1 B
, O
Sp3 B
, O
and O
NF B
- I
Y I
. O

We O
evaluated O
the O
likelihood O
of O
tissues O
to O
be O
positive O
for O
carcinoembryonic B
antigen I
and O
the O
intensity O
of O
carcinoembryonic B
antigen I
staining O
in O
specimens O
of O
villous O
adenomas O
, O
mixed O
polypoid O
villous O
adenomas O
, O
polypoid O
adenomas O
, O
and O
diverticulitis O
using O
the O
peroxidase B
- O
antiperoxidase O
technique O
. O

Mutational O
analysis O
of O
essential O
IncP O
alpha O
plasmid O
transfer O
genes O
traF B
and O
traG B
and O
involvement O
of O
traF B
in O
phage O
sensitivity O
. O

This O
study O
was O
designed O
to O
compare O
the O
efficacy O
of O
efegatran O
plus O
streptokinase O
versus O
heparin O
plus O
accelerated O
tissue B
plasminogen I
activator I
( O
TPA B
) O
in O
coronary O
reperfusion O
in O
acute O
MI O
. O

We O
used O
expression O
cloning O
to O
identify O
interleukin B
- I
6 I
( O
IL B
- I
6 I
) O
as O
one O
factor O
that O
suppressed O
growth O
of O
a O
pre O
- O
B O
- O
cell O
variant O
line O
, O
1A9 O
- O
M O
. O

Experimental O
adhesion O
prophylaxis O
with O
recombinant B
tissue I
plasminogen I
activator I
. O

One O
complex O
most O
likely O
contained O
Sp1 B
, O
and O
another O
complex O
showed O
S O
- O
phase O
- O
specific O
binding O
, O
suggesting O
a O
direct O
role O
in O
the O
cell O
- O
cycle O
- O
dependent O
R1 O
gene O
expression O
. O

We O
found O
that O
120 O
bp O
of O
the O
enhancer O
' O
s O
transcriptional O
core O
becomes O
DNase B
I I
hypersensitive O
early O
in O
B O
- O
cell O
development O
. O

Pokeweed O
antiviral O
protein O
( O
PAP B
) O
from O
Phytolacca O
americana O
is O
a O
highly O
specific O
N O
- O
glycosidase O
removing O
adenine O
residues O
( O
A4324 O
in O
28S B
rRNA I
and O
A2660 O
in O
23S O
rRNA O
) O
from O
intact O
ribosomes O
of O
both O
eukaryotes O
and O
prokaryotes O
. O

Patients O
with O
an O
enzymatic O
activity O
below O
X O
- O
- O
1 O
manifested O
a O
decrease O
of O
the O
content O
of O
IgA B
, O
IgG B
, O
IgM B
, O
T O
and O
B O
lymphocytes O
, O
and O
of O
phagocytic O
activity O
of O
neutrophils O
as O
compared O
to O
patients O
exhibiting O
a O
high O
enzymatic O
activity O
. O

Both O
carbachol O
( O
100 O
microM O
) O
and O
EGF B
( O
10 O
nM O
) O
induced O
Ras B
activation O
. O

Conversely O
, O
when O
VDR B
is O
overexpressed O
, O
vitamin O
D3 O
attenuates O
9 O
- O
cis O
RA O
induction O
from O
an O
RXR B
- O
responsive O
element O
. O

HeLa O
and O
Jurkat O
cell O
lines O
carrying O
the O
nef O
gene O
linked O
to O
the O
CMV O
promoter O
or O
the O
HIV B
- I
1 I
LTR I
were O
isolated O
by O
coselection O
for O
neomycin O
resistance O
. O

In O
canrenoate O
- O
treated O
rats O
, O
ANP B
infusion O
caused O
greater O
increases O
in O
sodium O
excretion O
( O
FENA O
from O
3 O
. O
05 O
+ O
/ O
- O
0 O
. O
71 O
to O
7 O
. O
21 O
+ O
/ O
- O
0 O
. O
45 O
% O
; O
P O
< O
0 O
. O
05 O
; O
n O
= O
8 O
) O
than O
saline O
infusion O
( O
FENA O
from O
4 O
. O
16 O
+ O
/ O
- O
1 O
. O
11 O
to O
5 O
. O
47 O
+ O
/ O
- O
0 O
. O
66 O
% O
; O
n O
= O
6 O
) O
, O
despite O
the O
hypocapnia O
. O

Serotonin B
receptors I
in O
suicide O
victims O
with O
major O
depression O
. O

Nucleotide O
sequences O
between O
the O
env B
gene I
and O
the O
LTR O
of O
SFV O
- O
1 O
were O
determined O
. O

The O
novel O
hematopoietic O
growth O
factor O
FLT3 O
ligand O
( O
FL O
) O
is O
the O
cognate O
ligand O
for O
the O
FLT3 O
, O
tyrosine B
kinase I
receptor I
( O
R B
) O
, O
also O
referred O
to O
as O
FLK O
- O
2 O
and O
STK O
- O
1 O
. O

It O
also O
suggests O
that O
there O
is O
another O
pathway O
which O
can O
activate O
SWI4 B
transcription O
in O
the O
absence O
of O
SWI6 B
. O

Oncogenic O
activation O
of O
the O
tyrosine B
kinase I
domain I
of O
the O
human O
trk O
proto O
- O
oncogene O
by O
fusion O
to O
a O
cell O
adhesion O
molecule O
. O

The O
absolute O
concentrations O
of O
alpha O
2 O
- O
plasmin O
inhibitor O
, O
alpha B
2 I
- I
macroglobulin I
, O
and O
antithrombin B
III I
increased O
with O
exercise O
( O
all O
P O
less O
than O
0 O
. O
005 O
) O
, O
but O
when O
concentrations O
were O
corrected O
for O
acute O
shifts O
of O
plasma O
water O
during O
exercise O
, O
the O
quantity O
of O
these O
inhibitors O
actually O
decreased O
( O
all O
P O
less O
than O
0 O
. O
005 O
) O
. O

Members O
of O
the O
Ras O
subfamily O
of O
small B
GTP I
- I
binding I
proteins I
have O
been O
shown O
to O
be O
promiscuous O
towards O
a O
variety O
of O
putative O
effector O
molecules O
such O
as O
the O
protein O
kinase O
c O
- O
Raf O
and O
the O
Ral O
- O
specific O
guanine O
nucleotide O
exchange O
factor O
( O
Ral O
- O
GEF O
) O
. O

Leukocyte O
cultures O
, O
prepared O
from O
blood O
drawn O
from O
these O
18 O
children O
at O
6 O
months O
of O
age O
, O
produced O
lower O
yields O
of O
IFN B
than O
those O
of O
the O
remaining O
53 O
children O
, O
when O
stimulated O
with O
adenovirus O
( O
P O
< O
0 O
. O
001 O
) O
, O
coronavirus O
( O
P O
< O
0 O
. O
001 O
) O
or O
rhinovirus O
( O
P O
= O
0 O
. O
002 O
) O
. O

In O
the O
absence O
of O
E1A243 O
, O
YY1 B
represses O
CRE O
- O
dependent O
transcription O
of O
c B
- I
fos I
by O
physically O
interacting O
with O
ATF B
/ O
CREB B
proteins O
bound O
to O
the O
- O
67 O
CRE O
. O

Moreover O
, O
the O
same O
mutations O
alter O
the O
structure O
of O
junB B
5 O
' O
flanking O
DNA O
within O
chromatin O
. O

Serial O
followup O
strength O
data O
for O
2 O
patients O
were O
compared O
to O
change O
in O
creatinine O
kinase O
( O
CK B
) O
levels O
. O

Basal O
components O
of O
the O
transcription O
apparatus O
( O
RNA B
polymerase I
II I
, O
TATA B
- I
binding I
protein I
) O
contain O
activation O
domains O
: O
is O
the O
repetitive O
C O
- O
terminal O
domain O
( O
CTD O
) O
of O
RNA B
polymerase I
II I
a O
" O
portable O
enhancer O
domain O
" O
? O

To O
determine O
the O
signal O
recognition O
particle O
( O
SRP B
) O
- O
SRP O
receptor O
( O
Srb O
) O
system O
in O
Bacillus O
subtilis O
( O
Bs O
) O
, O
we O
cloned O
the O
Bs O
srb O
gene O
, O
which O
encodes O
a O
homologue O
of O
the O
mammalian O
SRP O
receptor O
alpha O
- O
subunit O
[ O
Oguro O
et O
al O
. O
, O
DNA O
Res O
. O

We O
have O
previously O
demonstrated O
that O
expression O
of O
the O
gene O
for O
the O
reproductive O
neuropeptide O
, O
GnRH B
, O
is O
repressed O
by O
the O
glutamate O
/ O
NO O
/ O
cyclic O
GMP O
( O
cGMP O
) O
signal O
transduction O
pathway O
through O
cGMP O
- O
dependent O
protein O
kinase O
in O
the O
hypothalamic O
GnRH B
- O
secreting O
neuronal O
cell O
line O
GT1 O
- O
7 O
. O

Molecular O
cloning O
and O
characterization O
of O
a O
new O
member O
of O
the O
rat O
placental O
prolactin O
( O
PRL B
) O
family O
, O
PRL B
- O
like O
protein O
H O
. O

The O
variations O
were O
caused O
by O
opposite O
shifts O
in O
TSH B
frequency O
distribution O
in O
mothers O
and O
neonates O
. O

Cells O
containing O
alpha O
subunits O
that O
lacked O
a O
distal O
domain O
( O
term O
- O
3 O
) O
or O
had O
the O
alternatively O
spliced O
alpha O
- O
2 O
distal O
domain O
showed O
markedly O
decreased O
ability O
to O
support O
tyrosine O
phosphorylation O
of O
Jak O
- O
2 O
and O
its O
substrates O
or O
to O
up O
- O
regulate O
CD86 B
. O

Also O
, O
the O
human O
glycoprotein O
alpha O
- O
subunit O
promoter O
was O
induced O
10 O
- O
fold O
by O
FSK B
in O
GH4 O
rat O
pituitary O
cells O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

The O
differential O
investigation O
of O
lipoproteins O
, O
however O
, O
showed O
that O
the O
high B
- I
density I
lipoprotein I
( O
HDL B
) O
fractions O
are O
absolutely O
or O
relatively O
decreased O
with O
respect O
to O
low O
- O
density O
lipoproteins O
( O
LDL B
) O
in O
cerebral O
infarcts O
and O
in O
transient O
ischaemic O
attacks O
. O

Recruitment O
of O
an O
RNA O
polymerase O
II O
complex O
is O
mediated O
by O
the O
constitutive O
activation O
domain O
in O
CREB B
, O
independently O
of O
CREB B
phosphorylation O
. O

BCL B
- I
2 I
, O
an O
inhibitor O
of O
apoptosis O
in O
a O
wide O
variety O
of O
cell O
types O
, O
has O
been O
reported O
to O
prevent O
oxidative O
stress O
- O
induced O
cell O
death O
. O

These O
RZR O
subtypes O
represent O
members O
of O
a O
new O
family O
of O
orphan B
nuclear I
receptors I
that O
most O
likely O
regulate O
specific O
gene O
expression O
. O

Primary O
adrenal O
hypersensitivity O
to O
ACTH B
drive O
in O
obesity O
has O
also O
been O
suggested O
. O

Downregulation O
of O
FUS B
expression O
in O
BCR B
/ O
ABL B
- O
expressing O
32Dcl3 O
cells O
was O
associated O
with O
suppression O
of O
growth O
factor O
- O
independent O
colony O
formation O
, O
restoration O
of O
G B
- I
CSF I
- O
induced O
granulocytic O
differentiation O
and O
reduced O
tumorigenic O
potential O
in O
vivo O
. O

We O
have O
overexpressed O
, O
purified O
, O
characterized O
, O
and O
crystallized O
the O
BTB B
/ O
POZ O
domain O
from O
PLZF B
( O
PLZF B
- O
BTB B
/ O
POZ O
) O
. O

Study O
of O
antinuclear O
autoantibodies O
by O
immunofluorescence O
technic O
in O
collagen B
diseases O

Interestingly O
, O
continuation O
of O
the O
interferon B
therapy O
in O
the O
presence O
of O
a O
mild O
- O
to O
- O
moderate O
exacerbation O
of O
sarcoidosis O
may O
be O
safe O
in O
a O
minority O
of O
patients O
with O
noncritical O
organ O
involvement O
. O

Three O
of O
the O
short O
ORFs O
in O
the O
central O
region O
of O
BIV O
have O
been O
identified O
by O
location O
and O
structural O
similarity O
to O
the O
nonstructural O
/ O
regulatory O
genes O
( O
vif O
, O
tat B
, O
and O
rev B
) O
of O
other O
lentiviruses O
; O
we O
also O
discovered O
two O
unique O
ORFs O
, O
termed O
W O
and O
Y O
, O
which O
may O
serve O
as O
exons O
for O
novel O
genes O
. O

( O
2 O
) O
Erythroid O
32D O
Epo1 O
cells O
showed O
a O
lower O
level O
of O
bulk O
PKC B
catalytic O
activity O
, O
lacked O
the O
expression O
of O
epsilon O
and O
eta O
PKC O
isoforms O
, O
and O
showed O
a O
weak O
or O
absent O
upregulation O
of O
the O
remaining O
isoforms O
, O
except O
betaI O
, O
upon O
readdition O
of O
Epo B
to O
growth O
factor O
- O
starved O
cells O
. O

Removal O
of O
the O
GST O
domain O
from O
GST B
- O
Tax B
by O
thrombin B
restores O
Tax B
' O
s O
ability O
to O
assemble O
a O
ternary O
Tax B
- O
CREB B
- O
21 O
- O
bp O
- O
repeat O
complex O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

In O
the O
normal O
, O
basal O
( O
unstimulated O
) O
condition O
there O
were O
no O
significant O
correlations O
( O
p O
greater O
than O
0 O
. O
05 O
) O
between O
the O
systolic O
blood O
pressure O
and O
dopamine O
( O
r O
= O
0 O
. O
09 O
) O
, O
norepinephrine O
( O
r O
= O
0 O
. O
26 O
) O
, O
or O
epinephrine O
( O
r O
= O
0 O
. O
27 O
) O
, O
nor O
were O
there O
significant O
correlations O
between O
melatonin O
and O
dopamine O
( O
r O
= O
- O
0 O
. O
01 O
) O
, O
norepinephrine O
( O
r O
= O
- O
0 O
. O
26 O
) O
, O
or O
growth B
hormone I
( O
r O
= O
0 O
. O
17 O
) O
. O

RANTES B
( O
regulated O
upon O
activation O
, O
normally O
T O
- O
cell O
expressed O
and O
presumably O
secreted O
) O
is O
a O
CC O
chemokine O
which O
recruits O
and O
activates O
monocytes O
, O
lymphocytes O
, O
and O
eosinophils O
, O
all O
cell O
types O
present O
in O
the O
lung O
inflammatory O
infiltrate O
induced O
by O
RSV O
infection O
. O

The O
major O
promoter O
responds O
strongly O
to O
virus O
- O
encoded O
trans O
activators O
EIA B
and O
EIV O
and O
contains O
four O
elements O
: O
a O
TAGA O
motif O
analogous O
to O
the O
TATA O
box O
, O
two O
EIIF O
sites O
present O
in O
an O
inverted O
orientation O
, O
and O
an O
ATF B
/ O
CREB B
site O
. O

However O
, O
reoperation O
for O
bulky O
cervical O
disease O
( O
group O
3 O
) O
rarely O
results O
in O
normal O
calcitonin B
levels O
and O
is O
associated O
with O
a O
high O
incidence O
of O
permanent O
hypoparathyroidism O
. O

To O
confirm O
the O
GapIII O
protein O
activity O
, O
constructs O
containing O
different O
GapIII O
- O
GRD O
domains O
were O
transformed O
into O
iral O
mutant O
yeast O
to O
determine O
their O
relative O
ability O
to O
replace O
IRA1 B
functionally O
. O

These O
cell O
lines O
, O
selected O
for O
the O
ability O
to O
support O
the O
replication O
of O
a O
temperature O
- O
sensitive O
VP5 O
mutant O
, O
were O
used O
to O
isolate O
VP5 B
and O
VP23 O
null O
mutants O
. O

NF B
- I
kappaB I
, O
which O
is O
probably O
important O
for O
basal O
activity O
of O
the O
human O
NOS O
II O
promoter O
, O
is O
unlikely O
to O
function O
as O
a O
major O
effector O
of O
CM O
in O
DLD O
- O
1 O
cells O
. O

Because O
the O
Pit O
- O
1 O
sites O
in O
the O
hGH O
- O
N O
gene O
promoter O
are O
insufficient O
for O
such O
gene O
activation O
in O
vivo O
, O
these O
data O
suggested O
a O
unique O
chromatin O
- O
mediated O
developmental O
role O
for O
Pit B
- I
1 I
in O
the O
hGH O
LCR O
. O

A O
triple O
Ser O
- O
- O
> O
Ala O
mutant O
form O
of O
yeast O
eIF B
- I
2 I
alpha I
was O
found O
to O
be O
no O
longer O
phosphorylated O
by O
either O
of O
the O
yeast O
( O
or O
mammalian O
) O
casein B
kinase I
activities O
in O
vitro O
. O

In O
293 O
cells O
, O
expression O
of O
the O
NF B
- I
kappa I
B I
inhibitor O
, O
I B
kappa I
B I
- I
alpha I
, O
reduced O
the O
stimulatory O
activity O
of O
LMP O
. O

The O
studied O
protein O
fragments O
consist O
of O
residues O
Arg183 O
- O
His267 O
of O
the O
human O
ER O
and O
residues O
Lys438 O
- O
Gln520 O
of O
the O
rat O
GR B
. O

The O
revertant O
TATA O
boxes O
accelerated O
the O
kinetics O
of O
HIV O
replication O
when O
present O
in O
the O
context O
of O
an O
LTR O
containing O
a O
Sp1 B
mutation O
( O
deletion O
or O
site O
specific O
) O
; O
no O
effect O
was O
observed O
on O
the O
infectivity O
of O
wild O
- O
type O
HIV O
. O

In O
11 O
patients O
with O
Horton O
' O
s O
headache O
morphological O
investigations O
( O
differential O
white O
blood O
cell O
count O
) O
, O
cytoenzymatic O
determinations O
( O
alkaline O
and O
acid O
phosphatase O
, O
non O
- O
specific O
esterase O
) O
and O
cytoimmunological O
tests O
( O
IgM B
and O
IgG B
binding O
) O
were O
carried O
out O
on O
capillary O
blood O
neutrophils O
obtained O
from O
the O
area O
of O
pain O
, O
non O
- O
painful O
area O
of O
the O
skin O
on O
the O
head O
on O
the O
contralateral O
side O
, O
and O
from O
the O
finger O
. O

In O
co O
- O
transfection O
studies O
, O
an O
AP B
- I
2 I
but O
not O
an O
Egr B
- I
1 I
expression O
vector O
activated O
VPF O
/ O
VEGF B
transcription O
, O
thus O
indicating O
that O
AP B
- I
2 I
protein I
is O
functionally O
important O
in O
TGF B
alpha I
- O
induced O
VPF O
/ O
VEGF B
gene O
expression O
. O

Reverse B
transcriptase I
and O
protease O
activities O
of O
avian O
leukosis O
virus O
Gag B
- O
Pol B
fusion O
proteins O
expressed O
in O
insect O
cells O
. O

The O
codon O
usage O
is O
particularly O
marked O
for O
the O
gag B
, O
pol B
, O
and O
env B
genes I
. O

These O
data O
define O
a O
conserved O
pathway O
wherein O
sequential O
histone B
modifications O
establish O
a O
" O
histone B
code O
" O
essential O
for O
the O
epigenetic O
inheritance O
of O
heterochromatin O
assembly O
. O

Expression O
of O
a O
dominant O
- O
negative O
ras O
gene O
also O
blocks O
TIS10 O
/ O
PGS2 O
induction O
by O
v B
- I
src I
. O

No O
significant O
differences O
existed O
between O
the O
two O
age O
groups O
in O
baseline O
characteristics O
, O
including O
treatment O
protocol O
, O
performance O
status O
, O
and O
serum O
lactate O
dehydrogenase O
( O
LDH B
) O
level O
. O

Hepatitis B
B I
surface I
antigen I
was O
detected O
in O
2 O
patients O
, O
with O
negative O
hepatitis O
C O
virus O
antibody O
. O

No O
difference O
in O
telomere O
length O
was O
seen O
in O
mutants O
affected O
in O
the O
regulation O
of O
Cdc2 B
, O
whereas O
some O
of O
the O
DNA O
repair O
mutants O
examined O
had O
slightly O
longer O
telomeres O
than O
did O
the O
wild O
type O
. O

The O
gene O
structure O
of O
Elk1 B
spans O
15 O
. O
2 O
kb O
and O
consists O
of O
seven O
exons O
and O
six O
introns O
. O

Here O
, O
we O
present O
evidence O
that O
exposure O
of O
DT40 O
lymphoma O
B O
cells O
to O
low O
energy O
electromagnetic O
field O
( O
EMF O
) O
results O
in O
a O
tyrosine B
kinase I
- O
dependent O
activation O
of O
phospholipase O
Cgamma2 O
( O
PLC O
- O
gamma2 O
) O
leading O
to O
increased O
inositol O
phospholipid O
turnover O
. O

Twenty O
eligible O
patients O
with O
cirrhosis O
were O
randomized O
into O
two O
groups O
: O
10 O
patients O
treated O
with O
6 O
million O
units O
of O
natural O
IFN B
- I
beta I
twice O
a O
week O
for O
36 O
months O
and O
10 O
patients O
without O
IFN B
therapy O
. O

The O
results O
indicate O
that O
hrpRS O
and O
hrpL O
are O
part O
of O
a O
regulatory O
cascade O
in O
which O
HrpR O
and O
HrpS O
activate O
expression O
of O
hrpL O
and O
HrpL O
, O
a O
putative O
sigma B
factor I
, O
induces O
expression O
of O
HrpL O
- O
responsive O
genes O
. O

The O
general O
transcription O
factor O
IIA O
( O
TFIIA O
) O
interacts O
with O
the O
TATA B
binding I
protein I
( O
TBP B
) O
and O
promoter O
DNA O
to O
mediate O
transcription O
activation O
in O
vitro O
. O

CD4 B
lymphocyte O
and O
viral O
load O
levels O
suggested O
an O
optimal O
response O
to O
ARV O
therapy O
at O
the O
time O
LD O
developed O
. O

Effects O
of O
a O
perfluorochemical O
blood O
substitute O
on O
diazepam O
binding O
by O
human B
albumin I
. O

Since O
the O
regulation O
of O
SWI4 B
is O
required O
for O
normal O
cell O
cycle O
progression O
, O
we O
have O
characterized O
cis O
- O
and O
trans O
- O
acting O
regulators O
of O
SWI4 B
transcription O
. O

Surprisingly O
, O
there O
is O
no O
sequence O
homology O
between O
this O
region O
of O
Ly O
- O
6E O
and O
the O
established O
consensus O
for O
the O
interferon O
- O
stimulated O
response O
element O
, O
which O
has O
been O
shown O
functionally O
important O
to O
all O
previously O
characterized O
alpha B
/ I
beta I
interferon I
- O
inducible O
promoters O
. O

Analysis O
of O
lacZ O
transcriptional O
fusions O
shows O
that O
the O
KdgR O
- O
binding O
sites O
negatively O
affect O
the O
expression O
of O
rsmB B
. O

As O
expected O
, O
the O
insulin B
effect O
to O
increase O
ras O
GTP O
formation O
and O
MAP B
kinase I
activity O
was O
negligible O
in O
A O
/ O
K1018 O
cells O
but O
normal O
, O
or O
supernormal O
, O
in O
Y O
/ O
F2 O
cells O
. O

I O
report O
here O
that O
induction O
of O
HSP82 O
is O
regulated O
by O
the O
early O
meiotic O
IME1 B
- O
IME2 O
transcriptional O
cascade O
. O

This O
report O
substantiates O
that O
at O
least O
two O
of O
the O
18 O
kDa O
hsps B
in O
maize O
are O
products O
of O
different O
but O
related O
genes O
. O

Oligonucleotide O
competitors O
were O
used O
to O
evaluate O
the O
accessibility O
of O
the O
TATA O
- O
binding O
site O
in O
TIF B
- I
IB I
, O
TFIID B
, O
and O
TFIIIB O
. O

Insertion O
of O
short O
oligonucleotides O
encoding O
the O
basic O
amino O
acid O
motifs O
726 O
- O
GRKRKSP O
- O
732 O
from O
IE175 B
and O
500 O
- O
VRPRKRR O
- O
506 O
from O
IE110 B
into O
deleted O
cytoplasmic O
forms O
of O
the O
two O
proteins O
restored O
the O
karyophilic O
phenotype O
and O
confirmed O
that O
these O
motifs O
are O
both O
necessary O
and O
sufficient O
for O
proper O
nuclear O
localization O
. O

Addition O
of O
phalloidin O
- O
stabilized O
F B
- I
actin I
nuclei O
and O
phalloidin O
restored O
L266D O
actin B
' O
s O
ability O
to O
polymerize O
at O
4 O
degrees O
C O
. O

Recently O
, O
roles O
also O
have O
been O
suggested O
for O
the O
nuclear O
trans O
- O
factor O
GATA B
- I
1 I
in O
regulating O
progenitor O
cell O
proliferation O
. O

Six O
distinct O
Ets O
mRNAs O
were O
identified O
: O
Ets2 B
, O
Fli1 B
, O
GABPalpha B
, O
SAP1 B
, O
Elk1 B
, O
and O
PE1 O
. O

Both O
NUP98 B
- O
HOXA9 O
chimeras O
transformed O
NIH O
3T3 O
fibroblasts O
, O
and O
this O
transformation O
required O
the O
HOXA9 O
domains O
for O
DNA O
binding O
and O
PBX O
interaction O
. O

RESULTS O
: O
Patients O
in O
Group O
A O
had O
a O
higher O
incidence O
of O
posterolateral O
wall O
motion O
abnormalities O
( O
p O
< O
0 O
. O
001 O
) O
on O
radionuclide O
ventriculography O
, O
a O
larger O
infarct O
area O
( O
as O
evidenced O
by O
higher O
peak O
creatine B
kinase I
levels O
) O
( O
p O
< O
0 O
. O
02 O
) O
and O
a O
lower O
left O
ventricular O
ejection O
fraction O
( O
LVEF O
) O
at O
hospital O
discharge O
( O
p O
< O
0 O
. O
008 O
) O
than O
those O
in O
Group O
B O
. O

The O
Pro O
- O
258 O
- O
- O
> O
Leu O
( O
P258L O
) O
mutation O
caused O
constitutive O
receptor O
signaling O
that O
was O
equivalent O
to O
about O
45 O
% O
of O
the O
maximum O
level O
observed O
in O
wild O
- O
type O
cells O
stimulated O
with O
alpha B
- I
factor I
. O

The O
selenium O
level O
and O
glutathione B
peroxidase I
activity O
in O
the O
blood O
, O
liver O
, O
and O
stomach O
mucosa O
were O
significantly O
higher O
in O
the O
high O
- O
selenium O
diet O
group O
than O
in O
the O
low O
- O
selenium O
diet O
group O
. O

We O
have O
characterized O
a O
panel O
of O
6 O
monoclonal O
antibodies O
raised O
against O
human O
platelet O
talin O
by O
Western O
blotting O
, O
immune O
precipitation O
, O
and O
immunofluorescence O
, O
and O
shown O
that O
antibodies O
TA205 O
and O
TD77 O
disrupt O
actin B
stress O
fibers O
and O
focal O
adhesions O
, O
and O
inhibit O
cell O
motility O
when O
microinjected O
into O
human O
fibroblasts O
. O

The O
recently O
developed O
gamma B
- I
interferon I
( O
IFN B
- I
gamma I
) O
assay O
system O
for O
the O
diagnosis O
of O
bovine O
tuberculosis O
in O
cattle O
has O
been O
accredited O
by O
the O
Standing O
Committee O
on O
Agriculture O
for O
use O
in O
Australia O
. O

In O
these O
constructs O
, O
GUS B
expression O
was O
driven O
by O
promoter O
regions O
derived O
from O
the O
Arabidopsis O
alcohol O
dehydrogenase O
( O
Adh1 O
) O
, O
maize O
ubiquitin O
( O
Ubi1 O
) O
, O
rice O
actin O
( O
Act1 O
) O
and O
CaMV O
35S O
genes O
. O

Both O
Rep78 B
and O
Rep68 B
cut O
the O
terminal O
AAV O
sequence O
at O
the O
same O
site O
( O
nucleotide O
124 O
) O
. O

In O
this O
regard O
, O
it O
differs O
from O
a O
recently O
reported O
BFA O
- O
sensitive O
ARF B
- O
GEP O
that O
contains O
a O
Sec7 O
domain O
. O

Circulating O
platelets O
may O
be O
activated O
by O
exposed O
triple O
- O
helical O
collagen B
in O
atherosclerotic O
lesions O
in O
Mg O
- O
deficient O
ruminants O
. O

In O
the O
United O
States O
high O
- O
MW O
HES O
480 O
which O
is O
difficult O
to O
degrade O
is O
most O
frequently O
used O
and O
results O
in O
a O
larger O
in O
vivo O
MW O
and O
subsequent O
decrease O
in O
factor B
VIII I
/ O
von B
Willebrand I
factor I
levels O
. O

Cytokine O
- O
induced O
NF B
- I
kappa I
B I
DNA O
binding O
activity O
, O
RelA B
nuclear O
translocation O
, O
I B
kappa I
B I
alpha I
degradation O
, O
I B
kappa I
B I
serine O
32 O
phosphorylation O
, O
and O
I B
kappa I
B I
kinase I
( O
IKK B
) O
activity O
were O
blocked O
by O
curcumin O
treatment O
. O

However O
, O
alterations O
in O
electrostatic O
and O
hydrophobic O
interactions O
created O
by O
the O
three O
amino O
acid O
substitutions O
prevent O
the O
conformational O
change O
in O
the O
enzyme O
usually O
produced O
by O
calmodulin B
binding O
. O

We O
found O
that O
T3 O
( O
10 O
( O
- O
8 O
) O
M O
) O
selectively O
stimulates O
transcription O
from O
rGH B
- O
TRE O
- O
and O
TREpal O
- O
, O
but O
not O
ME O
- O
TRE O
- O
and O
F2 O
- O
TRE O
- O
, O
containing O
templates O
in O
which O
these O
TREs O
are O
linked O
in O
front O
of O
the O
rGH O
minimal O
promoter O
containing O
only O
the O
TATA B
box I
binding I
protein I
, O
but O
not O
any O
other O
proximal O
binding O
protein O
, O
sequence O
. O

All O
ribosomal B
protein I
( O
rp O
) O
gene O
promoters O
from O
Saccharomyces O
cerevisiae O
studied O
so O
far O
contain O
either O
( O
usually O
two O
) O
binding O
sites O
for O
the O
global O
gene O
regulator O
Rap1p O
or O
one O
binding O
site O
for O
another O
global O
factor O
, O
Abf1p O
. O

All O
three O
NR B
isoforms O
are O
expressed O
in O
cv O
. O

Heme B
oxygenase I
1 I
is O
an O
essential O
enzyme O
in O
heme O
catabolism O
that O
cleaves O
heme O
to O
form O
biliverdin O
, O
iron O
, O
and O
carbon O
monoxide O
. O

While O
determination O
of O
the O
protein O
content O
of O
the O
formulae O
gave O
no O
valid O
information O
, O
RAST O
/ O
EAST O
inhibition O
was O
highest O
for O
cow O
' O
s O
milk O
, O
followed O
by O
the O
partially O
hydrolysed O
whey O
formula O
, O
partially O
hydrolysed O
whey O
/ O
casein B
formula O
, O
soy O
/ O
pork O
collagen O
formula O
, O
and O
the O
amino O
acid O
formula O
. O

To O
determine O
which O
sequences O
in O
the O
rat O
P450c17 O
promoter O
may O
be O
responsible O
for O
basal O
and O
cAMP O
- O
stimulated O
gene O
transcription O
, O
deletion O
constructs O
containing O
between O
- O
1 O
, O
560 O
and O
- O
53 O
base O
pairs O
of O
5 O
' O
- O
flanking O
DNA O
from O
the O
rat O
P450c17 O
gene O
were O
ligated O
to O
plasmids O
expressing O
the O
reporter O
gene O
luciferase B
and O
transfected O
into O
two O
mouse O
cell O
lines O
, O
adrenal O
Y O
- O
1 O
cells O
, O
and O
testicular O
Leydig O
MA O
- O
10 O
cells O
. O

The O
transcription O
initiation O
site O
was O
determined O
by O
S1 B
nuclease I
mapping O
. O

This O
region O
contains O
a O
motif O
with O
partial O
identity O
with O
the O
binding O
site O
for O
the O
ubiquitous O
transcription O
factor O
upstream B
stimulatory I
factor I
( O
USF B
) O
, O
which O
binds O
to O
the O
human O
insulin O
promoter O
. O

The O
RAS B
- O
cyclic B
AMP I
- I
dependent I
protein I
kinase I
cAPK B
pathway O
prevents O
the O
UAS O
activity O
of O
IREu O
in O
the O
presence O
of O
glucose O
as O
the O
sole O
carbon O
source O
, O
while O
the O
transcriptional O
activators O
Msn2p B
and O
Msn4p B
promote O
the O
UAS O
activity O
of O
this O
repeat O
in O
the O
presence O
of O
acetate O
. O

As O
assessed O
by O
a O
genetic O
assay O
that O
measures O
AAI O
- O
dependent O
DNA O
binding O
, O
TraM O
inhibited O
TraR B
function O
before O
and O
after O
the O
transcription O
factor O
had O
bound O
to O
its O
DNA O
recognition O
site O
. O

Phorbol O
esters O
stimulated O
phosphorylation O
of O
CSK O
35H O
proteins O
, O
thus O
emphasizing O
that O
sequences O
isolated O
according O
to O
PKC B
binding O
activity O
in O
vitro O
are O
also O
PKC B
substrates O
in O
vivo O
. O

Structure O
and O
regulation O
of O
the O
gene O
encoding O
the O
neuron O
- O
specific O
protein B
kinase I
C I
substrate O
neurogranin B
( O
RC3 O
protein O
) O
. O

Mutations O
of O
the O
RET O
gene O
, O
encoding O
a O
receptor B
tyrosine I
kinase I
, O
have O
been O
associated O
with O
the O
inherited O
cancer O
syndromes O
MEN O
2A O
and O
MEN O
2B O
. O

We O
also O
provide O
evidence O
that O
gar2 O
is O
phosphorylated O
in O
vitro O
by O
a O
p13 O
( O
suc1 O
) O
- O
Sepharose O
- O
bound O
kinase O
from O
Schizosaccharomyces O
pombe O
extracts O
that O
displays O
cell O
cycle O
- O
regulated O
activity O
similar O
to O
that O
of O
the O
p34 O
( O
cdc2 B
( O
kinase O
. O

However O
, O
a O
10 O
- O
- O
15 O
% O
lengthening O
of O
the O
partial O
thromboplastin B
time O
is O
evident O
after O
24 O
hours O
of O
storage O
. O

As O
regards O
lipid O
metabolism O
, O
the O
mean O
values O
for O
total O
triglycerides O
, O
cholesterol O
, O
LDL B
- I
cholesterol I
and O
HDL B
- I
cholesterol I
seen O
at O
the O
end O
of O
five O
years O
of O
Norplant O
- O
2 O
rod O
use O
and O
six O
months O
postremoval O
were O
similar O
to O
the O
preinsertion O
mean O
. O

The O
fatigue O
exercise O
showed O
relatively O
high O
blood O
lactate O
concentration O
[ O
12 O
. O
5 O
( O
SD O
2 O
. O
6 O
) O
mmol O
x O
l O
( O
- O
1 O
) O
] O
and O
an O
increase O
of O
serum B
creatine I
kinase I
( O
CK B
) O
activity O
delayed O
by O
2 O
days O
[ O
540 O
( O
SD O
407 O
) O
U O
x O
l O
( O
- O
1 O
) O
] O
. O

However O
, O
L B
- I
plastin I
has O
been O
found O
in O
many O
types O
of O
malignant O
human O
cells O
of O
non O
- O
hemopoietic O
origin O
suggesting O
that O
its O
expression O
is O
induced O
accompanying O
tumorigenesis O
in O
solid O
tissues O
. O

The O
role O
of O
HIV O
tat O
, O
which O
is O
the O
main O
enhancing O
factor O
for O
viral B
LTR I
, O
in O
the O
regulation O
of O
IL B
- I
2 I
gene I
transcription O
has O
been O
studied O
following O
transient O
expression O
of O
the O
tat O
gene O
in O
phorbol O
ester O
and O
calcium O
ionophore O
- O
activated O
Jurkat O
cells O
transfected O
with O
IL B
- I
2 I
promoter O
- O
chloramphenicol B
acetyltransferase I
reporter O
constructs O
. O

An O
FP O
mutant O
, O
AcFP875 O
- O
2 O
, O
had O
a O
1 O
. O
6 O
- O
kbp O
insertion O
of O
S O
. O
frugiperda O
DNA O
near O
the O
5 O
' O
end O
of O
these O
transcripts O
which O
by O
S1 B
analysis O
were O
shown O
to O
initiate O
within O
the O
host O
cell O
sequence O
. O

These O
data O
suggest O
that O
other O
Ras O
effectors O
can O
collaborate O
with O
PI B
3 I
- I
kinase I
and O
with O
each O
other O
to O
activate O
Pak B
. O

MSSPs O
are O
believed O
to O
regulate O
DNA O
replication O
, O
transcription O
, O
apopotosis O
and O
cell O
cycle O
progression O
by O
interacting O
with O
the O
C B
- I
MYC I
protein I
. O

We O
have O
shown O
previously O
that O
in O
contrast O
to O
other O
extracellular O
matrix O
molecules O
pepsin B
- O
solubilized O
collagen O
VI O
( O
CVI B
) O
can O
stimulate O
DNA O
synthesis O
of O
various O
mesenchymal O
cell O
types O
, O
apparently O
independent O
of O
integrin B
- O
mediated O
signal O
transduction O
. O

Evidence O
for O
a O
role O
of O
endogenous B
corticotropin I
- I
releasing I
factor I
in O
cold O
, O
ether O
, O
immobilization O
, O
and O
traumatic O
stress O
. O

In O
addition O
, O
severe O
vision O
loss O
can O
be O
seen O
with O
interferon B
alfa I
- I
2b I
- O
associated O
retinopathy O
. O

Proteins O
known O
to O
bind O
the O
PEPCK B
CRE O
include O
the O
CRE B
- I
binding I
protein I
( O
CREB B
) O
and O
members O
of O
the O
CCAAT B
/ I
enhancer I
- I
binding I
protein I
( O
C B
/ I
EBP I
) O
family O
. O

Although O
IL B
- I
2 I
and O
IFN B
- I
alpha I
activated O
STAT1 O
alpha O
and O
STAT5 B
, O
IL B
- I
2 I
predominantly O
activated O
STAT5 B
, O
while O
IFN B
- I
alpha I
predominantly O
activated O
STAT1 O
alpha O
. O

These O
results O
suggest O
that O
G B
beta I
gamma I
- O
stimulated O
Shc B
phosphorylation O
represents O
an O
early O
step O
in O
the O
pathway O
leading O
to O
p21ras B
activation O
, O
similar O
to O
the O
mechanism O
utilized O
by O
growth O
factor O
tyrosine O
kinase O
receptors O
. O

Sp1 B
can O
activate O
transcription O
through O
immunoglobulin O
kappa O
- O
chain O
enhancer O
or O
P O
- O
selectin O
promoter O
NF O
- O
kappaB O
sites O
. O

p50 O
homodimers O
replace O
Sp1 B
from O
the O
P O
- O
selectin O
promoter O
by O
binding O
site O
competition O
and O
thereby O
either O
inhibit O
basal O
Sp1 B
- O
driven O
expression O
or O
, O
in O
concert O
with O
Bcl B
- I
3 I
, O
stimulate O
expression O
. O

A O
yeast O
DNA O
fragment O
carrying O
the O
gene O
CP O
A1 O
encoding O
the O
small O
subunit O
of O
the O
arginine O
pathway O
carbamoyl B
- I
phosphate I
synthetase I
has O
been O
sequenced O
. O

Interestingly O
, O
these O
response O
elements O
display O
dramatically O
reduced O
affinity O
for O
retinoic B
acid I
receptor I
- O
retinoid B
- I
X I
receptor I
heterodimers O
. O

The O
delta O
srb10 O
mutation O
also O
influenced O
on O
the O
transcript O
levels O
of O
meiosis O
- O
inducing O
genes O
called O
IME1 B
and O
IME2 O
: O
the O
mutation O
elevated O
the O
transcript O
level O
of O
IME1 B
but O
reduced O
that O
of O
IME2 O
, O
resulting O
in O
partial O
defects O
in O
premeiotic O
DNA O
synthesis O
and O
meiosis O
. O

c B
- I
Fos I
transcriptional O
activity O
stimulated O
by O
H O
- O
Ras O
- O
activated O
protein O
kinase O
distinct O
from O
JNK B
and O
ERK B
. O

Quantitative O
evaluation O
of O
the O
steady O
state O
kinetics O
of O
MEK B
inhibition O
by O
these O
compounds O
reveals O
that O
U0126 O
has O
approximately O
100 O
- O
fold O
higher O
affinity O
for O
deltaN3 O
- O
S218E O
/ O
S222D O
MEK O
than O
does O
PD098059 O
. O

These O
results O
provide O
evidence O
of O
a O
bypass O
of O
p53 B
- O
induced O
Waf1 B
/ O
Cip1 B
- O
mediated O
cell O
cycle O
regulatory O
pathways O
by O
a O
member O
of O
the O
myb O
oncogene O
family O
. O

Extracellular O
- O
regulated O
kinase O
( O
ERK B
) O
activation O
and O
molecular O
coupling O
of O
the O
adaptor O
proteins O
p130 B
Crk B
- I
associated I
substrate I
( O
CAS B
) O
and O
c O
- O
CrkII O
( O
Crk B
) O
represent O
two O
distinct O
pathways O
that O
induce O
cell O
invasion O
and O
protect O
cells O
from O
apoptosis O
in O
a O
three O
- O
dimensional O
collagen B
matrix O
. O

NF B
- I
kappa I
B I
p65 B
, O
p50 B
, O
and O
Rel B
functionally O
synergize O
with O
C B
/ I
EBP I
alpha I
, O
C B
/ I
EBP I
beta I
, O
and O
C B
/ I
EBP I
delta I
. O

Because O
L B
- I
plastin I
expression O
in O
tissue O
- O
specifically O
regulated O
in O
both O
humans O
and O
rodents O
, O
it O
is O
likely O
that O
similar O
mechanisms O
regulate O
L O
- O
plastin O
gene O
expression O
in O
human O
and O
rodent O
cells O
and O
that O
they O
could O
be O
identified O
by O
comparing O
the O
function O
and O
nucleotide O
sequences O
of O
the O
human O
and O
murine O
L B
- I
plastin I
gene O
promoters O
. O

A O
motif O
( O
TGATGTCA O
) O
which O
matches O
a O
CREB O
site O
and O
is O
similar O
to O
an O
AP B
- I
1 I
site I
is O
embedded O
within O
ER2 O
. O

The O
effects O
of O
the O
transfected O
receptors O
were O
associated O
with O
antagonism O
of O
activator B
protein I
1 I
( O
AP B
- I
1 I
) O
activity O
. O

Thus O
, O
dpp B
and O
omb O
promote O
both O
dorsal O
leg O
cell O
fate O
as O
well O
as O
transdetermination O
- O
competent O
leg O
disc O
cells O
. O

In O
the O
case O
of O
congenital O
protein B
C I
deficiency O
, O
vitamin O
K O
antagonists O
must O
be O
started O
cautiously O
due O
to O
the O
risk O
of O
skin O
necrosis O
. O

Y15170 O
( O
Surf O
- O
2 O
, O
Surf O
- O
4 O
) O
, O
Y15171 O
( O
Surf B
- I
3 I
, O
Surf B
- I
1 I
, O
Surf O
- O
6 O
) O
, O
and O
Y15172 O
( O
Surf O
- O
5 O
. O
) O
] O

The O
- O
64 O
/ O
- O
37 O
region O
interacted O
with O
purified O
Sp1 B
and O
an O
unidentified O
protein O
( O
s O
) O
, O
proximal O
regulatory O
factor O
( O
s O
) O
I O
( O
PRF O
- O
I O
) O
. O

In O
one O
acromegalic O
patient O
visual O
improvement O
was O
obtained O
while O
the O
abnormal O
GH B
secretion O
remained O
unaltered O
. O

Exposure O
of O
peripheral O
blood O
T O
cells O
from O
young O
subjects O
to O
PHA B
or O
cross O
- O
linked O
anti O
- O
CD3 O
monoclonal O
antibodies O
stimulated O
rapid O
increases O
in O
MAPK B
and O
MEK B
enzymatic O
activity O
. O

In O
the O
point O
mutant O
we O
observed O
normal O
repair O
of O
endonuclease O
III O
site O
( O
i O
. O
e O
. O
as O
wild O
type O
) O
, O
but O
no O
removal O
of O
CPDs O
at O
the O
MAT B
alpha I
and O
HML O
alpha O
loci O
. O

Marked O
thrombocytopenia O
, O
depletion O
of O
serum O
fibrinogen O
and O
prolonged O
prothrombin B
and O
activated O
partial O
thromboplastin B
time O
, O
were O
recorded O
at O
5 O
to O
10 O
and O
30 O
to O
40 O
minutes O
after O
intravenous O
envenomation O
. O

Competitive O
mobility O
shift O
assays O
using O
either O
alphaT3 O
- O
1 O
nuclear O
extract O
or O
recombinant O
SF O
- O
1 O
protein O
clearly O
indicated O
that O
SF B
- I
1 I
is O
able O
to O
interact O
specifically O
with O
this O
GSE O
element O
positioned O
at O
- O
134 O
. O

In O
both O
settings O
, O
it O
can O
be O
phosphorylated O
by O
cyclin B
D I
- I
dependent I
kinases I
, O
suggesting O
that O
its O
transcriptional O
activity O
may O
normally O
be O
regulated O
through O
such O
mechanisms O
. O

Also O
, O
samples O
of O
serum O
were O
absorbed O
with O
the O
various O
solid O
- O
phase O
allergens O
and O
the O
reactivity O
of O
the O
remaining O
IgE B
antibodies I
was O
determined O
. O

This O
c B
- I
Jun I
activity O
is O
inhibited O
by O
c B
- I
Fos I
, O
another O
protooncoprotein O
that O
can O
dimerize O
with O
c B
- I
Jun I
to O
form O
the O
transcription O
factor O
AP B
- I
1 I
. O

Surprisingly O
, O
the O
RXR B
- O
specific O
ligand O
9 O
- O
cis O
- O
retinoic O
acid O
induced O
binding O
of O
SRC B
- I
1 I
to O
the O
RXR O
component O
of O
the O
TRE O
- O
bound O
heterodimer O
. O

The O
ectopic O
expression O
of O
Oct B
- I
3 I
/ I
4 I
in O
hybrid O
cells O
under O
a O
constitutive O
promoter O
is O
sufficient O
for O
transcriptional O
activation O
of O
an O
octamer O
- O
dependent O
promoter O
. O

4 O
. O
26 O
+ O
/ O
- O
1 O
. O
54 O
mmol O
/ O
l O
, O
P O
< O
0 O
. O
01 O
) O
, O
and O
systolic O
BP O
responses O
to O
intravenous O
norepinephrine O
and O
angiotensin B
II I
were O
significantly O
higher O
on O
glibenclamide O
than O
on O
metformin O
( O
P O
< O
0 O
. O
02 O
and O
P O
< O
0 O
. O
05 O
, O
respectively O
) O
. O

Precipitation O
using O
GST O
fusion O
proteins O
containing O
Fyn B
SH2 B
, O
SH3 B
, O
and O
SH2 B
/ O
SH3 B
domains O
revealed O
that O
PI B
3 I
- I
kinase I
bound O
principally O
to O
the O
SH3 B
domain I
of O
Fyn B
. O

Binding O
of O
U2 B
small I
nuclear I
ribonucleoprotein I
( O
snRNP O
) O
to O
the O
pre O
- O
mRNA O
is O
an O
early O
and O
important O
step O
in O
spliceosome O
assembly O
. O

Mss4 O
also O
acts O
as O
a O
relatively O
inefficient O
guanine B
nucleotide I
exchange I
factor I
( O
GEF B
) O
. O

Plasma O
and O
erthrocyte O
lipid O
profile O
and O
lipoprotein B
lipase I
activity O
in O
postheparin O
plasma O
on O
vasectomized O
rabbits O
were O
studied O
and O
also O
the O
incidence O
of O
atherosclerosis O
in O
different O
arterial O
beds O
. O

From O
this O
library O
, O
LEU2 B
and O
HIS3 B
cDNAs O
were O
recovered O
at O
a O
frequency O
of O
about O
1 O
in O
10 O
( O
4 O
) O
and O
in O
12 O
out O
of O
13 O
cases O
these O
were O
expressed O
in O
a O
galactose O
- O
dependent O
manner O
. O

Comparison O
with O
the O
bHLH O
/ O
PAS B
family O
genes O
revealed O
that O
the O
intron O
/ O
exon O
splice O
pattern O
of O
mBMAL1 O
most O
closely O
matches O
that O
of O
the O
mAhr O
, O
which O
suggests O
that O
BMAL1 O
and O
Ahr B
belong O
to O
the O
same O
subclass O
and O
may O
be O
derived O
from O
a O
common O
primordial O
gene O
. O

Stable O
transfection O
of O
the O
BL O
cell O
line O
Raji O
with O
constructs O
containing O
core O
promoter O
mutations O
confirmed O
that O
the O
proximal O
Sp1 B
site I
and O
the O
TATA O
box O
are O
essential O
for O
the O
activation O
of O
promoter O
P1 O
by O
the O
Ig O
kappa O
enhancers O
. O

The O
continuing O
development O
of O
ligands O
that O
function O
as O
selective O
estrogens O
or O
antiestrogens O
for O
ERalpha B
or O
ERbeta O
should O
allow O
optimized O
tissue O
selectivity O
of O
these O
agents O
for O
menopausal O
hormone O
replacement O
therapy O
and O
the O
treatment O
and O
prevention O
of O
breast O
cancer O
. O

A O
role O
for O
glycogen B
synthase I
kinase I
- I
3 I
in O
the O
control O
of O
gene O
expression O
. O

In O
contrast O
to O
the O
wild O
- O
type O
protein O
, O
expression O
of O
p45 B
NF B
- I
E2 I
lacking O
this O
activation O
domain O
in O
an O
NF B
- I
E2 I
null O
cell O
line O
fails O
to O
support O
enhancer O
- O
dependent O
transcription O
in O
transient O
assays O
. O

Levels O
of O
the O
MEK B
inhibitor O
PD98059 O
that O
block O
EGF B
- O
induced O
mitogenesis O
and O
MAP B
kinase I
phosphorylation O
also O
abrogate O
EGF B
- O
induced O
focal O
adhesion O
disassembly O
and O
cell O
motility O
. O

Finally O
, O
there O
are O
a O
growing O
number O
of O
arguments O
favouring O
the O
use O
of O
ACE B
inhibitors O
very O
early O
in O
patients O
with O
diabetes O
mellitus O
. O

We O
found O
that O
both O
the O
E26 O
virus O
- O
encoded O
v B
- I
ets I
and O
the O
myeloid O
/ O
B O
- O
cell O
- O
specific O
factor O
PU O
. O
1 O
bind O
efficiently O
to O
this O
site O
in O
vitro O
. O

Deleting O
SNF1 B
repressed O
meiosis O
at O
the O
same O
three O
steps O
that O
were O
inhibited O
by O
glucose O
, O
suggesting O
that O
glucose O
blocks O
meiosis O
by O
inhibiting O
Snf1 B
. O

Entry O
of O
yeast O
cells O
into O
the O
mitotic O
cell O
cycle O
( O
Start O
) O
involves O
a O
form O
of O
the O
CDC28 O
kinase O
that O
associates O
with O
G1 O
- O
specific O
cyclins B
encoded O
by O
CLN1 B
and O
CLN2 B
( O
ref O
. O

Sequence O
analysis O
of O
the O
sMtCK O
genomic O
upstream O
sequences O
reveals O
a O
typical O
TATAA O
box O
within O
the O
80 O
base O
pairs O
( O
bp O
) O
that O
, O
by O
transfection O
experiments O
, O
are O
sufficient O
to O
promote O
expression O
of O
chimeric O
plasmids O
with O
the O
chloramphenicol B
acetyltransferase I
reporter I
. O

Sequence O
analysis O
of O
the O
sMtCK O
genomic O
upstream O
sequences O
reveals O
a O
typical O
TATAA O
box O
within O
the O
80 O
base O
pairs O
( O
bp O
) O
that O
, O
by O
transfection O
experiments O
, O
are O
sufficient O
to O
promote O
expression O
of O
chimeric O
plasmids O
with O
the O
chloramphenicol B
acetyltransferase I
reporter I
. O

In O
order O
to O
study O
the O
influence O
of O
iron O
overload O
on O
the O
polymorphonuclear O
leucocyte O
( O
PMN O
) O
metabolism O
of O
patients O
on O
chronic O
hemodialysis O
, O
generation O
of O
superoxide O
anion O
( O
O2 O
- O
) O
by O
PMN O
in O
whole O
blood O
was O
compared O
in O
two O
groups O
of O
hemodialyzed O
patients O
: O
group O
A O
consisted O
of O
twenty O
- O
one O
individuals O
with O
serum O
ferritin B
levels O
above O
1000 O
ng O
/ O
ml O
and O
group O
B O
of O
nineteen O
individuals O
with O
serum O
ferritin B
levels O
below O
1000 O
ng O
/ O
ml O
. O

These O
results O
suggest O
that O
VP1 B
was O
efficiently O
transported O
to O
the O
nucleus O
and O
localized O
in O
the O
discrete O
subnuclear O
regions O
, O
possibly O
with O
VP2 B
and O
VP3 B
. O

Zebrafish O
cyclops B
( O
cyc B
) O
encodes O
a O
Transforming B
Growth I
Factor I
beta I
( O
TGFbeta B
) O
signaling O
factor O
closely O
related O
to O
mouse O
Nodal O
. O

Combined O
expression O
of O
c B
- I
Jun I
and O
p65 B
induced O
vigorous O
transcription O
of O
IL B
- I
2 I
promoter O
- O
and O
CD28RE O
- O
driven O
reporter O
constructs O
in O
both O
LFA B
- I
3 I
- O
and O
B7 B
- I
1 I
- O
costimulated O
Jurkat O
cells O
. O

Unlike O
ARF B
, O
the O
ARP O
immunoreactivity O
was O
detected O
in O
plasma O
membranes O
but O
not O
in O
cytosol O
of O
fractionated O
3T3 O
- O
L1 O
cells O
. O

USF B
synthesized O
in O
an O
in O
vitro O
transcription O
and O
translation O
system O
also O
binds O
to O
the O
ADH O
promoter O
as O
well O
as O
to O
the O
MLP O
. O

The O
tyrosine O
hydroxylase O
gene O
( O
TH B
) O
contains O
a O
single O
copy O
of O
a O
consensus O
CRE O
at O
- O
45 O
to O
- O
38 O
base O
pair O
( O
bp O
) O
upstream O
of O
the O
transcription O
initiation O
site O
. O

Wild O
- O
type O
AT1A O
receptors O
, O
expressed O
in O
Chinese O
hamster O
ovary O
cells O
, O
rapidly O
internalized O
after O
Ang B
II I
stimulation O
[ O
t1 O
/ O
2 O
2 O
. O
3 O
min O
; O
maximal O
level O
of O
internalization O
( O
Ymax O
) O
78 O
. O
2 O
% O
] O
, O
as O
did O
mutant O
receptors O
carrying O
single O
acidic O
substitutions O
( O
T332E O
, O
t1 O
/ O
2 O
2 O
. O
7 O
min O
, O
Ymax O
76 O
. O
3 O
% O
; O
S335D O
, O
t1 O
/ O
2 O
2 O
. O
4 O
min O
, O
Ymax O
76 O
. O
7 O
% O
; O
T336E O
, O
t1 O
/ O
2 O
2 O
. O
5 O
min O
, O
Ymax O
78 O
. O
2 O
% O
; O

The O
dnaQ O
- O
lacZ B
and O
the O
rnh O
- O
lacZ B
fused O
genes O
were O
constructed O
and O
hybrid O
proteins O
with O
beta B
- I
galactosidase I
activity O
were O
produced O
. O

Moreover O
, O
this O
enhancement O
of O
transcriptional O
activation O
by O
COUP B
- I
TFI I
requires O
specifically O
the O
AF O
- O
1 O
transactivation O
function O
of O
ER B
and O
can O
be O
observed O
in O
the O
presence O
of O
E2 O
or O
4 O
- O
hydroxytamoxifen O
but O
not O
ICI O
164384 O
. O

The O
novel O
approach O
to O
insulin B
administration O
known O
as O
chronic O
intermittent O
intravenous O
insulin B
therapy O
( O
CIIIT O
) O
delivers O
insulin B
in O
a O
pulsatile O
fashion O
and O
achieves O
physiological O
insulin B
concentration O
in O
the O
portal O
vein O
. O

In O
hemodialyzed O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
) O
leptin B
levels O
were O
significantly O
higher O
when O
compared O
to O
CAPD O
patients O
( O
Epo B
and O
Non O
- O
Epo B
group O
, O
respectively O
) O
. O

Aryl B
hydrocarbon I
receptor I
nuclear I
translocator I
( O
ARNT B
) O
is O
a O
component O
of O
the O
transcription O
factors O
, O
aryl B
hydrocarbon I
receptor I
( O
AhR B
) O
and O
hypoxia B
- I
inducible I
factor I
1 I
, O
which O
transactivate O
their O
target O
genes O
, O
such O
as O
CYP1A1 O
and O
erythropoietin B
, O
in O
response O
to O
xenobiotic O
aromatic O
hydrocarbons O
and O
to O
low O
O2 O
concentration O
, O
respectively O
. O

Analysis O
of O
a O
set O
of O
deletion O
constructs O
in O
transient O
transfection O
assays O
measuring O
heterologous O
reporter O
gene O
( O
luciferase B
) O
activity O
demonstrated O
that O
the O
182 O
- O
bp O
5 O
' O
- O
flanking O
region O
provides O
full O
promoter O
activity O
in O
IL B
- I
2 I
- O
stimulated O
L2 O
cells O
. O

Systematic O
functional O
analysis O
of O
V1a O
/ O
V2 O
hybrid O
receptors O
showed O
that O
the O
second O
intracellular O
loop O
of O
the O
V1a O
receptor O
is O
required O
and O
sufficient O
for O
efficient O
coupling O
to O
Gq O
/ O
11 O
, O
whereas O
the O
third O
intracellular O
loop O
of O
the O
V2 O
receptor O
is O
required O
and O
sufficient O
for O
coupling O
to O
Gs B
. O

To O
determine O
whether O
P35 B
could O
activate O
the O
39k O
promoter O
in O
the O
absence O
of O
IE1 B
, O
the O
p35 B
open O
reading O
frame O
was O
cloned O
under O
the O
control O
of O
the O
ie1 B
promoter I
. O

The O
hypertension O
with O
elevated O
PRA O
, O
however O
, O
was O
resistant O
to O
the O
angiotensin B
II I
( O
AII O
) O
analog O
[ O
Sar1 O
, O
Ile8 O
] O
ALL O
. O

These O
data O
show O
that O
PTH B
and O
cAMP O
can O
repress O
collagen O
promoter O
activity O
in O
calvariae O
from O
transgenic O
mice O
, O
suggesting O
that O
the O
alpha O
1 O
( O
I O
) O
collagen O
promoter O
may O
contain O
cis O
elements O
down O
- O
stream O
of O
- O
2 O
. O
3 O
kilobases O
that O
mediate O
PTH B
and O
cAMP O
repression O
of O
collagen B
gene I
expression O
in O
bone O
. O

Reconstitution O
of O
complexes O
containing O
p62 B
and O
the O
src O
family O
kinase O
p59fyn O
in O
HeLa O
cells O
demonstrated O
that O
complex O
formation O
resulted O
in O
tyrosine O
phosphorylation O
of O
p62 B
and O
was O
mediated O
by O
both O
the O
SH3 B
and O
SH2 B
domains I
of O
p59fyn O
. O

The O
second O
patient O
had O
received O
pituitary O
- O
derived O
growth O
hormone O
for O
treatment O
of O
growth B
hormone I
deficiency O
, O
secondary O
to O
a O
third O
ventricle O
teratoma O
, O
exised O
13 O
yr O
earlier O
. O

To O
begin O
to O
understand O
this O
role O
, O
we O
overexpressed O
ATF B
- I
2 I
in O
a O
human O
cancer O
cell O
line O
. O

Analysis O
of O
the O
gag B
and O
rev O
proteins O
in O
the O
transfected O
cells O
demonstrated O
that O
these O
proteins O
were O
not O
detectable O
in O
cells O
transfected O
with O
the O
tat B
mutants I
but O
could O
be O
readily O
detected O
when O
the O
mutations O
were O
complemented O
in O
trans O
with O
a O
tat B
expression O
vector O
. O

Small O
GTPases O
of O
the O
Ypt B
/ O
Rab O
family O
are O
involved O
in O
the O
regulation O
of O
vesicular O
transport O
. O

Dopamine O
beta O
- O
hydroxylase O
( O
DBH B
) O
catalyzes O
the O
conversion O
of O
dopamine O
to O
noradrenaline O
and O
is O
selectively O
expressed O
in O
noradrenergic O
and O
adrenergic O
neurons O
and O
neuroendocrine O
cells O
. O

This O
result O
indicates O
that O
separate O
complexes O
exist O
containing O
ankyrin B
and O
fodrin B
with O
either O
uvomorulin O
or O
Na B
+ I
, I
K I
+ I
- I
ATPase I
. O

These O
results O
indicate O
that O
baculovirus O
- O
expressed O
TR B
mediates O
transcriptional O
activation O
and O
repression O
in O
a O
promoter O
- O
specific O
manner O
in O
vitro O
. O

Pitx2 B
rescues O
the O
GABAergic O
differentiation O
defect O
and O
partially O
rescues O
the O
axon O
guidance O
and O
behavioral O
phenotypes O
of O
unc O
- O
30 O
mutants O
, O
indicating O
a O
high O
degree O
of O
functional O
conservation O
between O
these O
evolutionarily O
related O
genes O
. O

Stimulation O
of O
[ O
3H O
] O
PA O
production O
upon O
CD3 B
cross O
- O
linking O
was O
77 O
% O
lower O
in O
permeabilized O
CD45 O
- O
cells O
than O
in O
CD45 O
+ O
cells O
, O
consistent O
with O
the O
reduced O
activity O
of O
p59fyn O
in O
CD45 O
- O
cells O
. O

Fenoldopam O
, O
a O
dopamine B
receptor I
agonist O
, O
has O
been O
shown O
, O
in O
animal O
experiments O
, O
to O
improve O
renal O
perfusion O
. O

One O
- O
third O
of O
the O
men O
with O
azoospermia O
and O
with O
sperm O
density O
of O
less O
than O
10 O
million O
had O
marked O
FSH B
elevation O
and O
our O
experience O
confirms O
the O
work O
of O
others O
that O
this O
indicates O
a O
poor O
prognosis O
. O

The O
resulting O
R O
protein O
terminates O
five O
codons O
downstream O
of O
the O
frameshift O
site O
at O
the O
V B
protein I
stop O
codon O
. O

Co O
- O
transfection O
of O
a O
tat B
expressing O
plasmid O
with O
these O
viruses O
containing O
the O
tat O
ORF O
mutations O
resulted O
in O
higher O
levels O
of O
virus O
production O
demonstrating O
that O
the O
effects O
of O
both O
mutants O
are O
tat B
specific O
. O

The O
H2 B
receptor I
antagonists O
and O
sucralfate O
cost O
about O
the O
same O
and O
have O
few O
side O
effects O
. O

The O
normal O
cell O
cycle O
is O
regulated O
by O
several O
molecules O
, O
such O
as O
the O
tumor O
- O
suppressor O
protein O
pRb O
, O
the O
G1 O
cyclins O
, O
the O
cyclin B
- I
dependent I
kinases I
, O
and O
their O
inhibitors O
. O

The O
N O
- O
terminal O
115 O
amino O
acids O
correspond O
to O
a O
putative O
DNA O
- O
binding O
domain O
and O
show O
significant O
sequence O
similarity O
with O
other O
cloned O
IFN O
response O
factors O
( O
IRF B
- I
1 I
and O
IRF B
- I
2 I
) O
. O

This O
construct O
, O
termed O
pDeltaCREC O
/ O
EBP O
, O
binds O
C O
/ O
EBPalpha O
and O
beta O
but O
not O
CREB B
, O
yet O
it O
confers O
a O
nearly O
complete O
glucocorticoid O
response O
when O
transiently O
transfected O
into O
H4IIE O
rat O
hepatoma O
cells O
. O

In O
the O
cell O
- O
free O
import O
assay O
, O
beta B
- I
catenin I
rapidly O
migrates O
into O
the O
nucleus O
without O
the O
exogenous O
addition O
of O
cytosol O
, O
Ran B
, O
or O
ATP O
/ O
GTP O
. O

Phosphorylation O
of O
myosin O
- O
binding O
subunit O
( O
MBS B
) O
of O
myosin B
phosphatase I
by O
Rho O
- O
kinase O
in O
vivo O
. O

Since O
RCC1p O
acts O
as O
GNRP O
for O
Ran B
, O
a O
small O
nuclear O
GTPase O
of O
the O
ras B
superfamily I
, O
we O
have O
identified O
two O
homologs O
of O
Ran B
in O
S O
. O
cerevisiae O
( O
CNR1 O
and O
CNR2 O
) O
. O

Although O
previous O
data O
have O
suggested O
that O
Rev B
uses O
the O
same O
export O
pathway O
as O
uracil O
- O
rich O
small O
nuclear O
RNAs O
and O
5S O
ribosomal O
RNA O
, O
the O
CTE O
seems O
to O
interact O
with O
evolutionarily O
conserved O
factors O
that O
are O
essential O
for O
cellular O
mRNA O
export O
. O

The O
E1 O
replication O
protein O
of O
bovine O
papillomavirus O
type O
1 O
contains O
an O
extended O
nuclear O
localization O
signal O
that O
includes O
a O
p34cdc2 B
phosphorylation O
site O
. O

Creatine B
kinase I
release O
after O
hepatic O
artery O
embolization O
in O
patients O
with O
carcinoid O
tumors O
. O

Like O
Epo B
, O
HNF B
- I
4 I
is O
expressed O
in O
kidney O
, O
liver O
, O
and O
Hep3B O
cells O
but O
not O
in O
HeLa O
cells O
. O

The O
promoter O
of O
the O
rat O
PGS O
- O
2 O
gene O
contains O
a O
CAAT O
enhancer O
- O
binding O
protein O
consensus O
site O
( O
CAAT O
box O
) O
which O
can O
confer O
hormone O
inducibility O
to O
a O
PGS O
- O
2 O
. O
CAT B
reporter O
gene O
, O
as O
well O
as O
a O
putative O
E O
- O
box O
region O
. O

The O
promoter O
region O
( O
P1 O
) O
corresponding O
to O
the O
main O
group O
of O
transcription O
initiation O
sites O
is O
devoid O
of O
TATA O
and O
CAAT O
boxes O
but O
has O
putative O
binding O
sites O
for O
the O
transcription B
factor I
SP1 I
and O
is O
embedded O
in O
a O
large O
G O
+ O
C O
- O
rich O
domain O
of O
a O
CpG O
island O
, O
features O
shared O
by O
the O
promoters O
of O
constitutively O
expressed O
housekeeping O
genes O
. O

The O
following O
evidence O
indicates O
that O
the O
69 O
- O
kD O
protein O
is O
a O
common O
, O
rather O
than O
a O
U1 B
- O
specific O
, O
protein O
, O
possibly O
associating O
with O
the O
snRNP O
core O
particles O
by O
protein O
- O
protein O
interaction O
. O

They O
suggest O
that O
decreased O
steady O
- O
state O
levels O
of O
IME1 B
and O
IME2 O
mRNA O
were O
not O
merely O
the O
result O
of O
non O
- O
specific O
adverse O
affects O
on O
nucleic O
acid O
metabolism O
caused O
by O
the O
yvh1 O
disruption O
. O

We O
remain O
convinced O
that O
antilymphocyte B
globulin I
( O
ALG B
) O
is O
a O
potent O
immunosuppressive O
agent O
in O
humans O
. O

Serum O
lipids O
and O
lipoproteins O
of O
29 O
insulin B
dependent O
diabetic O
children O
have O
been O
determined O
and O
related O
to O
the O
metabolic O
status O
of O
the O
patients O
. O

Thus O
, O
TRAF2 B
initiates O
SAPK B
and O
p38 B
activation O
by O
binding O
two O
proximal O
protein O
kinases O
: O
GCK O
and O
RIP O
. O

Protein B
C I
deficiency O
or O
protein B
S I
deficiency O
was O
the O
only O
identified O
risk O
factor O
for O
5 O
. O
4 O
% O
( O
2 O
patients O
) O
and O
13 O
. O
5 O
% O
( O
5 O
patients O
) O
, O
respectively O
, O
of O
these O
37 O
children O
. O

Among O
these O
360 O
ZFPs O
, O
a O
novel O
ZFP O
cDNA O
named O
HFHZ O
( O
human O
fetal O
heart O
ZFP O
) O
with O
sequence O
homology O
to O
a O
Kruppel O
- O
associated O
box O
( O
KRAB B
) O
was O
identified O
. O

The O
m7GpppN O
cap O
structure O
of O
eukaryotic O
mRNA O
is O
formed O
cotranscriptionally O
by O
the O
sequential O
action O
of O
three O
enzymes O
: O
RNA O
triphosphatase O
, O
RNA B
guanylyltransferase I
, O
and O
RNA O
( O
guanine O
- O
7 O
) O
- O
methyltransferase O
. O

Therefore O
, O
PC O
- O
PLC O
is O
a O
component O
of O
a O
signal O
transduction O
pathway O
leading O
to O
transcription O
of O
c B
- I
fos I
and O
junB B
that O
collaborates O
with O
c B
- I
myc I
and O
is O
independent O
of O
PKC B
- I
delta I
and O
Ras B
activation O
. O

They O
also O
negatively O
modulate O
the O
PI B
3 I
- I
kinase I
catalytic O
activity O
but O
to O
different O
extents O
, O
dependent O
on O
the O
unique O
N O
- O
terminal O
structure O
of O
each O
isoform O
. O

Taken O
together O
, O
these O
results O
suggest O
that O
silymarin O
may O
exert O
a O
strong O
anticarcinogenic O
effect O
against O
PCA O
and O
that O
this O
effect O
is O
likely O
to O
involve O
impairment O
of O
erbB1 B
- O
SHC B
- O
mediated O
signaling O
pathway O
, O
induction O
of O
CDKIs O
, O
and O
a O
resultant O
G1 O
arrest O
. O

Mutagenesis O
of O
IM1 O
enhances O
the O
ability O
of O
c B
- I
Fos I
to O
activate O
an O
AP1 O
bearing O
promoter O
. O

By O
using O
the O
full O
- O
length O
cytoplasmic O
domain O
and O
mutants O
with O
progressive O
carboxy O
- O
terminal O
deletions O
, O
internal O
deletions O
, O
or O
point O
mutations O
, O
we O
identified O
the O
first O
150 O
amino O
acid O
residues O
of O
LIFR B
as O
the O
minimal O
region O
necessary O
for O
signaling O
. O

Value O
of O
the O
method O
of O
passive O
hemagglutination O
with O
polysaccharide O
C O
in O
detecting O
C B
- I
reactive I
protein I
as O
compared O
to O
precipitation O
in O
capillaries O
and O
slide O
latex O
test O
with O
anti O
- O
CRP O
serum O

Evidence O
for O
a O
novel O
MAPKKK O
- O
independent O
pathway O
controlling O
the O
stress O
activated O
Sty1 O
/ O
Spc1 B
MAP O
kinase O
in O
fission O
yeast O
. O

The O
activity O
of O
Rac1 B
leads O
to O
STAT3 B
translocation O
to O
the O
nucleus O
coincident O
with O
STAT3 B
- O
dependent O
gene O
expression O
. O

The O
GEF B
and O
GAP B
activities O
for O
Ypt1p O
localize O
to O
particulate O
cellular O
fractions O
. O

Upon O
tyrosine O
phosphorylation O
at O
the O
ITIMs O
, O
these O
molecules O
recruit O
SH2 B
domain O
- O
containing O
phosphatases O
such O
as O
SH2 B
- O
containing O
tyrosine O
phosphatase O
- O
1 O
and O
negatively O
regulate O
cell O
activity O
. O

The O
promoter O
for O
HMG O
- O
CoA O
synthase O
contains O
two O
binding O
sites O
for O
the O
sterol B
regulatory I
element I
- I
binding I
proteins I
( O
SREBPs B
) O
. O

Here O
we O
provide O
the O
first O
evidence O
for O
the O
involvement O
of O
GCN1 B
- O
GCN2 B
interaction O
in O
activation O
of O
GCN2 B
per O
se O
. O

This O
transcriptional O
regulation O
occurs O
through O
modulation O
of O
the O
forkhead O
transcription O
factor O
FKHR O
- O
L1 O
, O
and O
IL B
- I
3 I
inhibited O
FKHR O
- O
L1 O
activity O
in O
a O
PI3K B
- O
dependent O
manner O
. O

The O
HiNF O
- O
D O
( O
CDP B
/ O
cut B
) O
complex O
with O
the O
H4 B
promoter I
is O
immunoreactive O
with O
antibodies O
against O
CDP B
/ O
cut B
and O
pRB B
but O
not O
p107 B
, O
whereas O
the O
CDP B
/ O
cut B
complex O
with O
a O
nonhistone O
promoter O
( O
gp91 B
- O
phox B
) O
reacts O
only O
with O
CDP B
and O
p107 B
antibodies O
. O

Binding O
activity O
in O
rat O
liver O
nuclear O
extracts O
includes O
these O
orphan O
receptors O
as O
judged O
from O
electromobility O
supershift O
experiments O
and O
from O
results O
obtained O
with O
expressed O
receptors O
, O
although O
the O
element O
in O
CYP2C11 O
did O
not O
bind O
HNF B
- I
4 I
. O

Isolation O
and O
characterization O
of O
the O
rat O
chromosomal O
gene O
for O
a O
polypeptide O
( O
pS1 B
) O
antigenically O
related O
to O
statin B
. O

These O
data O
reveal O
a O
complex O
network O
of O
interactions O
between O
GTPases B
in O
the O
ARF O
family O
and O
their O
effectors O
and O
reveal O
a O
potential O
for O
cross O
- O
talk O
not O
demonstrated O
previously O
. O

The O
interferon B
- O
induced O
RNA O
- O
dependent O
protein O
kinase O
( O
PKR B
) O
is O
considered O
to O
play O
an O
important O
role O
in O
the O
cellular O
defense O
against O
viral O
infection O
and O
, O
in O
addition O
, O
has O
been O
suggested O
to O
be O
a O
tumor O
suppressor O
gene O
because O
of O
its O
growth O
- O
suppressive O
properties O
. O

Immunoreactive O
AR B
content O
in O
transfected O
COS O
- O
1 O
cells O
was O
not O
influenced O
by O
exposure O
to O
8 O
- O
Br O
- O
cAMP O
. O

Substrates O
for O
p210 B
( O
bcr B
- O
abl B
) O
are O
likely O
to O
be O
involved O
in O
the O
pathogenesis O
of O
CML O
. O

We O
now O
demonstrate O
that O
CCAAT O
/ O
enhancer O
- O
binding O
protein O
( O
C O
/ O
EBP O
) O
delta O
is O
a O
major O
component O
of O
a O
PGE2 O
- O
stimulated O
DNA O
- O
protein O
complex O
involving O
HS3D O
and O
find O
that O
C B
/ I
EBPdelta I
transactivates O
IGF B
- I
I I
promoter I
1 I
through O
this O
site O
. O

Transactivation O
of O
oIFNtau O
enhancer O
- O
reporter O
constructs O
was O
primarily O
regulated O
by O
three O
regions O
containing O
AP B
- I
1 I
site I
, O
GATA O
like O
sequence O
and O
site O
( O
s O
) O
unidentified O
. O

Single O
amino O
acid O
substitutions O
at O
the O
acyl O
- O
CoA O
- O
binding O
domain O
interrupt O
14 O
[ O
C O
] O
palmitoyl O
- O
CoA O
binding O
of O
ACBP2 O
, O
an O
Arabidopsis O
acyl O
- O
CoA O
- O
binding O
protein O
with O
ankyrin B
repeats O
. O

This O
sequenced O
region O
of O
the O
V O
beta O
locus O
contains O
an O
average O
number O
of O
repetitive O
DNA O
elements O
( O
21 O
Alu B
, O
three O
L1 B
, O
three O
MER O
, O
and O
three O
retrovirus O
- O
related O
elements O
. O

Three O
mutants O
( O
pms1 B
, O
pms2 O
and O
pms3 O
) O
isolated O
earlier O
from O
MW104 O
- O
1B O
were O
shown O
to O
correct O
in O
vitro O
constructed O
plasmids O
with O
defined O
DNA O
mismatches O
( O
G O
/ O
T O
, O
A O
/ O
C O
, O
G O
/ O
G O
, O
etc O
. O
) O
poorly O
( O
Kramer O
et O
al O
. O
, O
1989a O
) O
. O

Platelet O
counts O
and O
function O
as O
well O
as O
fibrinogen B
and O
von B
Willebrand I
factor I
( O
vWF B
) O
levels O
were O
determined O
in O
each O
sample O
. O

The O
DNase B
I I
footprint O
extended O
5 O
' O
in O
the O
silencer O
region O
to O
include O
an O
inverted O
repeat O
of O
a O
six O
- O
nucleotide O
motif O
( O
epsilon O
- O
267 O
to O
- O
278 O
bp O
) O
which O
shares O
5 O
of O
6 O
bases O
with O
the O
GATA O
- O
1 O
consensus O
sequence O
. O

Because O
results O
of O
recent O
randomized O
trials O
indicate O
minimal O
efficacy O
of O
continuing O
MAC O
prophylaxis O
in O
patients O
who O
respond O
to O
potent O
combination O
antiretroviral O
therapy O
, O
the O
observed O
high O
incidence O
of O
macrolide O
- O
resistant O
bacterial O
colonization O
of O
the O
respiratory O
tract O
in O
this O
trial O
supports O
the O
discontinuation O
of O
macrolide O
prophylaxis O
in O
all O
AIDS O
patients O
whose O
CD4 B
counts O
have O
risen O
above O
100 O
cells O
/ O
microL O
. O

These O
data O
should O
be O
useful O
in O
developing O
reagents O
for O
heterozygote O
detection O
and O
prenatal O
diagnosis O
of O
11 B
beta I
- I
hydroxylase I
deficiency O
, O
the O
second O
most O
frequent O
cause O
of O
congenital O
adrenal O
hyperplasia O
. O

The O
first O
identification O
of O
the O
active O
37LRP O
/ O
p40 B
gene O
presented O
in O
this O
study O
is O
a O
critical O
step O
toward O
the O
isolation O
of O
the O
corresponding O
human O
gene O
and O
the O
understanding O
of O
the O
molecular O
mechanisms O
involved O
in O
the O
up O
- O
regulation O
of O
its O
expression O
during O
tumor O
invasion O
and O
metastasis O
. O

Platelet B
- I
derived I
growth I
factor I
- O
dependent O
activation O
of O
phosphatidylinositol B
3 I
- I
kinase I
is O
regulated O
by O
receptor O
binding O
of O
SH2 O
- O
domain O
- O
containing O
proteins O
which O
influence O
Ras B
activity O
. O

The O
high O
density O
lipoprotein O
( O
HDL O
) O
receptor O
mediates O
the O
uptake O
of O
cholesterol O
and O
cholesteryl O
esters O
, O
substrates O
for O
steroidogenesis O
, O
from O
an O
HDL B
particle O
in O
the O
adrenal O
gland O
and O
gonads O
. O

The O
mechanism O
involves O
Gbetagamma B
subunit O
- O
mediated O
increases O
in O
tyrosine O
phosphorylation O
of O
the O
Shc B
adapter I
protein I
, O
Shc B
* O
Grb2 B
complex O
formation O
, O
and O
recruitment O
of O
Ras O
guanine O
nucleotide O
exchange O
factor O
activity O
. O

Kaposi O
' O
s O
sarcoma O
- O
associated O
herpesvirus O
viral O
interferon O
regulatory O
factor O
confers O
resistance O
to O
the O
antiproliferative O
effect O
of O
interferon B
- I
alpha I
. O

The O
enhanced O
binding O
of O
c B
- I
Abl I
to O
DNA O
containing O
5 O
- O
methylcytosine O
residues O
may O
result O
from O
an O
increased O
propensity O
of O
the O
double O
helix O
to O
denature O
locally O
coupled O
with O
a O
protein O
- O
induced O
reduction O
in O
the O
base O
stacking O
interaction O
. O

In O
contrast O
, O
gel O
mobility O
shift O
experiments O
have O
failed O
to O
reveal O
that O
HAP2 B
or O
HAP3 B
binds O
to O
domain O
1 O
or O
that O
hap3 B
mutations O
affect O
the O
complexes O
bound O
to O
it O
. O

Here O
we O
report O
the O
purification O
of O
this O
larger O
form O
as O
an O
approximately O
320 O
- O
kDa O
particle O
that O
contains O
mRNP3 B
+ I
4 I
and O
nine O
additional O
polypeptides O
, O
including O
mRNA O
- O
binding O
polypeptides O
of O
34 O
and O
36 O
kDa O
and O
a O
doublet O
of O
110 O
/ O
105 O
kDa O
that O
proved O
to O
be O
nucleolin B
. O

Once O
the O
proliferation O
of O
fibroblasts O
and O
collagen B
synthesis O
had O
led O
to O
an O
increase O
of O
mechanical O
strength O
, O
no O
negative O
effect O
on O
wound O
healing O
could O
be O
detected O
applying O
the O
same O
chemotherapeutic O
agents O
. O

In O
co O
- O
transfection O
studies O
, O
the O
expression O
of O
c B
- I
Jun I
plus O
c B
- I
Fos I
enhanced O
the O
transactivation O
of O
oIFNtau O
- O
CAT B
but O
the O
expression O
of O
GATA B
- I
1 I
, O
GATA O
- O
2 O
or O
GATA B
- I
3 I
did O
not O
. O

Finally O
, O
some O
point O
mutations O
in O
the O
Gag B
- O
Pol B
PR O
domain O
inhibited O
activation O
of O
RT B
in O
trans O
by O
a O
wild O
- O
type O
PR B
, O
suggesting O
that O
the O
correct O
conformation O
of O
the O
PR B
domain O
in O
Gag B
- O
Pol B
is O
prerequisite O
for O
activation O
of O
RT B
. O

The O
activity O
of O
the O
EGF O
receptor O
promoter O
can O
be O
modulated O
by O
E1A B
protein I
and O
receptor O
RNA O
levels O
increased O
by O
stimulation O
with O
phorbol O
ester O
or O
fetal O
calf O
serum O
. O

Electrophoretic O
mobility O
shift O
assays O
revealed O
that O
Sp1 B
binds O
to O
two O
different O
regions O
in O
the O
proximal O
promoter O
, O
a O
typical O
Sp1 B
site I
located O
at O
( O
- O
38 O
; O
- O
33 O
) O
and O
a O
G O
/ O
C O
- O
rich O
region O
between O
( O
- O
67 O
; O
- O
62 O
) O
. O

Changes O
in O
immunologic O
reactivity O
in O
subjects O
receiving O
transfer B
factor I
could O
not O
be O
distinguished O
from O
those O
in O
subjects O
receiving O
placebo O
. O

The O
LTR O
- O
binding O
activities O
of O
VBP O
, O
a1 O
/ O
EBP O
, O
and O
B O
- O
cell O
nuclear O
extract O
protein O
were O
compared O
and O
mapped O
by O
gel O
shift O
, O
DNase B
I I
footprinting O
, O
and O
methylation O
interference O
assays O
. O

These O
results O
indicate O
that O
ATF B
- I
2 I
plays O
a O
central O
role O
in O
TGF B
- I
beta I
signaling O
by O
acting O
as O
a O
common O
nuclear O
target O
of O
both O
Smad B
and O
TAK1 B
pathways O
. O

This O
model O
is O
supported O
by O
experiments O
showing O
that O
Cdr2 B
associates O
with O
the O
N O
- O
terminal O
regulatory O
domain O
of O
Wee1 O
in O
cell O
lysates O
and O
phosphorylates O
Wee1 B
in O
vitro O
. O

These O
results O
support O
a O
model O
in O
which O
p53 B
protein I
contributes O
to O
the O
maintenance O
of O
genomic O
integrity O
through O
recombinational O
repair O
. O

The O
U14 O
genes O
of O
mouse O
as O
well O
as O
rat O
, O
hamster O
, O
human O
, O
Xenopus O
and O
trout O
are O
encoded O
within O
introns O
of O
the O
constitutively O
expressed O
70 O
- O
kDa O
- O
cognate O
- O
heat O
- O
shock O
protein O
gene O
( O
hsc70 B
) O
. O

Expression O
of O
human O
RACK1 O
efficiently O
relieves O
E1A B
- O
mediated O
growth O
inhibition O
in O
HF7c O
and O
protects O
human O
tumor O
cells O
from O
E1A B
- O
induced O
apoptosis O
. O

Taken O
together O
, O
these O
observations O
indicate O
that O
inhibition O
of O
p27 B
( O
KIP1 B
) O
transcription O
through O
PI3K B
- O
induced O
FKHR O
- O
L1 O
phosphorylation O
provides O
a O
novel O
mechanism O
of O
regulating O
cytokine O
- O
mediated O
survival O
and O
proliferation O
. O

We O
observed O
abundant O
levels O
of O
Rev B
- O
erbA O
alpha O
mRNA O
in O
dividing O
C2C12 O
myoblasts O
, O
which O
were O
suppressed O
when O
the O
cells O
differentiated O
into O
postmitotic O
multinucleated O
myotubes O
. O

Fowlpox O
virus O
encodes O
nonessential O
homologs O
of O
cellular O
alpha O
- O
SNAP O
, O
PC B
- I
1 I
, O
and O
an O
orphan O
human O
homolog O
of O
a O
secreted O
nematode O
protein O
. O

The O
gene O
is O
contained O
within O
a O
1 O
. O
8 O
- O
kilobase O
AccI O
- O
EcoRI B
restriction O
fragment O
mapping O
at O
map O
coordinates O
0 O
. O
136 O
to O
0 O
. O
148 O
in O
the O
UL O
region O
of O
the O
EHV O
- O
1 O
genome O
and O
is O
transcribed O
from O
right O
to O
left O
. O

A O
chimeric O
VP16 B
- O
Tat B
construct O
containing O
the O
leucine O
mutations O
showed O
no O
increased O
AP B
- I
1 I
responsiveness O
in O
comparison O
with O
that O
of O
the O
VP16 B
activation I
domain I
alone O
. O

CONCLUSIONS O
: O
This O
randomized O
study O
shows O
that O
Vivostat O
fibrin B
sealant O
is O
effective O
in O
preventing O
air O
leakage O
after O
small O
lung O
resections O
in O
pigs O
, O
even O
at O
high O
inspiratory O
pressures O
. O

Splice O
variations O
in O
genes O
coding O
for O
the O
transmembrane O
FGF O
receptor O
( O
FGFR B
) O
result O
in O
isoforms O
that O
vary O
in O
the O
ectodomain O
, O
intracellular O
juxtamembrane O
domain O
, O
and O
the O
intracellular O
kinase O
domain O
. O

A O
short O
sequence O
surrounding O
the O
major O
JNK B
phosphorylation O
site O
of O
c B
- I
Jun I
is O
conserved O
in O
c B
- I
Fos I
and O
is O
part O
of O
its O
activation O
domain O
, O
suggesting O
that O
c B
- I
Fos I
may O
be O
similarly O
regulated O
. O

In O
HCMV O
( O
Towne O
) O
- O
infected O
HF O
cells O
at O
24 O
to O
48 O
h O
, O
IE2 B
also O
accumulated O
in O
newly O
formed O
viral O
DNA O
replication O
compartments O
containing O
the O
polymerase O
processivity O
factor O
( O
UL44 O
) O
, O
the O
single O
- O
stranded O
DNA O
binding O
protein O
( O
SSB O
; O
UL57 O
) O
, O
the O
UL112 O
- O
113 O
accessory O
protein O
, O
and O
newly O
incorporated O
bromodeoxyuridine O
( O
BrdU O
) O
. O

We O
have O
followed O
37 O
phenytoin O
- O
treated O
patients O
with O
reduced O
serum B
IgA I
concentrations O
for O
2 O
- O
7 O
years O
. O

Moreover O
, O
Lck B
was O
reversibly O
co O
- O
immunoprecipitated O
with O
p95Vav O
, O
and O
the O
stoichiometry O
of O
binding O
increased O
in O
anti O
- O
CD3 O
- O
treated O
Jurkat O
cells O
. O

The O
binding O
of O
PH O
domains O
to O
Gbetagamma B
was O
inhibited O
by O
preincubation O
of O
Gbetagamma B
with O
the O
GDP O
- O
bound O
but O
not O
the O
GTP O
- O
bound O
form O
of O
Gialpha O
. O

A O
mutation O
in O
the O
C O
domain O
of O
Rb B
, O
L901Q O
, O
has O
been O
identified O
that O
completely O
abolishes O
cdk4 B
/ O
D1 O
phosphorylation O
of O
the O
isolated O
C O
domain O
. O

The O
highly O
amyloidogenic O
42 O
- O
residue O
form O
of O
Abeta B
( O
Abeta42 O
) O
is O
the O
first O
species O
to O
be O
deposited O
in O
both O
sporadic O
and O
familial O
AD O
. O

A O
strong O
trithorax O
binding O
site O
was O
found O
at O
the O
cytological O
location O
of O
the O
fork O
head O
gene O
, O
a O
region O
- O
specific O
homeotic B
gene I
not O
located O
within O
a O
homeotic O
complex O
. O

Protein O
kinase O
A O
- O
Ialpha O
subunit O
- O
directed O
antisense O
inhibition O
of O
ovarian O
cancer O
cell O
growth O
: O
crosstalk O
with O
tyrosine B
kinase I
signaling O
pathway O
. O

This O
short O
communication O
compares O
a O
novel O
fluorimetric O
microplate O
enzyme O
immunoassay O
( O
FEIA O
) O
with O
a O
commercial O
time O
- O
resolved O
fluoroimmunoassay O
for O
the O
determination O
of O
thyrotropin B
in O
dried O
blood O
spots O
. O

Furthermore O
, O
we O
demonstrated O
that O
Galpha11 O
Q209L O
stimulated O
Src B
family I
kinase O
activity O
and O
induced O
tyrosine O
phosphorylation O
of O
several O
proteins O
in O
HEK O
- O
293 O
cells O
. O

Sp1 B
binds O
two O
sites O
in O
the O
CD11c O
promoter O
in O
vivo O
specifically O
in O
myeloid O
cells O
and O
cooperates O
with O
AP1 B
to O
activate O
transcription O
. O

Small O
Maf O
proteins O
heterodimerize O
with O
Fos B
and O
may O
act O
as O
competitive O
repressors O
of O
the O
NF O
- O
E2 O
transcription O
factor O
. O

Naltrexone O
hydrochloride O
is O
a O
synthetic O
opioid B
receptor I
antagonist O
recently O
used O
in O
efforts O
to O
provide O
rapid O
opioid O
detoxification O
. O

Uses O
of O
orthoclone O
OKT3 B
for O
prophylaxis O
of O
rejection O
and O
induction O
in O
initial O
nonfunction O
in O
kidney O
transplantation O
. O

We O
concluded O
that O
activation O
of O
c O
- O
fosER O
mediated O
transcriptional O
inhibition O
of O
p21 B
( O
Cip1 B
/ O
WAF1 B
) O
through O
a O
previously O
uncharacterized O
AP B
- I
1 I
site I
, O
revealing O
an O
important O
role O
for O
c B
- I
fos I
in O
negative O
control O
of O
cell O
cycle O
regulatory O
genes O
. O

An O
inactive O
analog O
of O
wortmannin O
, O
WM12 O
, O
did O
not O
affect O
TCR B
/ O
CD3 B
- O
induced O
Erk2 B
activation O
, O
and O
wortmannin O
had O
no O
effect O
on O
the O
activity O
of O
Erk2 B
when O
added O
directly O
to O
the O
in O
vitro O
assays O
. O

Western O
blotting O
( O
immunoblotting O
) O
with O
an O
antiserum O
to O
a O
partial O
SOD B
expressed O
in O
Escherichia O
coli O
revealed O
two O
proteins O
with O
estimated O
molecular O
masses O
of O
19 O
and O
29 O
kDa O
. O

Plasmids O
were O
constructed O
with O
the O
mouse O
promoter O
region O
linked O
to O
the O
reporter O
gene O
chloramphenicol O
acetyltransferase O
( O
CAT B
) O
, O
and O
transiently O
and O
stably O
transfected O
in O
the O
INS O
- O
1 O
cells O
. O

TRAF2 B
is O
known O
to O
associate O
with O
TRADD B
, O
and O
expression O
of O
a O
dominant O
- O
negative O
N O
- O
terminal O
deletion O
TRAF2 O
mutant O
was O
found O
to O
partially O
inhibit O
LMP1 B
- O
induced O
JNK B
activation O
in O
293 O
cells O
. O

A O
contiguous O
and O
sequentially O
occupied O
secondary O
Fur O
- O
binding O
site O
in O
entC O
was O
protected O
at O
higher O
Fur B
concentrations O
, O
extending O
the O
protected O
region O
to O
+ O
49 O
, O
and O
sequestering O
the O
putative O
Shine O
- O
Dalgarno O
sequence O
. O

Epstein O
- O
Barr O
virus O
- O
encoded O
latent O
membrane O
protein O
1 O
activates O
the O
JNK B
pathway O
through O
its O
extreme O
C O
terminus O
via O
a O
mechanism O
involving O
TRADD B
and O
TRAF2 B
. O

Botulinum B
toxin I
: O
preferred O
treatment O
for O
hemifacial O
spasm O
. O

Angiotensin B
II I
induces O
nuclear O
factor O
( O
NF O
) O
- O
kappaB1 O
isoforms O
to O
bind O
the O
angiotensinogen O
gene O
acute O
- O
phase O
response O
element O
: O
a O
stimulus O
- O
specific O
pathway O
for O
NF B
- I
kappaB I
activation O
. O

Furthermore O
, O
this O
kinase O
- O
deficient O
mutant O
inhibited O
2 O
- O
MeSADP O
- O
induced O
caspase B
- I
3 I
stimulation O
and O
the O
associated O
decrease O
in O
cell O
number O
. O

Factor B
VIII I
procoagulant O
activity O
, O
antigen O
concentration O
and O
von O
Willebrand O
activity O
as O
ristocetin O
cofactor O
were O
determined O
several O
times O
in O
10 O
patients O
with O
DIC O
. O

The O
git1 O
, O
git3 O
, O
git5 O
, O
git7 O
, O
git8 O
and O
git10 O
genes O
act O
upstream O
of O
adenylate B
cyclase I
, O
presumably O
encoding O
an O
adenylate B
cyclase I
activation O
pathway O
. O

In O
a O
heterologous O
transcriptional O
system O
in O
which O
the O
upstream O
regions O
of O
oIFNtau O
were O
inserted O
in O
front O
of O
simian O
virus O
40 O
( O
SV40 O
) O
promoter O
, O
the O
regions O
between O
bases O
- O
654 O
and O
- O
555 O
were O
determined O
as O
being O
the O
enhancer O
region O
required O
for O
oIFNtau O
- O
SV40 O
- O
CAT B
transactivation O
. O

In O
an O
attempt O
to O
understand O
Wee1 B
regulation O
during O
cell O
cycle O
, O
yeast O
two O
- O
hybrid O
screening O
was O
used O
to O
identify O
Wee1 O
- O
binding O
protein O
( O
s O
) O
. O

C B
/ I
EBP I
alpha I
also O
activates O
the O
promoter O
of O
the O
rat O
class O
- O
I O
ADH O
gene O
in O
a O
sequence O
- O
specific O
manner O
[ O
Potter O
et O
al O
. O
, O
Arch O
. O

C B
/ I
EBP I
alpha I
also O
activates O
the O
promoter O
of O
the O
rat O
class O
- O
I O
ADH O
gene O
in O
a O
sequence O
- O
specific O
manner O
[ O
Potter O
et O
al O
. O
, O
Arch O
. O

Our O
results O
confirm O
the O
participation O
of O
intron O
1 O
in O
transcriptional O
regulation O
of O
the O
c B
- I
myb I
gene I
( O
in O
mouse O
and O
human O
) O
and O
implicate O
multiple O
and O
complex O
regulatory O
mechanisms O
of O
activation O
during O
myelomonocytic O
differentiation O
and O
leukemic O
cell O
growth O
control O
. O

This O
TC O
- O
II O
enhanson O
, O
which O
is O
identical O
to O
the O
kappa B
B I
motif I
from O
the O
kappa O
chain O
enhancer O
, O
was O
active O
in O
both O
lymphoid O
and O
non O
- O
lymphoid O
cells O
, O
which O
contrasts O
with O
the O
previously O
reported O
lymphoid O
cell O
specificity O
of O
the O
kappa B
B I
motif I
. O

Mutations O
in O
the O
nuclear O
gene O
CBP1 O
of O
Saccharomyces O
cerevisiae O
result O
in O
degradation O
of O
mitochondrially O
encoded O
cytochrome O
b O
( O
cob B
) O
RNA O
; O
thus O
, O
the O
cells O
are O
unable O
to O
respire O
. O

Plasma B
secretin I
, O
pancreozymin O
, O
and O
somatostatin O
- O
like O
hormone O
in O
chronic O
renal O
failure O
patients O
. O

DNase B
I I
genomic O
footprinting O
revealed O
that O
the O
c O
- O
Myb O
site O
is O
occupied O
in O
a O
tissue O
- O
specific O
fashion O
in O
vivo O
. O

Minor O
differences O
were O
noted O
with O
latamoxef O
producing O
mild O
persistant O
elevation O
of O
prothrombin B
time O
( O
0 O
. O
7 O
second O
) O
associated O
with O
depression O
of O
factor B
II I
and O
factor B
VII I
. O

Consistent O
with O
these O
findings O
, O
relatively O
weak O
transcriptional O
silencing O
by O
the O
native O
VDR B
was O
observed O
using O
the O
osteopontin O
VDRE O
. O

The O
U17 O
/ O
U16 O
and O
the O
U16 O
+ O
gene O
products O
transactivated O
the O
HIV B
LTR I
. O

Implication O
of O
PAF B
and O
acetylhydrolase O
( O
PAF O
- O
AH O
) O
activity O
in O
periodontal O
disease O
. O

RNase B
protection O
analysis O
of O
two O
rRNA O
fragments O
whose O
genes O
are O
adjacent O
provided O
evidence O
for O
a O
polycistronic O
transcript O
containing O
sequences O
from O
both O
, O
as O
well O
as O
separate O
small O
RNAs O
. O

PATIENTS O
AND O
METHODS O
: O
We O
report O
our O
experience O
with O
seven O
children O
with O
active O
small O
bowel O
Crohn O
' O
s O
disease O
given O
a O
casein B
- O
based O
, O
polymeric O
feed O
rich O
in O
TGF O
- O
beta O
2 O
( O
Specific O
Polymeric O
Diet O
; O
Nestle O
- O
Clintec O
; O
Vevey O
, O
Switzerland O
) O
as O
complete O
nutrition O
for O
8 O
weeks O
. O

Interestingly O
, O
the O
interaction O
of O
ZAP B
- I
70 I
with O
the O
motif O
was O
dependent O
on O
the O
presence O
of O
both O
ZAP B
- I
70 I
SH2 B
domains I
and O
both O
of O
the O
tyrosine O
residues O
in O
the O
motif O
, O
suggesting O
that O
ZAP B
- I
70 I
interacts O
with O
two O
phosphotyrosine O
residues O
and O
that O
the O
binding O
of O
the O
two O
SH2 B
domains I
is O
cooperative O
. O

Neither O
mutant O
exhibited O
derepression O
of O
the O
silent B
mating I
type I
loci I
. O

The O
carboxyl O
- O
terminal O
CCCC O
module O
is O
structurally O
related O
to O
the O
DNA O
- O
binding O
domain O
of O
the O
erythroid B
transcription I
factor I
GATA I
- I
1 I
. O

The O
cis O
- O
acting O
elements O
that O
control O
promoter O
activity O
include O
binding O
sites O
for O
transcription O
factors O
Sp1 B
and O
alphaCbf O
, O
a O
60 O
- O
kDa O
CCAAT O
box O
- O
binding O
protein O
. O

The O
level O
of O
serum B
creatine I
kinase I
was O
significantly O
high O
2 O
days O
after O
ESWIB O
, O
but O
it O
recovered O
in O
a O
week O
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
( O
HTLV O
- O
I O
) O
encodes O
a O
40 O
- O
kDa O
nuclear O
protein O
, O
Tax B
, O
which O
stimulates O
transcription O
from O
three O
21 O
- O
base O
pair O
( O
bp O
) O
repeats O
in O
its O
U3 O
region O
. O

Our O
results O
suggest O
that O
WASP O
activates O
transcription O
following O
TCR B
stimulation O
in O
a O
manner O
that O
is O
independent O
of O
its O
role O
in O
Arp2 O
/ O
3 O
- O
directed O
actin B
polymerization O
. O

Furthermore O
, O
stable O
expression O
of O
a O
constitutively O
active O
form O
of O
chicken O
Notch1 B
or O
Notch2 O
in O
a O
B O
cell O
line O
results O
in O
a O
down O
- O
regulation O
of O
surface O
IgM B
expression O
, O
which O
is O
accompanied O
by O
the O
reduction O
of O
IgH O
gene O
transcripts O
. O

The O
human O
cDNA O
was O
used O
to O
demonstrate O
that O
tumor B
necrosis I
factor I
- I
alpha I
could O
rapidly O
stimulate O
MARCKS O
gene O
transcription O
in O
the O
human O
promyelocytic O
leukemia O
cell O
line O
HL60 O
. O

Interleukin B
- I
1 I
levels O
remained O
low O
throughout O
the O
course O
. O

Intracellular O
localization O
studies O
using O
the O
mDAP O
- O
3 O
/ O
EGFP B
fusion O
protein O
, O
cell O
fractionation O
and O
protease O
protection O
experiments O
localized O
mDAP O
- O
3 O
to O
the O
mitochondrial O
matrix O
. O

Derivation O
and O
initial O
characterization O
of O
a O
mouse O
mammary O
tumor O
cell O
line O
carrying O
the O
polyomavirus B
middle I
T I
antigen I
: O
utility O
in O
the O
development O
of O
novel O
cancer O
therapeutics O
. O

Consistent O
with O
ErbB B
- I
2 I
being O
a O
shared O
receptor O
subunit O
, O
its O
tyrosine O
phosphorylation O
was O
increased O
by O
both O
heterologous O
ligands O
and O
it O
mediated O
a O
trans O
- O
inhibitory O
effect O
of O
NDF O
on O
EGF B
binding O
. O

The O
p97 B
- O
depleted O
nuclei O
remained O
largely O
competent O
for O
nuclear O
protein O
import O
. O

A O
cause O
of O
increase O
of O
alkaline B
phosphatase I
in O
children O

The O
gene O
encoding O
the O
receptor O
for O
macrophage O
colony O
- O
stimulating O
factor O
1 O
( O
CSF B
- I
1 I
) O
, O
the O
c O
- O
fms O
protooncogene O
, O
is O
selectively O
expressed O
in O
immature O
and O
mature O
mononuclear O
phagocytes O
and O
trophoblasts O
. O

Electrophoretic O
mobility O
- O
shift O
assays O
performed O
with O
the O
HNF B
- I
3 I
X O
and O
Y O
sites O
demonstrated O
that O
both O
sites O
are O
capable O
of O
binding O
HNF O
- O
3alpha O
and O
HNF O
- O
3beta O
. O

The O
observed O
phenotypes O
may O
be O
explained O
by O
( O
i O
) O
a O
selective O
disruption O
of O
very O
- O
low O
- O
density O
lipoprotein O
secretion O
due O
to O
decreased O
expression O
of O
genes O
encoding O
apolipoprotein O
B O
and O
microsomal O
triglyceride O
transfer O
protein O
, O
( O
ii O
) O
an O
increase O
in O
hepatic O
cholesterol O
uptake O
due O
to O
increased O
expression O
of O
the O
major O
high B
- I
density I
lipoprotein I
receptor I
, O
scavenger O
receptor O
BI O
, O
and O
( O
iii O
) O
a O
decrease O
in O
bile O
acid O
uptake O
to O
the O
liver O
due O
to O
down O
- O
regulation O
of O
the O
major O
basolateral O
bile O
acid O
transporters O
sodium O

RESULTS O
: O
Surprisingly O
, O
PAF B
blockade O
increased O
mortality O
after O
trauma O
( O
5 O
of O
11 O
WEB O
- O
2086 O
animals O
versus O
1 O
of O
9 O
vehicle O
animals O
; O
p O
= O
0 O
. O
15 O
) O
and O
depressed O
cardiac O
index O
and O
O2 O
delivery O
at O
72 O
hours O
( O
p O
< O
0 O
. O
05 O
) O
. O

The O
N O
- O
terminal O
small O
segment O
of O
yeast O
TAF145 O
( O
yTAF145 O
) O
binds O
to O
TBP B
and O
thereby O
inhibits O
TBP B
function O
. O

Relatively O
little O
is O
known O
regarding O
the O
role O
of O
5 B
- I
HT2 I
receptor I
activity O
in O
male O
rat O
sexual O
behavior O
. O

TNF B
Treatment O
of O
cell O
activated O
the O
p38 B
MAP I
kinase I
pathway O
, O
as O
revealed O
by O
increased O
phosphorylation O
of O
p38 B
MAP I
kinase I
itself O
, O
activation O
of O
the O
substrate O
protein O
MAPKAP B
kinase I
- I
2 I
, O
and O
culminating O
in O
the O
phosphorylation O
of O
the O
heat O
shock O
protein O
27 O
( O
hsp27 O
) O
. O

The O
deduced O
amino O
acid O
sequence O
of O
the O
gene O
has O
significant O
homology O
to O
the O
interferon B
regulatory I
factors I
( O
IRFs B
) O
. O

NF B
- I
kappa I
B I
/ O
Rel B
transcription O
factors O
participate O
in O
the O
activation O
of O
numerous O
genes O
involved O
in O
immune O
regulation O
/ O
inflammation O
including O
cytokines O
, O
cell O
surface O
receptors O
, O
adhesion O
molecules O
, O
and O
acute O
phase O
proteins O
. O

Tyrosine O
phosphorylation O
of O
cellular O
proteins O
is O
the O
earliest O
identifiable O
event O
following O
T O
- O
cell O
antigen O
receptor O
( O
TCR B
) O
stimulation O
and O
is O
essential O
for O
activating O
downstream O
signaling O
machinery O
. O

The O
interaction O
between O
DDB O
and O
E2F1 B
can O
also O
be O
detected O
by O
coimmunoprecipitation O
experiments O
. O

Multiple O
SWI6 B
- O
dependent O
cis O
- O
acting O
elements O
control O
SWI4 B
transcription O
through O
the O
cell O
cycle O
. O

To O
determine O
whether O
vanadate O
could O
inhibit O
PEPCK B
gene I
transcription O
, O
a O
series O
of O
chimeric O
genes O
containing O
several O
deletions O
in O
the O
P O
- O
enolypyruvate O
carboxykinase O
promoter O
between O
- O
550 O
and O
- O
68 O
was O
linked O
to O
the O
structural O
genes O
for O
either O
amino O
- O
3 O
- O
glycosyl O
phosphotransferase O
( O
neo B
) O
or O
chloramphenicol B
acetyltransferase I
and O
introduced O
into O
hepatoma O
cells O
using O
three O
methods O
: O
( O
a O
) O
infection O
with O
a O
Moloney O
murine O
leukemia O
virus O
- O
based O
retrovirus O
, O
( O
b O

) O
transfection O
and O
stable O
selection O
for O
neo B
expression O
, O
or O
( O
c O
) O
transient O
expression O
of O
chloroamphenicol O
acetyltransferase O
. O

The O
expression O
of O
alpha B
- I
amylase I
can O
be O
transactivated O
by O
the O
transcription O
factor O
GAMyb O
, O
which O
is O
itself O
induced O
by O
GA O
. O

Furthermore O
, O
transfection O
of O
cells O
with O
the O
spacer O
- O
RING O
domain O
alone O
suppressed O
the O
antiapoptotic O
function O
of O
the O
N O
- O
terminal O
BIR B
domain O
of O
c O
- O
IAP1 O
and O
induced O
apoptosis O
. O

Mutually O
exclusive O
interaction O
of O
the O
adenovirus O
E4 O
- O
6 O
/ O
7 O
protein O
and O
the O
retinoblastoma B
gene I
product I
with O
internal O
domains O
of O
E2F B
- I
1 I
and O
DP B
- I
1 I
. O

Comparable O
amounts O
of O
alpha O
5 O
beta O
1 O
integrin O
were O
isolated O
from O
these O
cells O
by O
chromatography O
of O
detergent O
extracts O
on O
a O
fibronectin B
cell O
- O
binding O
fragment O
affinity O
column O
and O
elution O
with O
EDTA O
. O

These O
data O
show O
that O
the O
alpha O
- O
helix O
domain O
of O
p57 O
( O
Kip2 O
) O
, O
which O
is O
conserved O
in O
the O
Cip O
/ O
Kip O
proteins O
, O
is O
implicated O
in O
protein O
- O
protein O
interaction O
and O
confers O
a O
specific O
regulatory O
mechanism O
, O
outside O
of O
their O
Cdk B
- O
inhibitory O
activity O
, O
by O
which O
the O
p57 O
( O
Kip2 O
) O
family O
members O
positively O
act O
on O
myogenic O
differentiation O
. O

Since O
AP B
- I
1 I
is O
an O
important O
mediator O
of O
tumor O
promoter O
action O
, O
these O
findings O
may O
explain O
the O
anti O
- O
tumor O
- O
promoting O
activity O
of O
phenolic O
antioxidants O
. O

Demonstration O
of O
tissue O
lesions O
after O
intramuscular O
injection O
by O
determination O
of O
creatine B
kinase I
in O
blood O

Higher O
fasting O
serum O
gastrin B
concentration O
( O
102 O
. O
0 O
+ O
/ O
- O
21 O
. O
1 O
vs O
63 O
. O
3 O
+ O
/ O
- O
8 O
. O
3 O
ng O
. O
l O
- O
1 O
) O
, O
and O
greater O
postprandial O
gastrin B
release O
( O
AUC0 O
- O
120 O
: O
16690 O
+ O
/ O
- O
2648 O
vs O
10654 O
+ O
/ O
- O
1283 O
ng O
. O
l O
- O
1 O
min O
) O
were O
observed O
after O
VTP O
- O
HM O
than O
after O
VTP O
- O
Cas O
. O

Mutations O
within O
conserved O
region O
2 O
( O
CR2 O
) O
of O
E1A B
that O
inhibit O
the O
binding O
of O
E1A B
to O
the O
retinoblastoma B
gene I
product I
( O
pRb B
) O
further O
enhanced O
the O
stimulation O
of O
transcription O
from O
the O
PEPCK O
promoter O
by O
2 O
3 O
- O
fold O
compared O
with O
wild O
type O
E1A O
. O

We O
used O
stored O
plasma O
samples O
from O
409 O
patients O
in O
the O
National O
Institute O
of O
Neurological O
Diseases O
and O
Stroke O
( O
NINDS O
) O
tissue B
plasminogen I
activator I
( O
t B
- I
PA I
) O
Stroke O
Trial O
to O
examine O
the O
relationship O
between O
an O
apolipoprotein O
( O
Apo O
) O
E2 O
or O
an O
Apo O
E4 O
phenotype O
and O
a O
favorable O
outcome O
3 O
months O
after O
stroke O
, O
the O
risk O
of O
intracerebral O
hemorrhage O
, O
and O
the O
response O
to O
intravenous O
t B
- I
PA I
therapy O
. O

Mapping O
of O
intracellular O
localization O
domains O
and O
evidence O
for O
colocalization O
interactions O
between O
the O
IE110 B
and O
IE175 B
nuclear O
transactivator O
proteins O
of O
herpes O
simplex O
virus O
. O

Vimentin B
positivity O
was O
noted O
in O
the O
undifferentiated O
and O
fibroblastic O
components O
. O

Increased O
erythropoietin B
synthesis O
in O
patients O
with O
COLD O
or O
left O
heart O
failure O
is O
related O
to O
alterations O
in O
renal O
haemodynamics O
. O

These O
results O
suggest O
that O
Cdc42p B
is O
in O
fact O
required O
for O
pheromone O
response O
and O
that O
interaction O
with O
the O
PAK B
Ste20p B
is O
critical O
for O
that O
role O
. O

Taken O
together O
, O
these O
results O
indicate O
that O
MAP B
kinase I
stimulates O
the O
hPL O
- O
B O
enhancer O
by O
an O
NF B
- I
IL I
- I
6 I
- O
dependent O
pathway O
. O

The O
discussion O
focuses O
primarily O
on O
the O
newer O
drugs O
like O
angiotensin B
converting I
enzyme I
inhibitors O
, O
alpha O
- O
adrenergic O
receptor O
blockers O
, O
and O
calcium O
antagonists O
. O

Specific O
IgE B
levels O
decreased O
slightly O
, O
but O
always O
remained O
within O
the O
pathological O
range O
. O

Effect O
of O
castration O
on O
pituitary O
and O
serum O
LH O
and O
FSH B
in O
testosterone O
- O
sterilized O
rats O
. O

Substantial O
evidence O
supports O
a O
critical O
role O
for O
the O
activation O
of O
the O
Raf B
- I
1 I
/ O
MEK B
/ O
mitogen B
- I
activated I
protein I
kinase I
pathway O
in O
oncogenic O
Ras B
- O
mediated O
transformation O
. O

A O
reciprocal O
binding O
assay O
using O
IM O
- O
9 O
cells O
as O
a O
source O
of O
SHP B
- I
1 I
and O
SHP B
- I
2 I
revealed O
specific O
association O
of O
SHP B
- I
2 I
( O
but O
not O
SHP B
- I
1 I
) O
with O
a O
glutathione O
S O
- O
transferase O
fusion O
incorporating O
GHR O
cytoplasmic O
domain O
residues O
485 O
- O
620 O
, O
but O
only O
if O
the O
fusion O
was O
first O
rendered O
tyrosine O
- O
phosphorylated O
. O

Several O
mutations O
disrupted O
the O
endonuclease O
and O
helicase B
activities O
; O
however O
, O
only O
one O
amino O
- O
terminal O
- O
charge O
cluster O
mutant O
protein O
( O
D40A O
- O
D42A O
- O
D44A O
) O
completely O
lost O
AAV O
hairpin O
DNA O
binding O
activity O
. O

The O
84 O
. O
1C O
mAb O
recognizes O
a O
site O
on O
IgE B
which O
is O
identical O
or O
very O
close O
to O
the O
Fc O
epsilon O
R O
binding O
site O
, O
and O
95 O
. O
3 O
recognizes O
a O
site O
on O
IgE B
which O
is O
related O
, O
but O
not O
identical O
to O
the O
Fc O
epsilon O
R O
binding O
site O
. O

Abrogation O
of O
p53 B
function O
by O
E6 B
resulted O
in O
an O
increase O
in O
the O
spontaneous O
mutation O
frequencies O
at O
the O
heterozygous O
thymidine B
kinase I
( O
TK B
) O
locus O
but O
not O
at O
the O
hemizygous O
hypoxanthine O
phosphoribosyl O
transferase O
( O
HPRT O
) O
locus O
. O

A O
second O
important O
molecule O
in O
TCR B
signal O
transduction O
is O
the O
guanine O
nucleotide O
binding O
protein O
, O
p21ras B
, O
which O
is O
coupled O
to O
the O
TCR B
by O
a O
protein B
tyrosine I
kinase I
dependent O
mechanism O
. O

The O
contribution O
that O
alternative O
splicing O
events O
in O
c B
- I
myb I
expression O
may O
make O
on O
c B
- I
myb I
function O
remains O
to O
be O
elucidated O
. O

However O
, O
by O
immobilized O
metal O
affinity O
chromatography O
assay O
, O
self O
- O
association O
of O
PR B
- I
A I
was O
3 O
. O
5 O
- O
fold O
more O
efficient O
than O
that O
of O
either O
the O
DhLBD O
or O
hLBD O
constructs O
. O

These O
similarities O
suggest O
that O
these O
E2 B
proteins I
are O
structurally O
and O
evolutionarily O
related O
. O

Secretory O
IgA O
and O
serum B
immunoglobulins I
as O
indices O
of O
the O
local O
immunity O
of O
the O
intestinal O
mucosa O
in O
acute O
leukemias O

Immunofluorescence O
studies O
in O
C2C12 O
myotubes O
show O
that O
Smad2 B
and O
MEF2A O
co O
- O
localise O
in O
the O
nucleus O
of O
multinuclear O
myotubes O
during O
differentiation O
. O

Tumor B
necrosis I
factor I
signaling O
to O
stress B
- I
activated I
protein I
kinase I
( O
SAPK B
) O
/ O
Jun O
NH2 O
- O
terminal O
kinase O
( O
JNK B
) O
and O
p38 B
. O

AMY O
- O
1 O
was O
localized O
in O
the O
cytoplasm O
in O
cells O
expressing O
c B
- I
myc I
at O
low O
levels O
, O
but O
in O
the O
nucleus O
in O
the O
cells O
of O
a O
high O
c B
- I
myc I
expression O
in O
transiently O
transfected O
cells O
. O

This O
region O
of O
hsp90 B
mediates O
ATP O
- O
independent O
chaperone O
activity O
, O
overlaps O
the O
hsp90 O
dimerization O
domain O
, O
and O
includes O
structural O
elements O
important O
for O
steroid O
receptor O
interaction O
. O

Serum O
insulin O
- O
like O
growth O
factor O
I O
( O
IGF B
- I
I I
) O
SD O
score O
increased O
from O
- O
2 O
. O
2 O
and O
- O
4 O
. O
2 O
in O
men O
and O
women O
, O
respectively O
, O
to O
1 O
. O
8 O
and O
- O
0 O
. O
9 O
at O
6 O
months O
and O
0 O
. O
8 O
and O
- O
0 O
. O
7 O
at O
12 O
months O
. O

The O
cDNA O
segment O
is O
flanked O
by O
the O
immunoglobulin O
gene O
recombination O
signal O
sequences O
so O
that O
the O
cDNA O
segment O
can O
invert O
and O
the O
human O
IL O
- O
2R O
L O
chain O
is O
subsequently O
expressed O
under O
the O
control O
of O
the O
SV40 B
promoter I
. O

Sequence O
comparisons O
strongly O
suggest O
that O
the O
S27a O
and O
the O
ubiquitin B
coding O
sequences O
found O
in O
the O
genome O
of O
CP O
Rit O
were O
both O
derived O
from O
a O
bovine O
mRNA O
encoding O
a O
hybrid O
protein O
with O
the O
structure O
NH2 O
- O
ubiquitin B
- O
S27a O
- O
COOH O
. O

Oncogenic O
signalling O
by O
E2F1 B
has O
recently O
been O
linked O
to O
stabilization O
and O
activation O
of O
the O
tumour O
suppressor O
p53 B
( O
refs O
1 O
, O
3 O
, O
4 O
) O
. O

TBP B
can O
be O
phosphorylated O
in O
vitro O
by O
extracts O
of O
U937 O
cells O
or O
by O
bacterially O
expressed O
activated O
ERK2 B
; O
the O
phosphorylation O
sites O
were O
mapped O
to O
ERK O
kinase O
consensus O
sites O
in O
the O
TBP O
amino O
- O
terminal O
domain O
. O

Although O
RAD17 O
, O
RAD24 B
and O
MEC3 O
are O
not O
required O
for O
cell O
cycle O
arrest O
when O
S O
phase O
is O
inhibited O
by O
hydroxyurea O
( O
HU O
) O
, O
they O
do O
contribute O
to O
the O
viability O
of O
yeast O
cells O
grown O
in O
the O
presence O
of O
HU O
, O
possibly O
because O
they O
are O
required O
for O
the O
repair O
of O
HU O
- O
induced O
DNA O
damage O
. O

DESIGN O
: O
Serum O
aldosterone O
and O
plasma B
renin I
activity O
were O
measured O
supine O
prior O
to O
and O
60 O
, O
90 O
, O
120 O
minutes O
after O
oral O
captopril O
, O
25 O
mg O
. O

We O
have O
found O
that O
the O
expression O
of O
GTPase B
- O
deficient O
mutants O
of O
alpha O
12 O
( O
alpha O
12Q229L O
) O
or O
alpha O
13 O
( O
alpha O
13Q226L O
) O
leads O
to O
robust O
activation O
of O
the O
Jun B
kinase I
/ O
stress B
- I
activated I
protein I
kinase I
( O
JNK B
/ O
SAPK B
) O
pathway O
. O

The O
effect O
of O
nitric B
oxide I
synthase I
inhibitor O
on O
reperfusion O
injury O
of O
the O
brain O
under O
hypothermic O
circulatory O
arrest O
. O

The O
present O
data O
also O
indicate O
that O
patients O
with O
TGBM O
nephropathy O
often O
have O
concomitant O
IgA B
nephropathy O
and O
mesangial O
proliferative O
glomerulonephritis O
. O

We O
previously O
showed O
that O
this O
proteolysis O
1 O
) O
can O
be O
acutely O
promoted O
by O
the O
phorbol O
ester O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
, O
2 O
) O
requires O
a O
metalloprotease B
activity O
, O
3 O
) O
generates O
both O
shed O
GHBP O
and O
a O
membrane O
- O
associated O
GHR O
transmembrane O
/ O
cytoplasmic O
domain O
remnant O
, O
and O
4 O
) O
results O
in O
down O
- O
regulation O
of O
GHR O
abundance O
and O
GH B
signaling O
. O

Blood O
GSH B
- I
Px I
activity O
was O
measured O
with O
a O
spectrophotometer O
, O
using O
a O
modification O
of O
a O
previously O
described O
assay O
. O

Sp1 B
and O
two O
Sp3 O
isoforms O
were O
detected O
as O
the O
primary O
cellular O
constituents O
of O
DNA O
- O
protein O
complexes O
formed O
with O
the O
NF O
- O
kappaB O
- O
proximal O
site O
. O

Spontaneous O
sensitization O
to O
cross O
- O
reacting O
chemicals O
in O
a O
proportion O
of O
control O
animals O
is O
strongly O
suggested O
, O
somewhat O
akin O
to O
spontaneous O
sensitization O
in O
patients O
with O
anaphylactoid O
reactions O
to O
neuromuscular O
blockers O
on O
first O
exposure O
, O
and O
in O
whom O
IgE B
antibodies I
are O
detected O
. O

This O
may O
account O
, O
at O
least O
in O
part O
, O
for O
the O
ability O
of O
excess O
wt B
p53 I
to O
inhibit O
cell O
proliferation O
and O
to O
interfere O
with O
neoplastic O
processes O
. O

IgG B
and O
IgM B
antibody O
activity O
was O
determined O
by O
adding O
a O
1 O
: O
100 O
dilution O
of O
serum O
to O
plates O
coated O
with O
A60 B
antigen I
. O

We O
demonstrate O
here O
that O
the O
- O
DEDDDL O
sequence O
stabilizes O
GDP O
binding O
to O
Ran B
, O
and O
that O
the O
domain O
is O
required O
for O
high O
affinity O
interaction O
with O
a O
Ran O
- O
binding O
protein O
, O
HTF9A O
/ O
RanBP1 B
. O

The O
major O
transcription O
factors O
controlling O
arginine O
metabolism O
in O
Escherichia O
coli O
and O
Bacillus O
subtilis O
, O
ArgR B
and O
AhrC O
, O
respectively O
, O
are O
homologous O
multimeric O
proteins O
that O
form O
l O
- O
arginine O
- O
dependent O
DNA O
- O
binding O
complexes O
capable O
of O
repressing O
transcription O
of O
the O
biosynthetic O
genes O
( O
both O
) O
, O
activating O
transcription O
of O
catabolic O
genes O
( O
AhrC O
only O
) O
or O
facilitating O
plasmid O
dimer O
resolution O
( O
both O
) O
. O

E2F1 B
- O
mediated O
transcriptional O
inhibition O
of O
the O
plasminogen O
activator O
inhibitor O
type O
1 O
gene O
. O

We O
also O
show O
that O
p65 B
binds O
to O
these O
targets O
with O
almost O
equal O
affinity O
and O
that O
different O
residues O
have O
variable O
roles O
in O
binding O
different O
kappaB O
targets O
. O

The O
RNase O
MRP O
RNA O
gene O
was O
deleted O
by O
insertional O
replacement O
and O
found O
to O
be O
essential O
for O
cellular O
viability O
, O
indicating O
a O
critical O
nuclear O
role O
for O
RNase B
MRP I
. O

SRE O
activity O
is O
dependent O
upon O
the O
activation O
by O
phosphorylation O
of O
a O
ternary O
complex O
factor O
; O
included O
among O
the O
ternary O
complex O
factors O
is O
Elk B
- I
1 I
. O

INTERVENTIONS O
: O
Patients O
received O
rt B
- I
PA I
, O
heparin O
, O
and O
aspirin O
. O

A O
poor O
correlation O
was O
also O
observed O
between O
PbB O
and O
ALAD B
activity O
of O
the O
stearate O
workers O
. O

These O
findings O
suggest O
a O
functional O
cross O
- O
talk O
between O
RB B
protein I
and O
p21ras B
, O
which O
balances O
the O
cell O
phenotype O
between O
normal O
and O
transformed O
states O
. O

GH B
failed O
to O
stimulate O
phosphorylation O
or O
activation O
of O
Jun B
N I
- I
terminal I
kinase I
under O
the O
conditions O
used O
. O

Three O
subgenomes O
also O
comprised O
15 O
to O
75 O
nucleotides O
derived O
from O
the O
5 O
' O
part O
of O
the O
NS2 B
gene I
. O

The O
p130 B
and O
p62 B
tyrosine O
- O
phosphorylated O
proteins O
that O
complexed O
v B
- I
Src I
SH2 B
in O
vitro O
also O
associated O
with O
v B
- I
Src I
in O
v B
- I
src I
- O
transformed O
Rat O
- O
2 O
cells O
; O
this O
in O
vivo O
binding O
was O
dependent O
on O
the O
v B
- I
Src I
SH2 B
domain O
. O

Previously O
, O
we O
showed O
that O
the O
APRE O
is O
a O
cytokine O
[ O
tumor B
necrosis I
factor I
- I
alpha I
( O
TNFalpha B
) O
] O
- O
inducible O
enhancer O
by O
binding O
the O
heterodimeric O
nuclear O
factor O
- O
kappaB O
( O
NF B
- I
kappaB I
) O
complex O
Rel O
A O
x O
NF O
- O
kappaB1 O
. O

Of O
the O
remaining O
seven O
, O
five O
reacted O
either O
with O
immediate O
and O
strong O
symptoms O
or O
had O
spontaneously O
reduced O
gluten O
intake O
, O
or O
had O
an O
acquired O
IgA B
deficiency O
. O

As O
no O
complete O
PPARgamma B
antagonists O
have O
been O
described O
hitherto O
, O
we O
have O
constructed O
a O
dominant O
- O
negative O
mutant O
receptor O
to O
inhibit O
wild O
- O
type O
PPARgamma B
action O
. O

When O
ligated O
to O
the O
proIL O
- O
1 O
beta O
cap O
site O
- O
proximal O
region O
( O
located O
between O
- O
131 O
to O
+ O
12 O
) O
, O
both O
the O
proIL O
- O
1 O
beta O
and O
the O
simian O
virus O
40 O
enhancer O
elements O
functioned O
more O
efficiently O
in O
monocytes O
than O
in O
HeLa O
cells O
, O
which O
are O
not O
normally O
competent O
for O
IL B
- I
1 I
beta I
expression O
. O

Using O
a O
conditional O
- O
lethal O
mutant O
allele O
of O
SUP45 O
( O
sup45 O
- O
2 O
) O
and O
a O
combination O
of O
in O
vivo O
and O
in O
vitro O
approaches O
, O
we O
demonstrate O
that O
the O
product O
of O
the O
SUP45 O
gene O
( O
Sup45p O
or O
eRF1 B
) O
is O
a O
factor O
required O
for O
translation O
termination O
in O
yeast O
. O

Expression O
of O
lacZ B
from O
the O
promoter O
of O
the O
Escherichia O
coli O
spc O
operon O
cloned O
into O
vectors O
carrying O
the O
W205 O
trp B
- O
lac B
fusion O
. O

We O
have O
now O
tested O
all O
known O
mammalian O
Groucho O
family O
members O
for O
their O
ability O
to O
interact O
specifically O
with O
individual O
Tcf B
/ O
Lef B
family O
members O
. O

These O
results O
further O
support O
an O
important O
role O
for O
CBF2 B
in O
mediating O
EBNA2 B
transactivation O
; O
they O
identify O
the O
hnRNP O
protein O
AUF1 O
as O
a O
major O
component O
of O
CBF2 B
and O
are O
also O
the O
first O
evidence O
of O
a O
cis O
- O
acting O
sequence O
other O
than O
a O
CBF1 O
binding O
element O
that O
is O
able O
to O
confer O
responsiveness O
to O
EBNA2 B
. O

To O
understand O
whether O
Shc B
localization O
in O
membrane O
rafts O
is O
sufficient O
to O
regulate O
Shc B
function O
, O
we O
constructed O
a O
Shc O
chimera O
containing O
the O
Ras O
membrane O
localization O
motif O
at O
the O
C O
- O
terminus O
. O

CM O
reduced O
the O
nuclear O
binding O
activity O
of O
transcription B
factor I
AP I
- I
1 I
. O

Diverse O
endogenous O
light O
chains O
contribute O
to O
basement O
membrane O
reactivity O
in O
nonautoimmune O
mice O
transgenic O
for O
an O
anti O
- O
laminin O
Ig B
heavy I
chain I
. O

The O
serum O
erythropoietin B
( O
EPO B
) O
concentrations O
of O
15 O
male O
triathletes O
( O
26 O
. O
3 O
U O
. O
ml O
- O
1 O
) O
were O
significantly O
lower O
than O
those O
of O
45 O
male O
distance O
runners O
( O
31 O
. O
6 O
U O
. O
ml O
- O
1 O
; O
P O
less O
than O
0 O
. O
05 O
) O
. O

At O
the O
C O
- O
terminus O
of O
the O
protein O
is O
a O
domain O
that O
contains O
sequences O
very O
similar O
to O
those O
found O
in O
the O
breakpoint O
cluster O
region O
gene O
product O
, O
n O
- O
chimerin O
, O
and O
rho O
GAP O
, O
all O
of O
which O
have O
been O
shown O
to O
possess O
intrinsic O
GAP B
activity O
on O
small O
GTPases O
. O

Both O
of O
these O
dogs O
had O
low O
serum O
IgG B
( O
3 O
. O
5 O
to O
7 O
. O
2 O
mg O
/ O
ml O
) O
and O
the O
second O
littermate O
also O
had O
reduced O
serum O
IgA B
( O
< O
0 O
. O
1 O
to O
0 O
. O
15 O
mg O
/ O
ml O
) O
. O

Overexpression O
of O
wild B
- I
type I
p53 I
also O
induces O
apoptosis O
in O
an O
LCL O
. O

Slap O
negatively O
regulates O
Src B
mitogenic O
function O
but O
does O
not O
revert O
Src B
- O
induced O
cell O
morphology O
changes O
. O

Unlike O
wild B
- I
type I
p53 I
, O
the O
delta O
proAE O
mutant O
cDNA O
can O
be O
stably O
expressed O
in O
tumor O
derived O
cell O
lines O
with O
few O
immediate O
detrimental O
effects O
. O

RT O
- O
PCR O
analysis O
showed O
that O
PLP O
- O
H O
as O
well O
as O
PLP O
- O
C O
and O
PLP O
- O
D O
are O
expressed O
in O
all O
rat O
strains O
examined O
, O
confirming O
that O
PLP B
diversity O
is O
not O
due O
to O
strain O
differences O
. O

Previous O
work O
showed O
that O
repA B
( O
initiator O
protein O
) O
expression O
requires O
tap O
( O
leader O
peptide O
) O
translation O
. O

In O
Rat O
1a O
cells O
, O
m1R O
stimulation O
of O
phospholipase O
C O
beta O
and O
the O
marked O
rise O
in O
intracellular O
calcium O
stimulated O
cyclic O
AMP O
( O
cAMP O
) O
synthesis O
, O
resulting O
in O
the O
activation O
of O
protein B
kinase I
A I
. O

Because O
the O
mutant O
defective O
in O
DNA O
binding O
also O
fails O
to O
stimulate O
Abf1 O
ARS1 O
DNA O
- O
binding O
activity O
, O
our O
results O
suggest O
that O
Cdc6 B
DNA O
- O
binding O
activity O
may O
play O
a O
pivotal O
role O
in O
the O
initiation O
of O
DNA O
replication O
. O

The O
statistical O
analysis O
of O
data O
of O
TRH B
test O
on O
a O
sample O
of O
57 O
healthy O
volunteers O
has O
permitted O
an O
evaluation O
of O
the O
upper O
limits O
of O
the O
normal O
thyrotropin B
response O
; O
the O
secretory O
area O
( O
As O
) O
was O
shown O
to O
be O
more O
discriminating O
. O

Neither O
gene O
possesses O
a O
distinct O
transcriptional O
start O
site O
as O
shown O
by O
nuclease B
S1 I
analysis O
. O

Results O
of O
the O
official O
inspection O
of O
the O
commercial O
anti O
- O
inflammatory O
enzyme O
preparations O
containing O
chymotrypsin O
and O
trypsin B
by O
means O
of O
modified O
NF O
13 O
methods O

Furthermore O
, O
a O
minor O
start O
site O
was O
localized O
179 O
bp O
upstream O
of O
the O
major O
site O
using O
reverse B
transcriptase I
- O
polymerase O
chain O
reaction O
with O
various O
P1 O
primers O
( O
primer O
walking O
) O
, O
primer O
extension O
, O
and O
cDNA O
cloning O
. O

LY290181 O
appears O
to O
inhibit O
uPA B
promoter I
activation O
by O
blocking O
phorbol O
ester O
- O
stimulated O
binding O
of O
nuclear O
proteins O
to O
the O
uPA O
PEA3 B
/ O
12 O
- O
0 O
- O
tetradecanoylphorbol O
13 O
- O
acetate O
responsive O
element O
( O
TRE O
) O
. O

We O
then O
demonstrated O
that O
1 O
) O
GAL4 B
- O
REV B
- O
erbA O
alpha O
chimeras O
that O
contain O
the O
' O
AB O
' O
region O
and O
lack O
the O
' O
E O
' O
region O
activated O
transcription O
of O
GAL4 O
response O
elements O
in O
the O
presence O
of O
8 O
- O
Br O
- O
cAMP O
and O
2 O
) O
the O
ligand O
- O
binding O
domain O
( O
LBD O
) O
contains O
an O
active O
transcriptional O
silencer O
. O

We O
also O
show O
that O
activation O
of O
protein B
kinase I
A I
( O
PKA B
) O
signaling O
is O
sufficient O
to O
down O
- O
regulate O
caveolin O
- O
1 O
protein O
expression O
and O
promoter O
activity O
. O

In O
adherent O
macrophages O
, O
absence O
of O
CD45 O
led O
to O
the O
hyperphosphorylation O
and O
hyperactivation O
of O
p56 O
/ O
59 O
( O
hck O
) O
and O
p53 O
/ O
56 O
( O
lyn B
) O
, O
but O
not O
of O
p58 B
( O
c O
- O
fgr O
) O
. O

The O
structural O
study O
of O
peptides O
belonging O
to O
the O
terminal O
domains O
of O
histone B
H1 I
can O
be O
considered O
as O
a O
step O
toward O
the O
understanding O
of O
the O
function O
of O
H1 B
in O
chromatin O
. O

In O
our O
previous O
studies O
, O
transcriptional O
activation O
was O
shown O
to O
correlate O
with O
IEP86 B
binding O
to O
both O
the O
TATA B
- I
box I
binding I
protein I
( O
TBP B
) O
and O
the O
transcription O
factor O
bound O
upstream O
. O

Peroxisome B
proliferator I
- I
activated I
receptors I
( O
PPARs B
) O
and O
retinoid O
X O
receptors O
( O
RXRs O
) O
are O
nuclear O
hormone O
receptors O
that O
are O
activated O
by O
fatty O
acids O
and O
9 O
- O
cis O
- O
retinoic O
acid O
, O
respectively O
. O

A O
point O
mutation O
in O
Galphao O
and O
Galphai1 O
blocks O
interaction O
with O
regulator O
of O
G B
protein I
signaling O
proteins O
. O

Activation O
of O
PKA B
by O
8 O
- O
bromo O
- O
cyclic O
AMP O
or O
forskolin O
, O
and O
inhibition O
of O
PKC B
by O
calphostin O
C O
, O
resulted O
in O
a O
significant O
decrease O
in O
3TP O
activity O
as O
well O
as O
in O
vitro O
ERK B
kinase I
activity O
in O
CRAC O
. O

Radiation O
- O
induced O
changes O
in O
the O
area O
of O
alveoli O
and O
septa O
as O
well O
as O
collagen B
content O
were O
seen O
11 O
weeks O
after O
irradiation O
. O

Our O
results O
suggest O
that O
the O
C O
- O
terminal O
region O
of O
Crk B
contains O
negative O
regulatory O
elements O
important O
for O
both O
Abl B
and O
FAK B
dependent O
signal O
pathways O
, O
and O
offers O
a O
paradigm O
for O
an O
autoinhibitory O
region O
in O
the O
SH3 B
linker O
/ O
C O
- O
terminal O
SH3 B
domain O
. O

The O
sequence O
and O
isolated O
cDNAs O
will O
provide O
useful O
reagents O
for O
studying O
the O
expression O
of O
Brca1 B
in O
the O
mouse O
, O
and O
for O
testing O
the O
importance O
of O
the O
evolutionarily O
conserved O
domains O
. O

RVR O
' O
loss O
of O
function O
' O
studies O
by O
constitutive O
over O
- O
expression O
of O
a O
dominant O
negative O
RVR O
delta O
E O
resulted O
in O
increased O
levels O
of O
p21Cip1 B
/ O
Waf1 B
and O
myogenin O
mRNAs O
after O
serum O
withdrawal O
. O

This O
soluble O
form O
of O
the O
HGFr O
( O
sHGFr O
) O
bound O
HGF B
with O
an O
affinity O
similar O
to O
that O
of O
the O
authentic O
, O
membrane O
- O
associated O
receptor O
. O

Patients O
with O
detectable O
serum O
TNF B
levels O
had O
significantly O
lower O
serum O
T3 O
concentrations O
compared O
to O
those O
with O
undetectable O
levels O
[ O
1 O
. O
072 O
+ O
/ O
- O
0 O
. O
588 O
vs O
. O

Finally O
, O
antibody O
binding O
to O
site O
IIIa O
on O
the O
hCG O
- O
ectodomain O
complex O
was O
also O
hindered O
by O
an O
anti O
- O
peptide O
mAb O
directed O
against O
a O
peptide O
encoded O
by O
the O
eighth O
exon O
( O
pE O
x O
8 O
) O
of O
the O
LHR B
. O

Northern O
( O
RNA O
) O
analysis O
demonstrated O
expression O
of O
human O
PI B
3 I
- I
kinase I
in O
all O
tissues O
and O
cell O
lines O
tested O
. O

Collectively O
, O
this O
study O
emphasizes O
a O
critical O
role O
of O
Phox2a O
as O
well O
as O
its O
functional O
synergism O
with O
other O
transcription O
factors O
( O
e O
. O
g O
. O
, O
CREB B
, O
AP2 B
, O
and O
Sp1 B
) O
in O
transcriptional O
activation O
of O
the O
DBH O
gene O
. O

Blood O
from O
dams O
was O
collected O
prior O
to O
inoculation O
and O
at O
time O
of O
necropsy O
for O
measurement O
of O
IgM B
and O
IgG B
antibodies I
to O
M O
. O
pulmonis O
. O

Consistent O
with O
this O
model O
, O
a O
synthetic O
construct O
containing O
three O
tandem O
copies O
of O
the O
native O
LDL O
receptor O
SREBP B
site O
linked O
to O
a O
single O
Sp1 B
site I
was O
also O
significantly O
activated O
in O
a O
buttonhead O
- O
independent O
fashion O
. O

Alternatively O
, O
PC12 O
- O
E2 O
cells O
were O
submitted O
to O
treatment O
with O
antibodies O
to O
the O
fibroblast O
growth O
factor O
( O
FGF O
) O
receptor O
, O
inhibitors O
of O
the O
nonreceptor O
tyrosine O
kinase O
p59 O
( O
fyn B
) O
, O
PLC O
, O
PKC B
and O
MEK B
and O
an O
activator O
of O
PKC B
, O
phorbol O
- O
12 O
- O
myristate O
- O
13 O
- O
acetate O
( O
PMA O
) O
. O

Cyclin O
- O
dependent O
kinase O
- O
2 O
( O
Cdk2 B
) O
forms O
an O
inactive O
complex O
with O
cyclin B
D1 I
since O
Cdk2 B
associated O
with O
cyclin B
D1 I
is O
not O
phosphorylated O
by O
Cdk7 B
- O
cyclin O
- O
H O
. O

A O
human O
cytoplasmic O
signaling O
protein O
has O
been O
cloned O
that O
possesses O
the O
same O
structural O
arrangement O
of O
SH3 B
- O
SH2 B
- O
SH3 B
domains O
as O
Grb2 B
. O

Liver O
transplantation O
in O
one O
patient O
resolved O
metabolic O
complications O
but O
did O
not O
improve O
PMN O
count O
or O
the O
infectious O
status O
, O
while O
neutropenia O
was O
corrected O
by O
G B
- I
CSF I
. O

According O
to O
the O
published O
sequence O
of O
the O
CHS1 O
gene O
, O
this O
fragment O
contains O
four O
repeats O
of O
a O
TGAAACA O
consensus O
sequence O
previously O
identified O
in O
the O
alpha B
- I
factor I
- O
inducible O
BAR1 O
promoter O
[ O
Kronstad O
, O
J O
. O

The O
epidermal O
growth O
factor O
( O
EGF O
) O
receptor O
, O
which O
exhibits O
intrinsic O
protein B
tyrosine I
kinase I
activity O
, O
undergoes O
a O
rapid O
, O
intramolecular O
self O
- O
phosphorylation O
reaction O
following O
EGF B
activation O
. O

However O
, O
tyrA O
can O
be O
expressed O
efficiently O
from O
an O
internal O
promoter O
which O
appears O
to O
lie O
within O
the O
3 O
' O
portion O
of O
aroF B
. O

SCID O
V O
( O
D O
) O
J O
recombination O
can O
be O
partly O
rescued O
in O
T O
- O
lymphocytes O
by O
either O
DNA O
- O
damaging O
agents O
( O
gamma O
- O
irradiation O
and O
bieomycin O
) O
or O
a O
null O
mutation O
of O
the O
p53 B
gene I
, O
possibly O
because O
of O
transiently O
elevated O
DNA O
repair O
activity O
in O
response O
to O
DNA O
damage O
or O
to O
delayed O
apoptosis O
in O
the O
absence O
of O
p53 B
. O

Examination O
of O
immediate O
- O
early O
transcription O
factor O
expression O
during O
the O
MDI O
regimen O
revealed O
that O
RA O
mediated O
an O
elevated O
, O
prolonged O
expression O
of O
c O
- O
Jun O
mRNA O
accompanied O
by O
diminished O
expression O
of O
c B
- I
Fos I
and O
Jun O
- O
B O
mRNAs O
. O

These O
cells O
fail O
to O
generate O
the O
signals O
to O
phosphorylate O
CREB B
and O
produce O
significantly O
less O
of O
the O
cytokine O
Interleukin B
- I
2 I
( O
IL B
- I
2 I
) O
in O
response O
to O
agents O
that O
either O
increase O
intracellular O
Ca2 O
+ O
and O
/ O
or O
activate O
protein B
kinase I
C I
. O

Treating O
renal O
anaemia O
with O
recombinant O
human O
erythropoietin B
. O

The O
activated O
glucocorticoid B
receptor I
forms O
a O
complex O
with O
Stat5 B
and O
enhances O
Stat5 B
- O
mediated O
transcriptional O
induction O
. O

We O
conclude O
that O
RPMS O
acts O
as O
a O
negative O
regulator O
of O
EBNA2 B
and O
Notch B
activity O
through O
its O
interactions O
with O
the O
CBF1 O
- O
associated O
corepressor O
complex O
. O

The O
human O
ABCG1 O
gene O
encodes O
a O
member O
of O
the O
ATP B
- I
binding I
cassette I
( O
ABC O
) O
superfamily O
of O
transporter O
proteins O
and O
is O
highly O
induced O
when O
macrophages O
are O
incubated O
with O
oxysterols O
. O

Here O
we O
describe O
an O
in O
vitro O
assay O
where O
the O
NS3 O
- O
4A O
polyprotein O
, O
NS3 B
, O
the O
serine O
proteinase O
domain O
( O
the O
N O
- O
terminal O
181 O
residues O
of O
NS3 O
) O
, O
and O
the O
NS4A O
cofactor O
were O
produced O
by O
cell O
- O
free O
translation O
and O
tested O
for O
trans O
- O
processing O
of O
radiolabeled O
substrates O
. O

These O
results O
indicate O
that O
the O
PCNA B
gene I
is O
a O
likely O
target O
gene O
of O
E2F B
. O

SBF B
binds O
to O
the O
promoter O
prior O
to O
the O
activation O
of O
transcription O
in O
late O
G1 O
, O
suggesting O
that O
Cln O
/ O
Cdc28 B
kinase O
regulates O
the O
ability O
of O
previously O
bound O
SBF B
to O
activate O
transcription O
. O

Altogether O
these O
results O
suggest O
that O
, O
in O
KG1a O
cells O
, O
TNFalpha B
can O
stimulate O
in O
parallel O
PC O
- O
PLC O
and O
PLD O
, O
whose O
lipid O
products O
activate O
in O
turn O
mitogen B
- I
activated I
protein I
kinase I
( O
MAP B
kinase I
) O
and O
NF B
- I
kappaB I
signalling O
respectively O
. O

Surprisingly O
, O
Northern O
( O
RNA O
) O
blot O
analysis O
and O
reverse B
transcriptase I
- O
PCRs O
performed O
after O
transfection O
of O
COS O
- O
7 O
or O
HeLa O
cells O
with O
these O
viral O
RNAs O
revealed O
that O
Y88S O
and O
Y88L O
RNAs O
replicated O
at O
only O
very O
low O
levels O
. O

Tissue B
plasminogen I
activator I
, O
its O
inhibitor O
and O
other O
parameters O
of O
fibrinolysis O
in O
blood O
of O
patients O
operated O
for O
mild O
hypertrophy O
of O
the O
prostate O

Deletion O
analyses O
implicate O
the O
N O
- O
terminal O
110 O
amino O
acids O
of O
Grb14 O
and O
ankyrin B
repeats O
10 O
- O
19 O
of O
tankyrase O
2 O
in O
mediating O
this O
interaction O
. O

The O
STAT O
- O
1 O
signaling O
pathway O
provides O
at O
least O
one O
mechanism O
for O
activation O
of O
the O
CAEV O
LTR O
by O
IFN B
- I
gamma I
in O
monocytes O
. O

Plasma O
CCK B
levels O
were O
determined O
at O
regular O
intervals O
. O

The O
algorithm O
also O
limited O
TG O
to O
20 O
and O
64 O
% O
, O
apoB B
to O
6 O
and O
20 O
% O
, O
and O
Lp B
( I
a I
) I
to O
15 O
and O
56 O
% O
, O
of O
low O
- O
and O
high O
- O
risk O
groups O
, O
respectively O
. O

These O
results O
are O
consistent O
with O
the O
roles O
that O
CCK B
and O
trypsin B
inhibitors O
are O
believed O
to O
play O
in O
the O
negative O
feedback O
control O
of O
pancreatic O
exocrine O
function O
. O

By O
DNase B
I I
footprint O
analysis O
of O
the O
PNR O
element O
, O
a O
palindrome O
of O
two O
high O
- O
affinity O
Ets B
- I
binding I
sites I
( O
CTTCCCTGGAAG O
) O
was O
identified O
. O

We O
show O
here O
that O
the O
in O
vitro O
transcription O
extract O
contains O
a O
binding O
activity O
that O
is O
specific O
for O
the O
initiator O
element O
and O
thus O
may O
participate O
in O
recruiting O
RNA B
polymerase I
II I
to O
the O
SL O
RNA O
gene O
promoter O
. O

Co O
- O
administration O
of O
5FU O
, O
angiotensin B
II I
and O
microspheres O
via O
the O
hepatic O
artery O
may O
reduce O
drug O
exposure O
in O
the O
systemic O
compartment O
and O
therefore O
may O
increase O
the O
therapeutic O
ratio O
of O
5FU O
administration O
via O
the O
hepatic O
artery O
. O

It O
is O
largely O
predicted O
by O
lupus O
anticoagulant O
( O
estimated O
by O
activated O
partial O
thromboplastin B
time O
) O
and O
/ O
or O
antibody O
to O
cardiolipin O
. O

The O
concentrations O
of O
apo B
A I
- I
I I
and O
apo O
A O
- O
II O
of O
abstainers O
decreased O
significantly O
compared O
with O
the O
corresponding O
changes O
in O
controls O
. O

TNFalpha B
and O
IL B
- I
6 I
levels O
were O
determined O
in O
the O
culture O
supernatants O
. O

Among O
these O
, O
ACT1 O
was O
isolated O
four O
times O
, O
and O
NSR1 B
three O
times O
. O

The O
phenotypes O
of O
the O
ICP0 B
nonsense O
mutants O
were O
intermediate O
between O
those O
of O
the O
wild O
- O
type O
virus O
and O
7134 O
in O
that O
the O
more O
ICP0 O
- O
coding O
sequence O
expressed O
by O
a O
given O
nonsense O
mutant O
, O
the O
more O
wild O
type O
- O
like O
was O
its O
phenotype O
. O

These O
results O
suggest O
that O
the O
c O
- O
met O
gene O
is O
also O
a O
target O
of O
p53 B
gene I
regulation O
. O

It O
is O
believed O
that O
these O
domains O
are O
important O
for O
directing O
specific O
protein O
- O
protein O
interactions O
necessary O
for O
the O
proper O
functioning O
of O
Src B
. O

By O
contrast O
, O
all O
proteins O
initiated O
with O
a O
methionine O
placed O
one O
residue O
upstream O
of O
the O
natural O
N O
terminus O
of O
PR B
failed O
to O
show O
specific O
proteolysis O
. O

Escherichia O
coli O
BL21 O
( O
DE3 O
) O
plysS O
, O
harbouring O
a O
recombinant O
plasmid O
containing O
the O
catalase B
- O
peroxidase B
gene O
, O
produced O
a O
large O
amount O
of O
proteins O
that O
co O
- O
migrated O
on O
SDS O
/ O
PAGE O
with O
the O
native O
enzyme O
. O

Using O
adenoviral O
transfer O
of O
IkappaBalpha B
( O
IkappaBalpha B
overexpression O
) O
, O
the O
production O
of O
TNF B
- I
alpha I
induced O
by O
whole O
GBS O
was O
inhibited O
by O
only O
20 O
% O
. O

Both O
groups O
were O
subjected O
to O
tests O
of O
delayed O
hypersensitivity O
with O
Candidin O
, O
Trycophytin O
and O
Tuberculin B
. O

Two O
putative O
Rev O
proteins O
with O
apparent O
molecular O
masses O
of O
18 O
and O
16 O
kDa O
were O
expressed O
by O
p2 O
/ O
2 O
and O
p176 O
, O
while O
p20 B
expressed O
only O
a O
16 O
- O
kDa O
species O
. O

TaqMan O
analysis O
of O
gene O
expression O
following O
chronic O
FA O
treatment O
showed O
neither O
a O
decrease O
in O
the O
amount O
of O
leptin B
receptor I
( O
Ob O
- O
R O
) O
mRNA O
, O
nor O
an O
increase O
in O
the O
negative O
regulators O
of O
STAT B
signalling O
, O
SOCS3 O
( O
suppressors O
of O
cytokine O
signalling O
) O
or O
cytokine O
inducible O
sequence O
( O
CIS O
) O
. O

That O
sequence O
strongly O
promoted O
the O
transcription O
of O
the O
promotorless O
chloramphenicol O
acetyltranferase O
( O
CAT B
) O
gene O
in O
cells O
of O
pancreatic O
origin O
( O
AR O
- O
42J O
) O
but O
not O
in O
cells O
of O
non O
- O
pancreatic O
origin O
( O
Rat O
2 O
and O
IEC O
6 O
) O
. O

We O
have O
determined O
the O
nucleotide O
( O
nt O
) O
sequence O
of O
the O
7 O
. O
5 O
- O
kb O
COR O
segment O
that O
encompasses O
a O
cluster O
of O
six O
genes O
( O
CYC1 B
, O
UTR1 O
, O
UTR3 O
, O
OSM1 O
, O
tRNA O
( O
Gly O
) O
and O
RAD7 O
) O
located O
on O
chromosome O
X O
of O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

Coronary O
vasoconstriction O
caused O
by O
endothelin B
- I
1 I
is O
enhanced O
by O
ischemia O
- O
reperfusion O
and O
by O
norepinephrine O
present O
in O
concentrations O
typically O
observed O
after O
neonatal O
cardiopulmonary O
bypass O
. O

We O
have O
therefore O
evaluated O
the O
efficacy O
and O
safety O
of O
doxazosin O
, O
a O
new O
orally O
active O
selective O
alpha B
1 I
blocker O
, O
in O
patients O
with O
systemic O
hypertension O
with O
concomitant O
airflow O
limitation O
. O

Thus O
, O
the O
positive O
effect O
of O
NS1 B
on O
the O
steady O
- O
state O
levels O
of O
P4 O
transcripts O
depends O
on O
the O
amplification O
of O
gene O
copy O
number O
and O
the O
integrity O
of O
the O
terminal O
repeats O
. O

The O
EPO B
levels O
were O
distinctly O
increased O
before O
transfusion O
; O
they O
did O
not O
significantly O
change O
just O
after O
transfusion O
, O
but O
subsequently O
decreased O
. O

This O
dynamic O
response O
strongly O
suggests O
that O
the O
p53 B
and O
Rb B
tumor O
suppressor O
pathways O
are O
intact O
in O
HeLa O
cells O
and O
that O
repression O
of O
HPV O
E6 O
and O
E7 B
mobilizes O
these O
pathways O
in O
an O
orderly O
fashion O
to O
deliver O
growth O
inhibitory O
signals O
to O
the O
cells O
. O

Stable O
expression O
of O
the O
chimeric O
alpha O
i O
( O
54 O
) O
/ O
s O
polypeptide O
in O
Chinese O
hamster O
ovary O
( O
CHO O
) O
cells O
constitutively O
increased O
both O
cAMP O
synthesis O
and O
cAMP B
- I
dependent I
protein I
kinase I
activity O
. O

The O
specific O
interaction O
between O
a O
defined O
structural O
element O
of O
the O
human O
immunodeficiency O
virus O
mRNA O
( O
RRE B
, O
the O
Rev O
response O
element O
) O
and O
the O
virus O
- O
encoded O
protein O
Rev O
has O
been O
implicated O
in O
the O
regulation O
of O
the O
export O
of O
unspliced O
or O
singly O
spliced O
mRNA O
from O
the O
nucleus O
to O
the O
cytoplasm O
. O

Recent O
studies O
have O
demonstrated O
that O
the O
U1 B
snRNP I
is O
recruited O
to O
the O
5 O
' O
splice O
site O
by O
protein O
/ O
protein O
interactions O
involving O
the O
SR O
domains O
of O
the O
U1 O
- O
70K O
protein O
and O
SF2 B
/ O
ASF B
. O

Human O
T O
- O
cell O
leukemia O
virus O
type O
I O
Tax B
activation O
of O
NF B
- I
kappa I
B I
/ O
Rel B
involves O
phosphorylation O
and O
degradation O
of O
I B
kappa I
B I
alpha I
and O
RelA B
( I
p65 I
) I
- O
mediated O
induction O
of O
the O
c O
- O
rel O
gene O
. O

Transient O
overexpression O
of O
c B
- I
Jun I
induced O
tenascin O
- O
C O
expression O
in O
primary O
REF O
and O
in O
FR3T3 O
, O
an O
established O
fibroblast O
cell O
line O
. O

2 O
- O
AP O
induced O
marked O
, O
steady O
rises O
in O
mRNA O
accumulation O
from O
both O
transfected O
and O
chromosomally O
integrated O
HIV O
- O
1 O
constructs O
but O
no O
increases O
from O
an O
endogenous O
gene O
encoding O
gamma O
- O
actin O
or O
glucose B
6 I
- I
phosphate I
dehydrogenase I
. O

The O
serum O
levels O
of O
beta O
- O
human O
chorionic O
gonadotropin O
( O
HCG B
) O
and O
placental O
alkaline O
phosphatase O
( O
PLAP B
) O
were O
not O
elevated O
. O

Gel O
filtration O
, O
sedimentation O
velocity O
, O
and O
immunoprecipitation O
experiments O
revealed O
that O
beta4 O
is O
a O
component O
of O
a O
multisubunit O
complex O
( O
AP B
- I
4 I
) O
that O
also O
contains O
the O
sigma4 O
polypeptide O
and O
two O
additional O
adaptor O
subunit O
homologs O
named O
mu4 O
( O
mu O
- O
ARP2 O
) O
and O
epsilon O
. O

Effects O
of O
long O
- O
term O
parenteral O
nutrition O
on O
gastrin B
release O
in O
dogs O
. O

The O
binding O
of O
transcription O
factor O
AP B
- I
1 I
and O
vitamin B
D I
receptor I
( O
VDR B
) O
to O
the O
composite O
AP O
- O
1 O
plus O
vitamin O
- O
D O
- O
responsive O
promoter O
region O
( O
AP O
- O
1 O
+ O
VDRE O
) O
of O
the O
human O
osteocalcin O
gene O
was O
characterized O
in O
osteocalcin B
- O
producing O
( O
MG O
- O
63 O
) O
and O
non O
- O
producing O
( O
U2 O
- O
Os O
, O
SaOs O
- O
2 O
) O
human O
osteosarcoma O
cell O
lines O
. O

The O
effect O
of O
osmotic O
flow O
on O
the O
distribution O
of O
horseradish B
peroxidase I
within O
the O
intercellular O
spaces O
of O
toad O
bladder O
epithelium O
. O

To O
better O
understand O
the O
role O
of O
Ets B
proteins I
in O
Ras B
transformation O
, O
we O
have O
now O
analyzed O
the O
effects O
of O
stably O
expressing O
a O
variety O
of O
Ets2 O
constructs O
in O
Ras B
- O
transformed O
NIH3T3 O
( O
DT O
) O
cells O
. O

Peroxisome B
proliferator I
- I
activated I
receptors I
( O
PPAR O
) O
modulate O
transcription O
by O
binding O
to O
specific O
peroxisome O
proliferator O
- O
response O
elements O
( O
PPRE O
) O
through O
heterodimerization O
with O
the O
9 O
- O
cis O
retinoic O
acid O
receptor O
( O
RXR B
) O
. O

Mutational O
analyses O
have O
demonstrated O
the O
importance O
of O
sequences O
within O
the O
327 O
bp O
segment O
that O
contain O
a O
putative O
cyclic O
AMP O
responsive O
element O
binding O
protein O
( O
CREB B
) O
binding O
site O
for O
TGF B
- I
beta I
1 I
and O
PMA O
responsiveness O
and O
putative O
PU B
- I
1 I
and O
Sp1 B
binding I
sites I
for O
basal O
promoter O
activity O
. O

Along O
with O
previously O
mapped O
genes O
including O
Ly O
- O
1 O
and O
CD20 B
, O
OSBP O
defines O
a O
new O
conserved O
syntenic O
group O
on O
the O
long O
arm O
of O
chromosome O
11 O
in O
the O
human O
and O
the O
proximal O
end O
of O
chromosome O
19 O
in O
the O
mouse O
. O

In O
a O
gntR O
deletion O
mutant O
, O
the O
expression O
of O
a O
chromosomal O
gntT O
: O
: O
lacZ B
fusion O
is O
both O
high O
and O
constitutive O
, O
confirming O
that O
GntR O
is O
the O
negative O
regulator O
of O
gntT O
. O

Expression O
of O
a O
hybrid O
protein O
containing O
the O
cytoplasmic O
C O
- O
terminal O
half O
of O
UhpB B
fused O
to O
glutathione B
S I
- I
transferase I
( O
GST B
) O
also O
interfered O
with O
Uhp B
signaling O
. O

Taken O
together O
, O
these O
results O
demonstrate O
that O
the O
RP O
, O
like O
the O
20S B
proteasome I
, O
is O
functionally O
and O
structurally O
conserved O
among O
eukaryotes O
and O
indicate O
that O
the O
plant O
RPT O
subunits O
, O
like O
their O
yeast O
counterparts O
, O
have O
non O
- O
redundant O
functions O
. O

In O
contrast O
, O
exogenous O
PTHrP1 O
- O
34 O
and O
1 O
- O
86 O
peptides O
did O
not O
significantly O
affect O
IL B
- I
8 I
production O
; O
moreover O
, O
PTHrP O
- O
neutralizing O
antibodies O
did O
not O
inhibit O
the O
production O
of O
IL B
- I
8 I
by O
transfected O
PTHrP B
. O

( O
ii O
) O
An O
AF O
G B
- I
CSF I
level O
> O
2000 O
pg O
/ O
ml O
is O
a O
strong O
positive O
predictor O
of O
CAM O
. O

Analysis O
with O
additional O
anti O
- O
peptide O
antibodies O
specific O
for O
alpha O
, O
beta O
, O
or O
gamma O
PKC O
indicated O
that O
all O
three O
types O
of O
PKC B
are O
expressed O
in O
JK O
cells O
; O
however O
, O
JKPE O
cells O
lost O
a O
major O
approximately O
82 O
kDa O
immunoreactive O
cytosolic O
protein O
detectable O
with O
anti O
- O
PKC O
alpha O
antibody O
. O

The O
urinary O
protein O
, O
serum O
albumin B
, O
BUN O
and O
SCr O
all O
had O
very O
significant O
improvement O
. O

MEKs O
and O
ERKs B
inhibited O
IL B
- I
6 I
activation O
of O
Stat3 B
harboring O
a O
mutation O
at O
serine O
- O
727 O
, O
the O
major O
site O
for O
serine O
phosphorylation O
, O
similar O
to O
inhibition O
of O
wild O
- O
type O
Stat3 O
, O
and O
inhibited O
Janus B
kinases I
Jak1 B
and O
Jak2 B
upstream O
of O
Stat3 B
in O
the O
Jak B
- O
STAT B
- O
signaling O
pathway O
. O

The O
predicted O
domain O
structures O
of O
FkbB O
and O
FkbC O
are O
analogous O
to O
that O
of O
FkbA O
and O
comprise O
30 O
fatty B
- I
acid I
- I
synthase I
( O
FAS B
) O
- O
like O
domains O
arranged O
in O
6 O
modules O
. O

We O
further O
demonstrate O
that O
the O
Stress B
- I
Activated I
- I
Protein I
- I
Kinase I
( O
SAPK B
) O
target O
sites O
of O
ATF2 O
, O
Thr69 O
and O
Thr71 O
are O
not O
required O
for O
the O
formation O
of O
the O
p300 B
/ O
CBP B
- O
ATF2 O
multiprotein O
complex O
. O

In O
all O
sessions O
under O
IFN B
, O
the O
latency O
of O
the O
P100 O
component O
of O
the O
VEP O
was O
shortened O
as O
compared O
to O
baseline O
conditions O
. O

Analysis O
of O
disassociation O
rates O
indicates O
that O
the O
Grf10 O
- O
Swi5 B
- O
DNA O
complex O
has O
a O
longer O
half O
- O
life O
than O
protein O
- O
DNA O
complexes O
that O
contain O
only O
Swi5 B
or O
Grf10 O
. O

Several O
genes O
or O
transcriptional O
units O
were O
identified O
, O
including O
the O
3 O
' O
end O
of O
ribosomal O
s6 O
kinase O
( O
Rsk3 B
) O
; O
two O
apparently O
intronless O
and O
ORF O
- O
less O
genes O
; O
and O
Gpr31 O
, O
an O
intronless O
, O
putative O
G B
- I
protein I
coupled I
receptor I
. O

Interaction O
of O
HRI B
with O
Hsc70 B
was O
required O
for O
the O
transformation O
of O
HRI B
, O
as O
the O
Hsc70 B
antagonist O
clofibric O
acid O
inhibited O
the O
folding O
of O
HRI B
into O
a O
mature O
- O
competent O
conformation O
. O

Evidence O
from O
the O
structure O
of O
a O
number O
of O
cDNA O
clones O
, O
as O
well O
as O
S1 B
nuclease I
and O
primer O
extension O
studies O
supports O
the O
hypothesis O
that O
the O
PTHrP O
gene O
contains O
at O
least O
two O
mRNA O
transcription O
start O
points O
that O
define O
two O
putative O
regulatory O
domains O
. O

Toward O
this O
end O
, O
we O
prepared O
synthetic O
proteins O
with O
either O
the O
catalytic O
domain O
of O
FAP O
- O
1 O
( O
C O
- O
terminal O
399 O
amino O
acids O
) O
or O
its O
inactive O
form O
( O
Cys2408 O
- O
- O
> O
Ser O
) O
fused O
to O
glutathione B
- I
S I
- I
transferase I
( O
GST B
) O
. O

TGF B
beta I
1 I
expression O
is O
largely O
governed O
by O
three O
AP O
- O
1 O
binding O
sites O
located O
in O
two O
different O
promoters O
of O
this O
gene O
. O

Structure O
and O
expression O
of O
the O
alternative O
sigma B
factor I
, O
RpoN B
, O
in O
Rhodobacter O
capsulatus O
; O
physiological O
relevance O
of O
an O
autoactivated O
nifU2 O
- O
rpoN B
superoperon O
. O

Here O
we O
focused O
on O
the O
role O
of O
the O
5 O
' O
proximal O
regulatory O
cassette O
( O
- O
190 O
; O
+ O
53 O
bp O
) O
of O
the O
rat O
enkephalin O
( O
rENK O
) O
gene O
in O
the O
developmental O
regulation O
of O
the O
enkephalin B
phenotype O
. O

The O
transcription O
factor O
Jun B
( O
c B
- I
Jun I
) O
functions O
as O
a O
recipient O
of O
extracellular O
growth O
signals O
and O
converts O
them O
into O
patterns O
of O
gene O
expression O
. O

Phd B
antibody O
- O
immunoreactive O
peptides O
are O
seen O
in O
light O
- O
adapted O
mouse O
retinal O
cytosolic O
and O
nuclear O
extracts O
. O

We O
obtained O
the O
prevalence O
of O
IgG B
antibodies I
against O
Trypanosoma O
cruzi O
among O
1076 O
blood O
donors O
at O
the O
Instituto O
Nacional O
de O
Cardiologia O
" O
Ignacio O
Chavez O
" O
in O
Mexico O
City O
. O

Our O
observations O
suggest O
that O
members O
of O
the O
HMG O
- O
I O
family O
play O
an O
important O
role O
in O
SRF B
- O
dependent O
transcription O
and O
that O
their O
effect O
is O
mediated O
primarily O
by O
a O
protein O
- O
protein O
interaction O
. O

Ligand O
- O
independent O
activation O
of O
platelet B
- I
derived I
growth I
factor I
receptor I
is O
a O
necessary O
intermediate O
in O
lysophosphatidic O
, O
acid O
- O
stimulated O
mitogenic O
activity O
in O
L O
cells O
. O

A O
suspected O
hypothalamic O
dysfunction O
and O
a O
slightly O
impaired O
pituitary O
function O
manifested O
as O
GH B
deficiency O
were O
their O
common O
endocrinological O
features O
. O

The O
NarX O
and O
NarQ O
proteins O
with O
amino O
acid O
substitutions O
at O
the O
first O
conserved O
histidine O
position O
were O
also O
unable O
to O
dephosphorylate O
NarL B
- O
phosphate O
in O
vitro O
. O

Using O
immunogold O
electron O
microscopy O
, O
we O
found O
that O
p58 B
/ O
p45 B
and O
p54 B
are O
localized O
on O
both O
sides O
of O
the O
nuclear O
pore O
complex O
, O
like O
p62 B
. O

Our O
results O
indicate O
that O
the O
minimal O
requirements O
for O
induction O
of O
PEPCK B
by O
PKA B
and O
inhibition O
by O
insulin B
include O
: O
1 O
) O
the O
CREB O
activation O
domain O
, O
2 O
) O
the O
PEPCK O
TATA O
sequence O
, O
and O
3 O
) O
insulin B
- O
responsive O
hepatoma O
cells O
. O

To O
get O
further O
insights O
into O
the O
molecular O
mechanisms O
that O
control O
tal B
- I
1 I
expression O
, O
we O
have O
isolated O
5 O
' O
sequences O
of O
the O
murine O
gene O
and O
compared O
them O
to O
their O
human O
counterparts O
. O

Although O
the O
Src O
tyrosine O
kinase O
induces O
constitutive O
Stat3 B
phosphorylation O
on O
tyrosine O
, O
activation O
of O
Stat3 B
- O
mediated O
gene O
regulation O
requires O
both O
tyrosine O
and O
serine O
phosphorylation O
of O
Stat3 B
. O

The O
recognition O
specificity O
of O
the O
p55 B
PDZ O
domain O
appears O
to O
be O
unique O
, O
since O
the O
three O
PDZ O
domains O
of O
hDlg O
( O
human O
lymphocyte O
homologue O
of O
the O
Drosophila O
discs O
large O
tumor O
suppressor O
) O
do O
not O
bind O
the O
cytoplasmic O
domain O
of O
glycophorin O
C O
. O

The O
Cdk2 B
- O
cyclin B
- I
D1 I
complex O
did O
not O
phosphorylate O
any O
tested O
substrates O
, O
such O
as O
H1 O
histone O
, O
pRB B
, O
SV40 O
large O
T O
antigen O
, O
p53 B
, O
E2F B
- I
1 I
or O
a O
preparation O
of O
nuclear O
proteins O
from O
HeLa O
cells O
; O
in O
contrast O
, O
Cdk2 B
- O
cyclin B
- I
E I
and O
Cdk2 B
- O
cyclin B
- I
A I
phosphorylated O
these O
proteins O
. O

These O
data O
further O
define O
a O
role O
for O
TRADD B
and O
TRAF2 B
in O
JNK B
activation O
and O
confirm O
that O
LMP1 B
utilizes O
signalling O
mechanisms O
used O
by O
the O
TNF O
receptor O
/ O
CD40 B
family O
to O
elicit O
its O
pleiotropic O
activities O
. O

These O
results O
demonstrate O
the O
existence O
of O
different O
PI O
3 O
- O
kinase O
isoforms O
and O
define O
a O
family O
of O
genes O
encoding O
distinct O
PI O
3 O
- O
kinase O
catalytic O
subunits O
that O
can O
associate O
with O
p85 B
. O

The O
immune O
system O
is O
closely O
integrated O
with O
the O
neuroendocrine O
system O
, O
and O
infection O
- O
induced O
increases O
in O
cytokines O
such O
as O
IL B
- I
1 I
, O
IL B
- I
6 I
and O
TNF B
have O
numerous O
effects O
on O
the O
central O
nervous O
system O
. O

Here O
we O
localize O
a O
transferable O
40 O
- O
amino O
acid O
region O
within O
the O
LBDs O
of O
RXR B
, O
RAR B
, O
TR B
, O
and O
chicken B
ovalbumin I
upstream I
promoter I
transcription I
factor I
that O
is O
critical O
for O
determining O
identity O
in O
the O
heterodimeric O
interaction O
and O
for O
high O
- O
affinity O
DNA O
binding O
. O

Null O
mutations O
in O
daf O
- O
3 O
suppress O
mutations O
in O
genes O
encoding O
this O
TGF B
- I
beta I
signal O
, O
its O
receptors O
, O
and O
associated O
Smad O
signal O
transduction O
proteins O
. O

In O
vitro O
interaction O
studies O
, O
using O
proteins O
fused O
to O
glutathione B
- I
S I
- I
transferase I
, O
showed O
that O
RBP B
- I
J I
kappa I
and O
Su O
( O
H O
) O
bind O
directly O
to O
the O
RAM23 O
regions O
of O
mouse O
Notch1 O
and O
Drosophila O
Notch O
, O
respectively O
. O

Therefore O
, O
we O
conclude O
that O
DnaA O
may O
contact O
the O
beta O
subunit O
of O
RNA B
polymerase I
during O
activation O
of O
the O
pR O
promoter O
. O

The O
presence O
of O
truncated O
receptor O
isoforms O
in O
diverse O
species O
suggests O
that O
these O
proteins O
may O
have O
important O
functional O
roles O
in O
regulating O
EGFR B
activity O
. O

It O
is O
present O
in O
the O
nucleus O
of O
the O
cells O
in O
which O
it O
is O
expressed O
and O
can O
phosphorylate O
and O
activate O
the O
cyclic B
AMP I
response I
element I
binding I
proteins I
CREB B
and O
CREM O
tau O
in O
a O
manner O
analogous O
to O
protein B
kinase I
A I
. O

These O
results O
demonstrate O
that O
a O
diverse O
set O
of O
carboxyl O
- O
terminal O
sequence O
motifs O
and O
posttranslational O
modifications O
lead O
to O
functional O
Ras B
proteins I
in O
yeast O
. O

Further O
, O
Ser O
/ O
Thr O
phosphorylation O
of O
downstream O
molecules O
Akt B
and O
p70 B
S6 I
kinase I
was O
inhibited O
. O

We O
conclude O
that O
c B
- I
Myb I
regulates O
the O
RAG O
- O
2 O
promoter O
in O
T O
cells O
by O
binding O
to O
this O
consensus O
c O
- O
Myb O
binding O
site O
. O

Ras O
- O
and O
ultra O
- O
violet O
- O
responsive O
protein O
kinases O
that O
phosphorylate O
c B
- I
Jun I
on O
serine O
residues O
at O
positions O
63 O
and O
73 O
and O
stimulate O
its O
transcriptional O
activity O
have O
been O
identified O
. O

At O
temperatures O
permissive O
for O
transformation O
, O
6m2 O
cells O
contain O
P58gag O
produced O
from O
the O
4 O
. O
0 O
- O
kilobase O
( O
kb O
) O
viral O
RNA O
genome O
and O
P85gag O
- O
mos B
translated O
from O
a O
3 O
. O
5 O
- O
kb O
spliced O
mRNA O
. O

ENV B
also O
was O
secreted O
from O
P O
. O
pastoris O
using O
the O
S O
. O
cerevisiae O
alpha O
- O
factor O
prepro O
secretion O
leader O
and O
the O
S O
. O
cerevisiae O
invertase O
signal O
sequence O
. O

Functional O
rearranged O
antibody O
genes O
were O
detected O
with O
JH B
and O
VH O
heavy O
chain O
probes O
and O
with O
Jk O
and O
Vk O
light O
chain O
probes O
. O

During O
both O
encephalopathy O
episodes O
, O
CSF O
protein O
and O
immunoglobulin B
G I
( O
IgG B
) O
levels O
were O
elevated O
without O
an O
increased O
IgG B
index O
or O
IgG B
synthesis O
rate O
. O

In O
vivo O
association O
between O
Shb B
- O
SH3 B
domain O
proteins O
v B
- I
Src I
and O
Eps8 O
was O
detected O
by O
coimmunoprecipitation O
. O

IE2 B
- O
IE2 B
interactions O
were O
mapped O
to O
a O
domain O
containing O
a O
putative O
helix O
- O
turn O
- O
helix O
motif O
located O
near O
the O
C O
terminus O
of O
IE2 B
, O
between O
amino O
acids O
456 O
and O
539 O
. O

In O
addition O
, O
another O
derivative O
of O
pCMVJS21 O
( O
pCMVJS21DeltaGP O
) O
in O
which O
the O
gag B
, O
pol B
( O
and O
orf O
- O
x O
) O
coding O
sequences O
were O
deleted O
also O
gave O
transformed O
foci O
. O

In O
contrast O
, O
over O
- O
expression O
of O
RAR B
beta I
only O
poorly O
restored O
differentiation O
, O
although O
it O
could O
replace O
RAR O
gamma O
for O
the O
activation O
of O
target O
genes O
. O

At O
Cabras O
( O
Oristano O
) O
, O
a O
town O
characterized O
by O
a O
high O
incidence O
of O
thalassaemia O
and O
G6PD B
deficiency O
less O
than O
half O
the O
people O
between O
18 O
and O
35 O
have O
a O
fair O
knowledge O
of O
genetic O
diseases O
and O
of O
their O
prevention O
. O

We O
found O
that O
PML B
was O
expressed O
at O
a O
lower O
level O
in O
S O
, O
G2 O
, O
and O
M O
phases O
and O
at O
a O
significantly O
higher O
level O
in O
G1 O
phase O
. O

The O
localization O
of O
ZAP B
- I
70 I
to O
the O
cell O
cortex O
is O
, O
therefore O
, O
regulated O
by O
the O
activity O
of O
SRC B
- I
family I
kinases I
, O
independently O
of O
their O
ability O
to O
phosphorylate O
immunoreceptor O
tyrosine O
- O
based O
activation O
motifs O
of O
the O
TCR B
. O

However O
, O
we O
could O
not O
find O
the O
homologous O
regions O
with O
guanine B
nucleotide I
exchange I
factors I
or O
GTPase B
- I
activating I
proteins I
in O
the O
c O
- O
cbl O
gene O
. O

Interleukin B
- I
8 I
( O
IL B
- I
8 I
) O
is O
a O
potent O
inflammatory O
mediator O
that O
belongs O
to O
the O
family O
of O
C O
- O
X O
- O
C O
chemokines O
. O

SL1 B
trans O
- O
splicing O
specified O
by O
AU O
- O
rich O
synthetic O
RNA O
inserted O
at O
the O
5 O
' O
end O
of O
Caenorhabditis O
elegans O
pre O
- O
mRNA O
. O

The O
unphosphorylated O
form O
of O
RNA B
polymerase I
II I
is O
designated O
IIA O
, O
whereas O
the O
phosphorylated O
form O
is O
designated O
IIO O
. O

Cdk2 B
formed O
a O
complex O
with O
cyclin B
D1 I
in O
this O
system O
. O

Five O
cell O
strains O
of O
human O
dermal O
fibroblasts O
were O
each O
treated O
with O
three O
samples O
of O
burn O
blister O
fluid O
and O
the O
effect O
compared O
with O
the O
rate O
of O
contraction O
of O
free O
floating O
fibroblast O
populated O
collagen B
lattices O
( O
FPCL O
) O
. O

Deletion O
analysis O
of O
rOC O
promoter O
- O
chloramphenicol B
acetyltransferase I
constructs O
demonstrates O
that O
an O
AML O
- O
1 O
- O
binding O
sequence O
within O
the O
proximal O
promoter O
( O
- O
138 O
to O
- O
130 O
nt O
) O
contributes O
to O
75 O
% O
of O
the O
level O
of O
osteocalcin O
gene O
expression O
. O

Recent O
studies O
using O
isolated O
rat O
adipocytes O
and O
chemically O
synthesized O
PIG O
compounds O
point O
to O
IRS1 O
/ O
3 O
tyrosine O
phosphorylation O
by O
p59Lyn O
kinase O
as O
the O
site O
of O
cross O
- O
talk O
, O
the O
negative O
regulation O
of O
which O
by O
interaction O
with O
caveolin B
is O
apparently O
abrogated O
by O
PIG O
. O

METHODS O
: O
rHb1 O
. O
1 O
or O
human B
serum I
albumin I
was O
administered O
intravenously O
to O
fasting O
male O
volunteers O
. O

In O
addition O
, O
a O
noncanonical O
C B
/ I
EBP I
- I
binding I
site I
within O
the O
Gadd45gamma O
promoter O
where O
C B
/ I
EBPbeta I
and O
C B
/ I
EBPdelta I
could O
bind O
, O
was O
identified O
by O
electrophoretic O
mobility O
shift O
assay O
( O
EMSA O
) O
and O
reporter O
gene O
analysis O
. O

Hematopoietic B
growth I
factors I
are O
being O
used O
to O
accelerate O
the O
recovery O
of O
myelopoiesis O
following O
high O
- O
dose O
chemotherapy O
in O
cancer O
patients O
. O

The O
remainder O
( O
18 O
. O
4 O
% O
) O
was O
with O
IgA B
nephropathy O
, O
which O
was O
histologically O
mild O
. O

In O
addition O
serum B
IgE I
concentrations O
were O
not O
statistically O
different O
. O

No O
such O
benefits O
were O
seen O
for O
children O
with O
CD4 B
+ I
counts O
below O
0 O
. O
2 O
x O
10 O
( O
9 O
) O
per O
liter O
at O
entry O
. O

Two O
mammalian O
enzymes O
, O
the O
haem O
- O
controlled O
repressor O
( O
HCR O
) O
and O
the O
double O
- O
stranded O
RNA O
- O
activated O
inhibitor O
( O
dsI O
) O
, O
phosphorylate O
Ser O
- O
51 O
of O
the O
alpha O
subunit O
, O
thereby O
inhibiting O
the O
exchange O
of O
bound O
nucleotides O
on O
, O
and O
thus O
the O
recycling O
of O
, O
eIF B
- I
2 I
. O

Polypyrimidine O
and O
ssDNA O
binding O
by O
the O
isolated O
VH O
domain O
of O
immunization O
- O
induced O
anti O
- O
Z O
- O
DNA O
Ab O
resembles O
the O
activity O
of O
natural O
autoantibodies O
and O
suggests O
that O
VH B
- O
dependent O
binding O
to O
a O
ligand O
mimicked O
by O
polypyrimidines O
may O
play O
a O
role O
in O
B O
cell O
selection O
before O
immunization O
with O
Z O
- O
DNA O
. O

We O
have O
been O
studying O
the O
interaction O
of O
the O
oncogenic O
human O
polyomavirus O
BK O
( O
BKV O
) O
with O
the O
tumor O
- O
suppressor O
protein O
p53 O
to O
understand O
the O
biology O
of O
this O
virus O
as O
well O
as O
to O
understand O
the O
basic O
mechanisms O
of O
p53 B
transactivation O
. O

These O
results O
suggest O
that O
, O
for O
the O
HML B
ARS O
cluster O
( O
ARS303 O
, O
ARS320 O
, O
and O
ARS302 O
) O
, O
inactivity O
of O
origins O
is O
independent O
of O
local O
transcriptional O
silencing O
, O
even O
though O
origins O
and O
silencers O
share O
key O
cis O
- O
and O
trans O
- O
acting O
components O
. O

Furthermore O
, O
deletion O
and O
mutation O
analyses O
of O
the O
VCAM O
- O
1 O
promoter O
performed O
with O
chloramphenicol O
acetyltransferase O
constructs O
revealed O
that O
Tax B
was O
trans O
activating O
the O
VCAM O
- O
1 O
promoter O
via O
two O
NF O
- O
kappaB O
sites O
present O
at O
bp O
- O
72 O
and O
- O
57 O
in O
the O
VCAM O
- O
1 O
gene O
promoter O
, O
with O
both O
of O
them O
being O
required O
for O
the O
Tax B
- O
induced O
expression O
of O
this O
adhesion O
molecule O
. O

In O
this O
study O
we O
provide O
evidence O
that O
B B
- I
Myb I
is O
a O
direct O
physiological O
target O
for O
cyclin B
A I
/ O
Cdk2 B
. O

During O
treatment O
, O
the O
phosphorylation O
state O
of O
Rb B
shifted O
to O
a O
hypophosphorylated O
form O
. O

mRNA O
for O
the O
HPV O
E6 B
/ O
E7 B
genes O
decreased O
; O
however O
, O
significant O
changes O
in O
the O
E7 O
protein O
were O
not O
observed O
, O
while O
increased O
levels O
of O
Rb B
immunoprecipitated O
with O
anti O
- O
E7 O
antibodies O
were O
observed O
. O

Acquired O
factor B
VIII I
inhibitor O
in O
non O
- O
hemophilic O
patients O

Thus O
, O
we O
have O
identified O
an O
activation O
target O
of O
a O
human O
activator O
, O
Oct B
- I
1 I
, O
within O
its O
cognate O
basal O
transcription O
complex O
. O

Transcript O
analysis O
reveals O
that O
lethal O
B O
block O
substitutions O
reduce O
U6 B
RNA I
synthesis O
at O
least O
10 O
- O
fold O
in O
vivo O
and O
20 O
- O
fold O
in O
vitro O
. O

The O
two O
- O
hybrid O
assay O
was O
then O
performed O
using O
full O
- O
length O
genes O
of O
CI B
, O
HC O
- O
Pro O
, O
P1 B
, O
P3 B
, O
and O
CP B
, O
but O
no O
heterologous O
interactions O
were O
detected O
. O

CPDs O
at O
these O
three O
sites O
may O
partially O
displace O
TFIIIA B
, O
thereby O
enabling O
rapid O
repair O
. O

axl O
, O
a O
transforming O
gene O
isolated O
from O
primary O
human O
myeloid O
leukemia O
cells O
, O
encodes O
a O
novel O
receptor B
tyrosine I
kinase I
. O

Thyrotropin B
- I
releasing I
hormone I
- O
induced O
contraction O
of O
urethral O
and O
vaginal O
muscle O
. O

NF B
- I
kappaB I
is O
involved O
in O
the O
regulation O
of O
CD154 O
( O
CD40 O
ligand O
) O
expression O
in O
primary O
human O
T O
cells O
. O

Moreover O
, O
promoters O
containing O
a O
TATA O
box O
in O
the O
absence O
of O
Sp1 B
sites I
or O
Sp1 B
sites I
in O
the O
absence O
of O
a O
TATA O
box O
were O
equally O
inducible O
in O
vitro O
, O
as O
was O
an O
RNA O
polymerase O
III O
promoter O
. O

NF B
kappa I
B I
was O
activated O
to O
a O
much O
greater O
extent O
by O
roscovitine O
in O
the O
WT O
cells O
than O
in O
Y8 O
cells O
. O

Plasma B
renin I
activity O
does O
not O
predict O
the O
antihypertensive O
efficacy O
of O
chlorthalidone O
. O

The O
yeast O
gene O
that O
encodes O
eIF B
- I
5 I
, O
designated O
TIF5 O
, O
has O
been O
isolated O
and O
expressed O
in O
Escherichia O
coli O
to O
yield O
a O
catalytically O
active O
eIF B
- I
5 I
protein I
. O

In O
conclusion O
, O
IgM B
class O
CIC O
is O
the O
predominant O
CIC O
in O
acute O
hepatitis O
A O
and O
correlated O
with O
disease O
activity O
. O

The O
activity O
of O
the O
coat O
protein O
promoter O
of O
chloris O
striate O
mosaic O
virus O
is O
enhanced O
by O
its O
own O
and O
C1 B
- O
C2 B
gene O
products O
. O

Prostate B
specific I
antigen I
shows O
the O
metastatic O
cases O
better O
[ O
correction O
of O
worse O
] O
than O
prostatic B
acid I
phosphatase I
. O

CONCLUSIONS O
: O
XCoe2 O
may O
play O
a O
pivotal O
role O
in O
the O
transcriptional O
cascade O
that O
specifies O
primary O
neurons O
in O
Xenopus O
embryos O
: O
by O
maintaining O
Delta O
- O
Notch B
signalling O
, O
XCoe2 O
stabilises O
the O
higher O
neural O
potential O
of O
selected O
progenitor O
cells O
that O
express O
X O
- O
ngnr O
- O
1 O
, O
ensuring O
the O
transition O
between O
neural O
competence O
and O
irreversible O
commitment O
to O
a O
neural O
fate O
; O
and O
it O
promotes O
neuronal O
differentiation O
by O
activating O
XNeuroD O
expression O
, O
directly O
or O
indirectly O
. O

In O
contrast O
, O
an O
amino O
- O
terminal O
fragment O
containing O
the O
C O
/ O
H1 O
domain O
was O
sufficient O
for O
coactivation O
of O
Zta B
transcription O
and O
viral O
reactivation O
function O
. O

